data_1v5a_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1v5a _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.524 ' CB ' HG13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.314 0.578 . . . . 0.0 110.109 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.585 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 31.2 p -42.33 146.33 0.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 110.043 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.464 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 92.9 mt -89.92 128.52 49.73 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.411 -0.805 . . . . 0.0 110.519 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 5' ' ' SER . 48.2 Cg_endo -74.35 141.5 28.81 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.904 1.476 . . . . 0.0 109.512 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 87.9 p -40.11 159.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.323 -0.861 . . . . 0.0 110.764 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.55 15.6 56.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.81 163.35 22.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.099 -1.236 . . . . 0.0 109.837 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.0 91.7 7.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.053 . . . . 0.0 110.614 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 26.7 p -81.34 90.9 6.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.022 -1.048 . . . . 0.0 109.768 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.5 71.19 1.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 110.004 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 175.43 65.7 0.06 OUTLIER Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 11' ' ' GLY . 74.7 t -39.28 -28.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.675 -0.897 . . . . 0.0 110.311 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.471 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.9 t -89.78 38.64 0.92 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 109.605 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' A' ' 17' ' ' PRO . 29.7 pt20 -87.24 -178.55 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 0.0 110.016 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.459 ' O ' HD11 ' A' ' 16' ' ' ILE . 10.5 mmtt -71.31 -43.47 67.0 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.402 -0.811 . . . . 0.0 109.743 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.524 HG13 ' CB ' ' A' ' 1' ' ' ARG . 21.1 mm -140.63 139.47 20.24 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.547 -0.72 . . . . 0.0 110.496 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.457 ' HA ' ' NE2' ' A' ' 14' ' ' GLN . 47.0 Cg_endo -74.42 -176.35 2.69 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.132 1.596 . . . . 0.0 111.05 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 7.5 t -66.82 122.08 16.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.589 -0.694 . . . . 0.0 110.397 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.585 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -44.17 -31.27 0.93 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.413 ' N ' ' C ' ' A' ' 18' ' ' CYS . . . -102.5 -107.3 3.1 Favored Glycine 0 C--N 1.296 -1.686 0 N-CA-C 106.062 -2.815 . . . . 0.0 106.062 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.2 p -142.7 123.69 14.42 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.084 -1.245 . . . . 0.0 109.732 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 18' ' ' CYS . 4.4 t -78.15 117.94 19.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.167 -0.958 . . . . 0.0 110.538 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.92 142.29 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.414 -0.804 . . . . 0.0 109.635 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 6.5 tpm_? 58.51 36.04 25.01 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.116 0.96 . . . . 0.0 110.183 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 59.86 28.2 65.54 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -140.47 116.43 10.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.692 -0.887 . . . . 0.0 110.953 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 5' ' ' SER . 0.3 OUTLIER -53.52 113.43 1.17 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.287 -0.883 . . . . 0.0 109.223 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.235 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.483 ' HB2' HD12 ' A' ' 16' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.286 0.565 . . . . 0.0 110.252 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.62 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 14.8 p -162.52 143.21 9.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 110.401 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.437 ' CD2' ' HE3' ' A' ' 7' ' ' LYS . 11.2 mt -80.89 135.23 52.07 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.531 -0.731 . . . . 0.0 110.597 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 5' ' ' SER . 47.4 Cg_endo -76.09 149.74 32.78 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.016 1.534 . . . . 0.0 110.126 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 60.3 p -40.58 157.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.454 -0.779 . . . . 0.0 110.687 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.443 ' O ' ' HG2' ' A' ' 7' ' ' LYS . . . 87.57 20.09 52.45 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 26' ' ' LYS . 7.8 mmmt -141.39 -172.16 3.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -1.093 . . . . 0.0 109.785 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.81 166.47 23.31 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.755 -0.778 . . . . 0.0 108.992 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 26' ' ' LYS . 8.4 p -147.37 45.41 1.14 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.786 -1.196 . . . . 0.0 111.083 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 14' ' ' GLN . . . -103.84 61.72 0.75 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.144 -0.972 . . . . 0.0 109.831 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.96 -18.22 11.25 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 13' ' ' THR . 27.6 m -53.9 -40.7 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -1.201 . . . . 0.0 109.478 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.422 ' N ' HG22 ' A' ' 12' ' ' VAL . 8.9 t -119.2 9.33 11.7 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.727 -0.608 . . . . 0.0 109.73 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -104.85 162.09 13.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.363 -0.836 . . . . 0.0 110.172 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.523 ' CG ' HG12 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -86.1 -15.97 39.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.3 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.537 ' CG2' ' HA ' ' A' ' 2' ' ' CYS . 49.1 mm -140.04 117.67 8.34 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.74 . . . . 0.0 109.74 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.1 170.35 19.85 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.867 1.456 . . . . 0.0 111.214 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 21' ' ' SER . 1.8 t -69.04 118.72 12.3 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.79 0.805 . . . . 0.0 110.118 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.62 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -45.15 -33.71 2.36 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.28 -111.67 2.32 Favored Glycine 0 C--N 1.292 -1.888 0 N-CA-C 106.321 -2.712 . . . . 0.0 106.321 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.522 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 29.7 m -141.9 173.26 11.68 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.955 -1.321 . . . . 0.0 109.889 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 48.3 t -95.82 106.96 19.16 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.134 -0.979 . . . . 0.0 110.704 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 26' ' ' LYS . 1.8 m -123.82 123.6 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.338 -0.851 . . . . 0.0 109.881 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.52 30.86 12.73 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 122.363 1.077 . . . . 0.0 109.283 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.422 ' C ' ' SG ' ' A' ' 9' ' ' CYS . . . 69.19 18.5 73.15 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 7' ' ' LYS . 5.9 ttmt -141.45 129.36 21.85 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.368 -1.078 . . . . 0.0 111.825 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 5' ' ' SER . 20.1 t -45.84 112.99 0.53 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.422 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.511 ' OXT' ' CB ' ' A' ' 5' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.505 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.221 0.534 . . . . 0.0 110.149 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.57 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 22.4 p -176.96 145.67 0.49 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 0.0 110.331 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 1.8 mp -87.43 131.77 43.03 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.557 -0.715 . . . . 0.0 110.498 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 5' ' ' SER . 45.7 Cg_endo -72.6 139.81 31.74 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.916 1.482 . . . . 0.0 109.301 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 1.8 m -39.32 161.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -0.834 . . . . 0.0 110.811 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.52 17.36 52.8 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' ALA . 7.9 mttp -149.58 146.57 27.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -1.208 . . . . 0.0 109.958 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -43.2 165.64 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.299 -0.875 . . . . 0.0 109.995 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.478 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 6.6 p -141.55 62.48 1.45 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 0.0 110.507 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 14' ' ' GLN . . . -86.41 57.2 4.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.868 -1.145 . . . . 0.0 110.134 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 14' ' ' GLN . . . -71.98 -11.05 74.02 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -52.85 -33.69 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.143 . . . . 0.0 109.57 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -126.88 -26.26 3.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.589 -0.694 . . . . 0.0 109.764 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.488 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 8.0 tt0 -63.9 164.13 10.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 0.0 109.82 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.406 ' N ' ' CG ' ' A' ' 14' ' ' GLN . 10.4 mmtp -85.7 -38.91 17.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.43 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.545 ' CG2' ' HA ' ' A' ' 2' ' ' CYS . 2.1 mp -108.21 108.03 60.78 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 110.258 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.441 ' O ' HD11 ' A' ' 3' ' ' LEU . 50.6 Cg_endo -76.75 175.3 11.55 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.062 1.559 . . . . 0.0 111.363 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 21' ' ' SER . 2.0 t -62.74 119.41 9.25 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.775 0.798 . . . . 0.0 110.961 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.57 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -43.85 -35.36 1.91 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.96 -112.4 1.88 Allowed Glycine 0 C--N 1.29 -2.006 0 N-CA-C 106.187 -2.765 . . . . 0.0 106.187 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.509 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -142.37 161.64 37.51 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.117 -1.225 . . . . 0.0 109.821 177.517 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 45.9 t -94.04 88.94 5.85 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.123 -0.985 . . . . 0.0 110.337 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 28' ' ' SER . 1.6 m -111.03 131.31 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.419 -0.8 . . . . 0.0 109.754 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER 64.56 33.05 11.14 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.222 1.01 . . . . 0.0 109.441 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.29 21.82 64.66 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.53 142.11 35.24 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.379 -1.071 . . . . 0.0 111.318 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 5' ' ' SER . 49.9 t -67.92 94.45 0.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.755 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.49 ' HB2' HG21 ' A' ' 23' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.097 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.426 ' HA ' ' CD1' ' A' ' 16' ' ' ILE . 4.2 ptp180 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.268 0.556 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.54 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 14.1 p -164.08 150.31 11.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.327 -0.858 . . . . 0.0 110.248 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.434 ' HG ' ' CG2' ' A' ' 16' ' ' ILE . 19.0 mt -97.84 137.0 20.92 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.463 -0.773 . . . . 0.0 110.171 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.477 ' O ' ' O ' ' A' ' 5' ' ' SER . 46.0 Cg_endo -72.45 135.15 23.83 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 O-C-N 124.08 1.568 . . . . 0.0 109.061 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.529 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 10.0 m -39.68 162.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.455 -0.778 . . . . 0.0 110.474 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.22 17.49 50.25 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -150.9 147.45 27.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.472 -1.016 . . . . 0.0 109.552 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -40.52 160.72 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.433 -0.792 . . . . 0.0 110.155 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 6.6 p -133.77 65.7 1.57 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.196 -0.94 . . . . 0.0 111.052 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.481 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -90.24 61.33 5.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.057 -1.027 . . . . 0.0 109.463 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.511 ' HA2' ' HG2' ' A' ' 14' ' ' GLN . . . -77.36 -10.2 86.38 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.5 t -80.4 -13.53 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.041 -1.27 . . . . 0.0 110.302 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.8 -17.59 2.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.159 -0.963 . . . . 0.0 111.278 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.511 ' HG2' ' HA2' ' A' ' 11' ' ' GLY . 14.7 pt20 -98.1 177.59 5.36 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.864 -1.148 . . . . 0.0 110.377 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.447 ' HG3' HG12 ' A' ' 16' ' ' ILE . 4.6 ptmt -88.47 -28.27 20.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.868 . . . . 0.0 110.608 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.447 HG12 ' HG3' ' A' ' 15' ' ' LYS . 32.5 mm -102.66 103.89 35.22 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 0.0 110.573 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.409 ' HD2' ' O ' ' A' ' 1' ' ' ARG . 50.6 Cg_endo -76.61 171.99 17.02 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.918 1.483 . . . . 0.0 110.228 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 21' ' ' SER . 29.8 t -72.22 116.55 12.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.248 -0.907 . . . . 0.0 110.109 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.54 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -46.53 -33.61 4.2 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.87 -110.34 2.71 Favored Glycine 0 C--N 1.292 -1.909 0 N-CA-C 106.204 -2.758 . . . . 0.0 106.204 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.458 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 1.2 m -141.98 164.98 28.7 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.042 -1.269 . . . . 0.0 109.42 177.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 54.1 t -99.8 92.68 5.42 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.713 -1.242 . . . . 0.0 110.722 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.443 HG21 ' HB3' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.27 135.0 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.292 -0.88 . . . . 0.0 110.402 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.91 33.79 20.78 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 122.067 0.937 . . . . 0.0 110.601 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.61 26.44 74.47 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.426 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 1.9 ttmm -141.52 143.65 33.89 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.173 -1.192 . . . . 0.0 111.075 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 5' ' ' SER . 23.9 t -77.22 111.38 12.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 109.195 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.443 ' HB3' HG21 ' A' ' 23' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.268 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.454 ' O ' HG22 ' A' ' 16' ' ' ILE . 8.1 mtm180 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.27 0.557 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.603 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 29.3 p -41.66 148.09 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 110.422 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 16' ' ' ILE . 0.5 OUTLIER -96.78 135.97 21.91 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.0 110.378 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 5' ' ' SER . 47.3 Cg_endo -74.85 149.53 37.6 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.964 1.507 . . . . 0.0 110.021 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 2.9 m -39.62 161.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.372 -0.83 . . . . 0.0 110.315 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.54 13.84 59.22 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -125.55 162.33 25.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -1.151 . . . . 0.0 109.81 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.21 98.72 11.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.001 -1.062 . . . . 0.0 111.291 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 29.1 p -85.91 95.11 9.36 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.134 -0.978 . . . . 0.0 108.612 178.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -107.22 68.16 0.72 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.112 -0.993 . . . . 0.0 110.617 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.49 ' O ' ' C ' ' A' ' 12' ' ' VAL . . . 158.7 65.4 0.01 OUTLIER Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.49 ' C ' ' O ' ' A' ' 11' ' ' GLY . 1.7 m -36.6 -33.41 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.785 -0.833 . . . . 0.0 109.896 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.9 t -88.46 42.73 1.09 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.448 -0.783 . . . . 0.0 109.103 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -91.46 154.87 18.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.507 -0.746 . . . . 0.0 110.121 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt -65.38 -35.88 82.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 108.865 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.47 HG23 ' HA ' ' A' ' 2' ' ' CYS . 5.9 mm -125.17 82.93 61.37 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.34 178.7 6.67 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 124.128 1.594 . . . . 0.0 111.332 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 21' ' ' SER . 3.9 t -61.79 120.02 9.89 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.556 0.693 . . . . 0.0 110.551 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.603 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -43.96 -35.72 2.15 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.027 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.35 -107.04 0.89 Allowed Glycine 0 C--N 1.291 -1.97 0 N-CA-C 105.983 -2.847 . . . . 0.0 105.983 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.507 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.2 OUTLIER -142.56 170.59 15.43 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.014 -1.286 . . . . 0.0 110.055 177.382 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 46.6 t -108.39 94.59 5.14 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.994 -1.066 . . . . 0.0 110.13 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.471 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -121.76 138.75 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -0.932 . . . . 0.0 109.776 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 37.7 mtp180 61.31 34.51 18.48 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.152 0.977 . . . . 0.0 110.203 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.6 18.49 59.02 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 7' ' ' LYS . 2.5 ttpp -140.84 131.48 25.58 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.327 -1.102 . . . . 0.0 111.528 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 5' ' ' SER . 25.2 t -58.13 119.95 7.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.457 -0.777 . . . . 0.0 109.645 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--N 1.3 -1.58 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.14 -179.837 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.223 0.535 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.585 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 8.9 p -162.85 138.84 7.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 110.517 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 5.8 mt -59.76 123.73 72.9 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.594 -0.692 . . . . 0.0 109.809 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' A' ' 5' ' ' SER . 43.1 Cg_endo -70.55 125.92 12.25 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.811 1.427 . . . . 0.0 109.746 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 16.0 t -38.7 156.82 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.547 -0.721 . . . . 0.0 110.504 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.9 14.84 58.8 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.98 169.92 14.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.401 -1.058 . . . . 0.0 109.746 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.82 112.7 24.73 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.923 -1.11 . . . . 0.0 111.094 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 25.9 p -91.74 91.02 7.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.316 -0.865 . . . . 0.0 109.209 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -110.27 63.14 0.6 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.246 -0.909 . . . . 0.0 109.435 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 14' ' ' GLN . . . -172.62 66.37 0.12 Allowed Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 m -50.54 -32.57 10.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.937 -1.331 . . . . 0.0 109.411 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 14' ' ' GLN . 12.8 t -89.53 -21.18 23.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.509 -0.745 . . . . 0.0 110.476 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.536 ' NE2' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -37.15 158.1 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.563 -0.711 . . . . 0.0 110.124 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.473 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 12.8 mttm -73.5 -35.64 65.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.008 -1.057 . . . . 0.0 110.34 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.423 ' N ' ' HG2' ' A' ' 14' ' ' GLN . 7.9 mt -99.93 103.06 19.84 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.48 -0.763 . . . . 0.0 110.273 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.536 ' HA ' ' NE2' ' A' ' 14' ' ' GLN . 48.3 Cg_endo -75.94 169.15 22.73 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.973 1.512 . . . . 0.0 110.697 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 21' ' ' SER . 3.0 t -68.56 116.65 9.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.87 . . . . 0.0 109.593 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.585 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -42.84 -33.23 0.73 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.72 -111.87 3.0 Favored Glycine 0 C--N 1.293 -1.817 0 N-CA-C 106.15 -2.78 . . . . 0.0 106.15 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.553 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -142.07 141.61 32.77 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.059 -1.259 . . . . 0.0 110.162 177.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.7 t -79.93 81.77 6.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.091 -1.006 . . . . 0.0 110.251 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 6.6 m -109.95 133.25 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.668 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 62.4 34.08 15.82 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.231 1.015 . . . . 0.0 109.722 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.29 24.46 67.42 Favored Glycine 0 C--N 1.291 -1.969 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -139.13 138.67 37.21 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.483 -1.01 . . . . 0.0 110.607 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 5' ' ' SER . 14.5 t -69.92 81.04 0.47 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.487 -0.758 . . . . 0.0 109.61 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.449 ' O ' ' OG ' ' A' ' 5' ' ' SER . 58.4 p . . . . . 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 0.0 110.174 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.515 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 120.76 0.314 . . . . 0.0 110.265 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.58 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 16.2 p 175.39 145.43 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.23 -0.919 . . . . 0.0 109.648 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.471 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 79.8 mt -86.44 122.69 71.95 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.068 -1.02 . . . . 0.0 110.985 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 5' ' ' SER . 44.6 Cg_endo -73.97 144.4 34.21 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.414 1.218 . . . . 0.0 110.945 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.559 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 2.2 m -39.28 153.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.532 -0.73 . . . . 0.0 110.641 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' A' ' 7' ' ' LYS . . . 90.87 24.85 26.46 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.119 -1.039 . . . . 0.0 110.535 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 34.0 mttt -159.27 148.31 18.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.084 -1.244 . . . . 0.0 110.373 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -44.3 125.97 4.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.97 . . . . 0.0 110.487 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.475 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 23.8 p -98.06 82.58 2.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.201 -0.937 . . . . 0.0 110.005 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.51 ' O ' ' CG ' ' A' ' 14' ' ' GLN . . . -91.37 60.55 4.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.048 -1.032 . . . . 0.0 109.974 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.495 ' HA2' ' HG2' ' A' ' 14' ' ' GLN . . . -87.68 -11.17 68.82 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -82.74 -5.32 8.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.3 -1.117 . . . . 0.0 110.1 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.16 -30.19 0.87 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 110.855 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.51 ' CG ' ' O ' ' A' ' 10' ' ' ALA . 15.8 pt20 -81.65 179.88 7.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.017 -1.052 . . . . 0.0 110.278 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.79 -35.76 51.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.356 -0.84 . . . . 0.0 111.437 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.529 ' CG2' ' HA ' ' A' ' 2' ' ' CYS . 7.8 mm -120.23 136.44 25.12 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.008 -1.057 . . . . 0.0 110.78 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.469 ' HA ' ' HA3' ' A' ' 11' ' ' GLY . 49.3 Cg_endo -77.0 -172.14 1.35 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.991 1.521 . . . . 0.0 110.696 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -79.35 127.96 32.74 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.99 0.9 . . . . 0.0 110.64 -179.067 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.58 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -46.35 -31.1 2.39 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.94 -112.99 2.36 Favored Glycine 0 C--N 1.294 -1.751 0 N-CA-C 105.544 -3.022 . . . . 0.0 105.544 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 14.4 m -143.05 162.24 36.04 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.098 -1.236 . . . . 0.0 109.387 177.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 48.9 t -101.7 115.67 31.04 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.941 -1.099 . . . . 0.0 109.836 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.528 ' O ' ' CG ' ' A' ' 24' ' ' ARG . 9.6 m -137.46 124.58 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.703 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.528 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 63.48 33.12 13.85 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.349 1.071 . . . . 0.0 109.818 -179.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.71 15.54 66.7 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.445 ' O ' HG23 ' A' ' 23' ' ' VAL . 7.1 tptt -140.77 126.08 18.68 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.471 -1.017 . . . . 0.0 110.437 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.559 ' HB3' ' HA ' ' A' ' 5' ' ' SER . 0.7 OUTLIER -46.93 125.1 7.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.427 -0.795 . . . . 0.0 110.234 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.459 ' OG ' HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.057 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.235 0.54 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.603 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 30.3 p -148.63 144.44 27.19 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.325 -0.86 . . . . 0.0 110.37 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.459 HD23 HG22 ' A' ' 16' ' ' ILE . 19.7 mt -83.89 134.39 44.24 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.555 -0.715 . . . . 0.0 110.269 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.47 ' O ' ' C ' ' A' ' 5' ' ' SER . 47.9 Cg_endo -81.51 144.2 14.08 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.026 1.54 . . . . 0.0 109.787 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.473 ' HB2' ' OXT' ' A' ' 28' ' ' SER . 4.6 t -38.73 151.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.391 -0.818 . . . . 0.0 110.216 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.473 ' HA2' ' HE2' ' A' ' 26' ' ' LYS . . . 90.52 15.7 56.46 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -122.08 172.21 8.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.392 -1.064 . . . . 0.0 109.778 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.77 155.26 18.37 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.017 -1.052 . . . . 0.0 110.477 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.424 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 27.1 p -160.72 73.02 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.575 -0.703 . . . . 0.0 109.287 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.28 72.17 0.89 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.323 -0.861 . . . . 0.0 110.484 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 12' ' ' VAL . . . -167.01 -48.3 0.02 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.562 ' CB ' ' O ' ' A' ' 11' ' ' GLY . 0.4 OUTLIER 81.49 -30.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.905 -0.762 . . . . 0.0 110.454 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.453 ' O ' ' C ' ' A' ' 14' ' ' GLN . 4.0 t -90.88 -13.6 33.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.111 -0.993 . . . . 0.0 109.732 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 13' ' ' THR . 15.9 pt20 -41.34 160.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.484 -0.76 . . . . 0.0 109.602 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -79.54 -19.38 49.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.946 -1.096 . . . . 0.0 110.562 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.473 HG21 ' HA ' ' A' ' 2' ' ' CYS . 71.2 mt -119.97 102.39 46.63 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 110.604 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.79 166.78 26.46 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.228 1.646 . . . . 0.0 110.203 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 19' ' ' CYS . 6.0 t -65.14 120.87 13.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.079 -1.013 . . . . 0.0 109.989 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.603 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -43.91 -30.72 0.73 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.162 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.427 ' N ' ' C ' ' A' ' 18' ' ' CYS . . . -108.74 -106.17 3.03 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 28' ' ' SER . 58.3 m -142.08 136.46 30.16 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.072 -1.252 . . . . 0.0 109.378 177.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.424 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 3.8 t -78.88 126.06 30.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.092 -1.005 . . . . 0.0 111.145 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.423 HG22 ' C ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -137.89 138.11 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.511 -0.743 . . . . 0.0 109.485 179.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 5.6 ttt180 60.77 33.38 20.11 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.999 0.904 . . . . 0.0 110.794 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.25 6.57 47.96 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.473 ' HE2' ' HA2' ' A' ' 6' ' ' GLY . 5.8 tptt -129.59 124.91 34.94 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.262 -1.14 . . . . 0.0 111.236 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.469 ' HB3' ' HA ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -42.53 124.41 2.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.568 -0.707 . . . . 0.0 109.574 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 21' ' ' SER . 39.0 t . . . . . 0 C--N 1.299 -1.614 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.186 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.4 ' HB2' HD12 ' A' ' 16' ' ' ILE . 53.2 mtm180 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.252 0.548 . . . . 0.0 110.324 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.541 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 17.0 p -158.87 150.34 20.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.364 -0.835 . . . . 0.0 110.139 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.51 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 81.1 mt -113.84 101.1 53.53 Favored Pre-proline 0 N--CA 1.493 1.704 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.013 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.516 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 48.2 Cg_endo -97.7 16.86 0.58 Allowed 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 121.629 1.552 . . . . 0.0 109.464 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 t -93.55 11.4 28.83 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.366 -0.833 . . . . 0.0 112.435 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 27' ' ' CYS . . . 67.91 20.99 73.08 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -59.63 144.9 46.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.499 -1.0 . . . . 0.0 109.521 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 25' ' ' GLY . . . -59.7 103.23 0.19 Allowed 'General case' 0 C--N 1.29 -1.985 0 O-C-N 120.582 -1.324 . . . . 0.0 110.144 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 25.4 p -86.99 88.28 7.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.575 -0.703 . . . . 0.0 110.278 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.66 64.0 0.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.981 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 12' ' ' VAL . . . 176.69 68.14 0.06 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 11' ' ' GLY . 24.3 t -40.28 -30.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.429 -1.042 . . . . 0.0 110.368 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 11' ' ' GLY . 6.6 t -88.29 38.01 0.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.947 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -89.75 146.25 24.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 110.123 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HG3' HG12 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -68.97 -24.42 64.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.115 -0.991 . . . . 0.0 109.578 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.476 HG12 ' HG3' ' A' ' 15' ' ' LYS . 12.4 mm -110.67 99.64 42.43 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.35 -0.844 . . . . 0.0 109.844 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.473 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 44.4 Cg_endo -72.04 167.06 27.78 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.125 1.592 . . . . 0.0 111.188 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.1 t -76.4 127.93 33.83 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.535 -0.728 . . . . 0.0 110.816 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -57.96 -29.13 64.95 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.42 -113.57 3.81 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 106.357 -2.697 . . . . 0.0 106.357 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.4 t -142.61 157.75 44.37 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.87 -1.371 . . . . 0.0 110.691 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.6 t -83.44 91.73 7.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.834 . . . . 0.0 109.849 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -124.15 131.29 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.21 -0.931 . . . . 0.0 111.566 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 1.9 mmp_? 63.23 34.71 13.15 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 122.072 0.939 . . . . 0.0 110.229 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 8' ' ' ALA . . . 62.58 21.47 62.71 Favored Glycine 0 C--N 1.288 -2.1 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 6' ' ' GLY . 12.7 ttmt -129.09 138.17 51.68 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.723 -0.869 . . . . 0.0 110.038 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -75.0 78.52 2.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.423 -0.798 . . . . 0.0 110.474 -179.248 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 27' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.953 -1.023 . . . . 0.0 110.232 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.601 ' O ' ' O ' ' A' ' 2' ' ' CYS . 3.2 mtt85 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.601 ' O ' ' O ' ' A' ' 1' ' ' ARG . 13.4 p 46.14 140.7 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 CA-C-O 122.632 1.206 . . . . 0.0 112.521 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.482 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 94.7 mt -90.78 139.2 26.14 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.051 -1.031 . . . . 0.0 110.941 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -80.66 142.85 14.61 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.878 1.462 . . . . 0.0 110.342 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.48 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 40.8 t -43.65 151.24 0.2 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.283 -0.885 . . . . 0.0 110.431 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.76 27.93 20.34 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.03 -175.5 4.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -1.117 . . . . 0.0 109.694 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.39 111.01 22.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.414 -0.804 . . . . 0.0 109.223 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 26' ' ' LYS . 27.4 p -91.18 84.47 5.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -0.925 . . . . 0.0 111.078 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.533 ' O ' ' CG ' ' A' ' 14' ' ' GLN . . . -88.77 55.65 3.45 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.627 -1.295 . . . . 0.0 109.338 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.463 ' HA2' ' HG2' ' A' ' 14' ' ' GLN . . . -76.88 2.88 58.63 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.45 -22.41 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.185 -1.185 . . . . 0.0 109.908 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.6 t -142.75 3.23 1.43 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.288 -0.882 . . . . 0.0 111.053 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.533 ' CG ' ' O ' ' A' ' 10' ' ' ALA . 12.7 pt20 -99.92 -166.87 1.38 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.882 -1.136 . . . . 0.0 110.714 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.487 ' N ' ' HG3' ' A' ' 14' ' ' GLN . 7.6 ttpt -77.17 -49.26 15.58 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.696 -0.627 . . . . 0.0 111.024 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.515 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 5.6 mt -133.58 140.8 37.96 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.267 -0.895 . . . . 0.0 111.078 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.461 ' HB3' ' HA3' ' A' ' 11' ' ' GLY . 47.4 Cg_endo -78.28 -165.78 0.36 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 124.313 1.691 . . . . 0.0 112.17 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 20.2 t -68.9 122.31 18.38 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.737 0.78 . . . . 0.0 111.472 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.484 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -46.14 -35.71 5.27 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.072 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.1 -103.55 1.6 Allowed Glycine 0 C--N 1.295 -1.717 0 N-CA-C 106.768 -2.533 . . . . 0.0 106.768 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.1 p -142.23 122.96 14.28 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.268 -1.136 . . . . 0.0 109.007 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 26.2 t -77.98 121.12 23.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.075 -1.015 . . . . 0.0 111.353 -178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.47 134.95 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.804 0.811 . . . . 0.0 109.947 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 58.3 34.1 23.75 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.996 0.903 . . . . 0.0 110.439 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.38 26.12 70.44 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.512 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 11.7 tttp -139.18 123.05 17.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.603 -0.94 . . . . 0.0 110.219 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 3' ' ' LEU . 0.5 OUTLIER -52.9 107.17 0.2 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.4 -0.812 . . . . 0.0 109.956 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.413 ' HB3' ' OG ' ' A' ' 5' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.397 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.242 0.544 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.574 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 20.4 p -136.29 144.32 44.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.119 -0.988 . . . . 0.0 110.392 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.457 ' HG ' HG22 ' A' ' 16' ' ' ILE . 25.3 mt -86.22 141.58 35.08 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.481 -0.762 . . . . 0.0 110.644 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 5' ' ' SER . 46.8 Cg_endo -74.41 125.96 10.01 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.068 1.562 . . . . 0.0 109.638 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -39.46 158.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.453 -0.78 . . . . 0.0 110.757 -179.399 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.48 ' O ' ' HG2' ' A' ' 7' ' ' LYS . . . 90.24 25.03 27.47 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 6' ' ' GLY . 4.6 mmtt -151.69 153.7 34.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -1.102 . . . . 0.0 110.288 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.0 143.5 34.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.089 -1.007 . . . . 0.0 110.492 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -123.59 -91.06 0.56 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.702 0.763 . . . . 0.0 109.811 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -162.27 -135.42 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.245 1.022 . . . . 0.0 108.443 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.465 ' C ' ' CG2' ' A' ' 12' ' ' VAL . . . -102.99 -73.39 0.96 Allowed Glycine 0 C--N 1.273 -2.935 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.465 ' CG2' ' C ' ' A' ' 11' ' ' GLY . 5.2 t -149.98 -39.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.383 -1.069 . . . . 0.0 110.058 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.504 ' O ' ' CG2' ' A' ' 13' ' ' THR . 8.9 t -103.05 83.36 2.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.314 -0.866 . . . . 0.0 110.143 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -118.16 174.73 6.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.887 . . . . 0.0 110.053 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.503 ' HG2' ' N ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -67.01 -26.38 66.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.645 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.503 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 87.3 mt -141.02 107.56 6.28 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.452 -0.78 . . . . 0.0 109.683 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.59 157.36 56.14 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.944 1.497 . . . . 0.0 111.349 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.539 ' SG ' ' N ' ' A' ' 21' ' ' SER . 4.5 t -69.07 119.97 14.19 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.83 0.824 . . . . 0.0 109.878 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.574 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -45.52 -33.29 2.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.35 -104.88 2.02 Favored Glycine 0 C--N 1.293 -1.831 0 N-CA-C 106.149 -2.78 . . . . 0.0 106.149 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.539 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 1.7 p -141.68 116.97 10.11 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.132 -1.216 . . . . 0.0 109.547 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.522 ' N ' ' HB3' ' A' ' 18' ' ' CYS . 41.1 t -78.87 82.01 5.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 110.295 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.453 ' CG2' ' OG ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -106.72 143.68 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.454 -0.778 . . . . 0.0 109.851 179.725 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER 59.96 37.38 21.44 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.114 0.959 . . . . 0.0 109.879 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.04 26.13 65.26 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -140.21 140.24 35.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.48 -1.012 . . . . 0.0 111.203 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 5' ' ' SER . 36.9 t -83.29 89.43 7.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.56 -0.713 . . . . 0.0 109.337 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.313 -179.456 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 50.7 mtt-85 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.162 0.506 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.63 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 4.8 p 174.32 138.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -0.88 . . . . 0.0 110.168 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 2.9 mt -61.37 119.0 42.48 Favored Pre-proline 0 C--N 1.303 -1.453 0 C-N-CA 119.659 -0.817 . . . . 0.0 109.513 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 5' ' ' SER . 41.3 Cg_endo -68.22 125.96 13.68 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.951 1.5 . . . . 0.0 109.977 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 72.1 m -38.49 152.93 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.682 -0.637 . . . . 0.0 110.296 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.94 18.97 49.1 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 8' ' ' ALA . 10.8 mttt -154.89 148.44 25.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.395 -1.062 . . . . 0.0 110.147 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -42.03 160.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.883 . . . . 0.0 110.541 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . 4.8 p -147.37 68.64 1.14 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.49 -0.756 . . . . 0.0 110.231 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.01 59.07 5.41 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.149 -0.969 . . . . 0.0 109.789 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.528 ' HA2' ' CD ' ' A' ' 14' ' ' GLN . . . -85.41 -6.84 83.33 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 t -54.85 -20.3 5.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.093 -1.24 . . . . 0.0 108.562 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.6 t -123.99 -12.51 7.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.622 -0.674 . . . . 0.0 109.663 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.586 ' HG2' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -97.48 164.37 12.47 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.271 -0.893 . . . . 0.0 109.33 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.586 ' N ' ' HG2' ' A' ' 14' ' ' GLN . 4.7 mmtt -82.65 -35.64 26.74 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.933 -1.104 . . . . 0.0 112.386 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.593 ' CG2' ' HA ' ' A' ' 2' ' ' CYS . 9.6 mm -101.54 95.97 5.77 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.917 -1.114 . . . . 0.0 110.994 -178.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 46.8 Cg_endo -70.09 -176.01 1.43 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 124.15 1.605 . . . . 0.0 112.394 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -63.08 119.85 10.3 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.994 0.902 . . . . 0.0 110.504 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.63 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -42.35 -34.45 0.81 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 122.553 1.168 . . . . 0.0 107.993 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.36 -112.14 2.59 Favored Glycine 0 C--N 1.288 -2.126 0 N-CA-C 105.976 -2.85 . . . . 0.0 105.976 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.533 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.2 OUTLIER -141.79 133.08 26.45 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.24 -1.153 . . . . 0.0 109.126 177.053 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 47.1 t -78.84 119.91 22.71 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.098 -1.001 . . . . 0.0 110.208 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 2.4 t -140.95 160.93 23.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER 36.93 30.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.855 0.836 . . . . 0.0 111.836 -179.488 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 23' ' ' VAL . . . 87.11 -24.29 9.54 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.062 177.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.04 147.33 36.22 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.49 -1.594 . . . . 0.0 112.686 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 5' ' ' SER . 43.1 t -66.98 103.49 1.16 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.544 0.687 . . . . 0.0 109.69 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.137 -179.677 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.469 ' O ' ' C ' ' A' ' 2' ' ' CYS . 17.0 mmt180 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.013 0.435 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.583 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 32.1 p -35.45 147.78 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.534 -0.729 . . . . 0.0 111.07 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 3' ' ' LEU . 23.4 mt -80.26 123.42 83.18 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.501 -0.75 . . . . 0.0 110.822 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.484 ' O ' ' O ' ' A' ' 5' ' ' SER . 51.0 Cg_endo -75.82 143.89 27.06 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.95 1.5 . . . . 0.0 110.034 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 7.1 t -39.71 164.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.504 -0.747 . . . . 0.0 110.862 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.12 13.53 58.77 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 2.6 mptt -147.68 158.95 44.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.98 -1.306 . . . . 0.0 109.669 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -47.57 169.09 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.286 -1.509 . . . . 0.0 109.757 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.577 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 5.4 p -135.15 64.5 1.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 111.635 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.49 ' C ' ' NE2' ' A' ' 14' ' ' GLN . . . -86.55 59.12 5.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.059 -1.026 . . . . 0.0 109.152 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.565 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -69.43 84.3 0.26 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.565 ' CG2' ' O ' ' A' ' 11' ' ' GLY . 0.9 OUTLIER 174.12 -33.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.719 -0.871 . . . . 0.0 108.681 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -126.24 -26.35 3.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.573 -0.704 . . . . 0.0 109.954 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.562 ' OE1' ' HA ' ' A' ' 17' ' ' PRO . 3.3 pt20 -56.89 173.87 0.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 0.0 109.994 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.62 -39.03 81.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.896 . . . . 0.0 109.696 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.541 ' CG2' ' HD2' ' A' ' 17' ' ' PRO . 32.3 mt -134.34 143.69 48.0 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.576 -0.702 . . . . 0.0 109.699 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.562 ' HA ' ' OE1' ' A' ' 14' ' ' GLN . 47.3 Cg_endo -73.59 152.15 47.98 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.146 1.603 . . . . 0.0 111.983 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 19' ' ' CYS . 23.1 t -55.96 117.88 4.11 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.422 -0.799 . . . . 0.0 110.073 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.583 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -41.19 -32.7 0.29 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.568 1.175 . . . . 0.0 107.865 179.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 18' ' ' CYS . . . -106.62 -114.13 3.87 Favored Glycine 0 C--N 1.289 -2.072 0 N-CA-C 106.189 -2.764 . . . . 0.0 106.189 177.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 m -142.55 -179.12 6.11 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.108 -1.231 . . . . 0.0 109.613 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.577 ' HA ' ' CB ' ' A' ' 9' ' ' CYS . 53.7 t -96.65 88.52 4.67 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.059 -1.025 . . . . 0.0 110.071 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -113.12 143.42 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.503 -0.748 . . . . 0.0 109.466 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 60.79 36.36 19.24 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 122.102 0.953 . . . . 0.0 109.987 -179.448 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.85 20.46 48.26 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -141.47 176.71 8.66 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.675 -0.897 . . . . 0.0 111.339 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -86.02 119.7 26.61 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.5 ' HB3' ' CB ' ' A' ' 5' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.294 -1.83 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.208 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 6.5 mtp85 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.219 0.533 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.558 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 21.3 p -174.34 146.97 1.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.878 . . . . 0.0 110.682 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.479 ' HG ' HG21 ' A' ' 16' ' ' ILE . 39.1 mt -81.52 139.62 47.85 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.477 -0.764 . . . . 0.0 110.443 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.514 ' O ' ' O ' ' A' ' 5' ' ' SER . 47.3 Cg_endo -74.63 117.12 4.83 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.03 1.542 . . . . 0.0 110.191 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.514 ' O ' ' O ' ' A' ' 4' ' ' PRO . 27.4 p -40.88 168.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.39 -0.819 . . . . 0.0 110.959 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.21 3.88 69.27 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -149.23 154.22 38.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -1.139 . . . . 0.0 109.978 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.15 155.34 37.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.259 -0.901 . . . . 0.0 109.974 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.42 ' HA ' HD13 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -115.67 -85.98 0.61 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.671 0.748 . . . . 0.0 109.447 179.501 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.433 ' HB3' ' CD ' ' A' ' 14' ' ' GLN . . . -162.08 -137.69 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 122.432 1.11 . . . . 0.0 108.67 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.541 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -106.63 -67.99 0.68 Allowed Glycine 0 C--N 1.272 -2.976 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 11' ' ' GLY . 2.3 t -168.7 -33.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.466 -1.02 . . . . 0.0 110.132 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.9 t -84.91 19.14 2.19 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.188 -0.945 . . . . 0.0 111.413 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.433 ' CD ' ' HB3' ' A' ' 10' ' ' ALA . 6.2 tt0 -67.81 146.13 54.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.796 -1.19 . . . . 0.0 109.853 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 ptpt -67.53 -27.74 67.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.049 -1.032 . . . . 0.0 109.353 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.479 HG21 ' HG ' ' A' ' 3' ' ' LEU . 5.0 mt -117.26 106.18 47.48 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.52 -0.738 . . . . 0.0 109.48 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.32 158.94 53.2 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.995 1.524 . . . . 0.0 110.682 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 21' ' ' SER . 11.0 t -64.04 121.3 13.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.445 -0.784 . . . . 0.0 110.134 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.558 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -47.04 -34.35 5.67 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 179.222 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.92 -108.99 2.41 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 106.308 -2.717 . . . . 0.0 106.308 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.537 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 23.9 p -141.73 129.59 21.78 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.011 -1.288 . . . . 0.0 109.781 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 7.5 t -78.61 78.94 5.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 109.677 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.452 HG23 ' OG ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -113.11 138.51 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.342 -0.849 . . . . 0.0 111.156 -179.384 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 59.81 35.99 22.03 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.047 0.927 . . . . 0.0 110.247 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.43 27.09 71.24 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -133.24 152.8 51.94 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.645 -0.915 . . . . 0.0 110.084 -179.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.508 ' HB3' ' HA ' ' A' ' 5' ' ' SER . 46.2 t -91.0 62.48 4.91 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.995 -1.066 . . . . 0.0 110.417 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.231 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.448 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 13.2 mmt180 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.204 0.526 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.612 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 31.6 p -177.53 145.22 0.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.407 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.543 ' HG ' ' CG2' ' A' ' 16' ' ' ILE . 12.5 mt -107.97 144.2 28.89 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.393 -0.817 . . . . 0.0 110.305 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 5' ' ' SER . 48.0 Cg_endo -73.45 158.45 47.96 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 O-C-N 124.201 1.632 . . . . 0.0 109.776 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 60.7 p -42.6 169.28 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.929 . . . . 0.0 110.831 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.92 4.72 69.01 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -145.3 141.59 28.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.887 -1.361 . . . . 0.0 110.565 179.493 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -39.19 145.05 0.11 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.432 0.634 . . . . 0.0 110.708 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.471 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 9.0 p -119.91 59.9 0.87 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.558 -0.714 . . . . 0.0 109.865 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.529 ' CB ' HG22 ' A' ' 13' ' ' THR . . . -86.91 59.99 5.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.14 -0.975 . . . . 0.0 109.885 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.499 ' HA2' ' HG2' ' A' ' 14' ' ' GLN . . . -57.27 -45.38 92.8 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -59.59 -32.82 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.445 -1.033 . . . . 0.0 110.843 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.529 HG22 ' CB ' ' A' ' 10' ' ' ALA . 3.5 t -116.38 29.76 7.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.13 -0.981 . . . . 0.0 111.288 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.499 ' HG2' ' HA2' ' A' ' 11' ' ' GLY . 5.4 pt20 -152.54 176.07 12.09 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.876 -1.14 . . . . 0.0 110.222 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.465 ' HG3' HG13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -88.8 -34.47 17.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.891 . . . . 0.0 111.374 -179.039 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.543 ' CG2' ' HG ' ' A' ' 3' ' ' LEU . 50.5 mt -115.7 111.31 43.67 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.886 -1.134 . . . . 0.0 110.944 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.71 -179.26 5.01 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.896 1.472 . . . . 0.0 110.623 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.6 t -75.24 117.52 17.15 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.635 0.731 . . . . 0.0 110.171 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.612 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -48.65 -34.5 11.91 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.271 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.31 -111.15 0.82 Allowed Glycine 0 C--N 1.294 -1.789 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -142.26 148.52 38.22 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 120.915 -1.344 . . . . 0.0 109.724 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 53.2 t -78.84 122.09 25.63 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.999 -1.063 . . . . 0.0 110.09 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.727 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -140.0 -176.62 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.622 0 O-C-N 121.424 -0.798 . . . . 0.0 108.94 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.574 ' N ' ' CG1' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 10.28 44.58 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.727 ' N ' ' O ' ' A' ' 23' ' ' VAL . . . 73.17 -10.82 5.51 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.235 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 23' ' ' VAL . 3.2 tttp -129.27 150.69 50.53 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 120.413 -1.64 . . . . 0.0 110.791 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 5' ' ' SER . 7.6 t -63.39 137.06 58.03 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.76 0.791 . . . . 0.0 109.725 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 5' ' ' SER . 3.3 p . . . . . 0 C--N 1.296 -1.733 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.317 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.524 ' CB ' HG13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.314 0.578 . . . . 0.0 110.109 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.585 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 31.2 p -42.33 146.33 0.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 110.043 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.464 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 92.9 mt -89.92 128.52 49.73 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.411 -0.805 . . . . 0.0 110.519 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 5' ' ' SER . 48.2 Cg_endo -74.35 141.5 28.81 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.904 1.476 . . . . 0.0 109.512 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 87.9 p -40.11 159.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.323 -0.861 . . . . 0.0 110.764 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.55 15.6 56.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.81 163.35 22.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.099 -1.236 . . . . 0.0 109.837 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.0 91.7 7.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.053 . . . . 0.0 110.614 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 26.7 p -81.34 90.9 6.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.022 -1.048 . . . . 0.0 109.768 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.5 71.19 1.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 110.004 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 175.43 65.7 0.06 OUTLIER Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 11' ' ' GLY . 74.7 t -39.28 -28.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.675 -0.897 . . . . 0.0 110.311 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.471 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.9 t -89.78 38.64 0.92 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 109.605 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' A' ' 17' ' ' PRO . 29.7 pt20 -87.24 -178.55 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 0.0 110.016 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.459 ' O ' HD11 ' A' ' 16' ' ' ILE . 10.5 mmtt -71.31 -43.47 67.0 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.402 -0.811 . . . . 0.0 109.743 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.524 HG13 ' CB ' ' A' ' 1' ' ' ARG . 21.1 mm -140.63 139.47 20.24 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.547 -0.72 . . . . 0.0 110.496 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.457 ' HA ' ' NE2' ' A' ' 14' ' ' GLN . 47.0 Cg_endo -74.42 -176.35 2.69 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.132 1.596 . . . . 0.0 111.05 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 7.5 t -66.82 122.08 16.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.589 -0.694 . . . . 0.0 110.397 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.585 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -44.17 -31.27 0.93 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.413 ' N ' ' C ' ' A' ' 18' ' ' CYS . . . -102.5 -107.3 3.1 Favored Glycine 0 C--N 1.296 -1.686 0 N-CA-C 106.062 -2.815 . . . . 0.0 106.062 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.2 p -142.7 123.69 14.42 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.084 -1.245 . . . . 0.0 109.732 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 18' ' ' CYS . 4.4 t -78.15 117.94 19.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.167 -0.958 . . . . 0.0 110.538 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.92 142.29 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.414 -0.804 . . . . 0.0 109.635 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 6.5 tpm_? 58.51 36.04 25.01 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.116 0.96 . . . . 0.0 110.183 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 59.86 28.2 65.54 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -140.47 116.43 10.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.692 -0.887 . . . . 0.0 110.953 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 5' ' ' SER . 0.3 OUTLIER -53.52 113.43 1.17 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.287 -0.883 . . . . 0.0 109.223 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.235 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.483 ' HB2' HD12 ' A' ' 16' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.286 0.565 . . . . 0.0 110.252 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.62 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 14.8 p -162.52 143.21 9.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 110.401 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.437 ' CD2' ' HE3' ' A' ' 7' ' ' LYS . 11.2 mt -80.89 135.23 52.07 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.531 -0.731 . . . . 0.0 110.597 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 5' ' ' SER . 47.4 Cg_endo -76.09 149.74 32.78 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.016 1.534 . . . . 0.0 110.126 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 60.3 p -40.58 157.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.454 -0.779 . . . . 0.0 110.687 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.443 ' O ' ' HG2' ' A' ' 7' ' ' LYS . . . 87.57 20.09 52.45 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 26' ' ' LYS . 7.8 mmmt -141.39 -172.16 3.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -1.093 . . . . 0.0 109.785 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.81 166.47 23.31 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.755 -0.778 . . . . 0.0 108.992 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 26' ' ' LYS . 8.4 p -147.37 45.41 1.14 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.786 -1.196 . . . . 0.0 111.083 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 14' ' ' GLN . . . -103.84 61.72 0.75 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.144 -0.972 . . . . 0.0 109.831 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.96 -18.22 11.25 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 13' ' ' THR . 27.6 m -53.9 -40.7 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -1.201 . . . . 0.0 109.478 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.422 ' N ' HG22 ' A' ' 12' ' ' VAL . 8.9 t -119.2 9.33 11.7 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.727 -0.608 . . . . 0.0 109.73 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -104.85 162.09 13.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.363 -0.836 . . . . 0.0 110.172 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.523 ' CG ' HG12 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -86.1 -15.97 39.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.3 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.537 ' CG2' ' HA ' ' A' ' 2' ' ' CYS . 49.1 mm -140.04 117.67 8.34 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.74 . . . . 0.0 109.74 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.1 170.35 19.85 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.867 1.456 . . . . 0.0 111.214 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 21' ' ' SER . 1.8 t -69.04 118.72 12.3 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.79 0.805 . . . . 0.0 110.118 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.62 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -45.15 -33.71 2.36 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.28 -111.67 2.32 Favored Glycine 0 C--N 1.292 -1.888 0 N-CA-C 106.321 -2.712 . . . . 0.0 106.321 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.522 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 29.7 m -141.9 173.26 11.68 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.955 -1.321 . . . . 0.0 109.889 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 48.3 t -95.82 106.96 19.16 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.134 -0.979 . . . . 0.0 110.704 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 26' ' ' LYS . 1.8 m -123.82 123.6 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.338 -0.851 . . . . 0.0 109.881 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.52 30.86 12.73 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 122.363 1.077 . . . . 0.0 109.283 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.422 ' C ' ' SG ' ' A' ' 9' ' ' CYS . . . 69.19 18.5 73.15 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 7' ' ' LYS . 5.9 ttmt -141.45 129.36 21.85 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.368 -1.078 . . . . 0.0 111.825 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 5' ' ' SER . 20.1 t -45.84 112.99 0.53 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.422 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.511 ' OXT' ' CB ' ' A' ' 5' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.505 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.221 0.534 . . . . 0.0 110.149 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.57 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 22.4 p -176.96 145.67 0.49 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 0.0 110.331 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 1.8 mp -87.43 131.77 43.03 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.557 -0.715 . . . . 0.0 110.498 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 5' ' ' SER . 45.7 Cg_endo -72.6 139.81 31.74 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.916 1.482 . . . . 0.0 109.301 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 1.8 m -39.32 161.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -0.834 . . . . 0.0 110.811 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.52 17.36 52.8 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' ALA . 7.9 mttp -149.58 146.57 27.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -1.208 . . . . 0.0 109.958 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -43.2 165.64 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.299 -0.875 . . . . 0.0 109.995 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.478 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 6.6 p -141.55 62.48 1.45 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 0.0 110.507 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 14' ' ' GLN . . . -86.41 57.2 4.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.868 -1.145 . . . . 0.0 110.134 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 14' ' ' GLN . . . -71.98 -11.05 74.02 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -52.85 -33.69 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.143 . . . . 0.0 109.57 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -126.88 -26.26 3.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.589 -0.694 . . . . 0.0 109.764 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.488 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 8.0 tt0 -63.9 164.13 10.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 0.0 109.82 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.406 ' N ' ' CG ' ' A' ' 14' ' ' GLN . 10.4 mmtp -85.7 -38.91 17.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.43 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.545 ' CG2' ' HA ' ' A' ' 2' ' ' CYS . 2.1 mp -108.21 108.03 60.78 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 110.258 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.441 ' O ' HD11 ' A' ' 3' ' ' LEU . 50.6 Cg_endo -76.75 175.3 11.55 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.062 1.559 . . . . 0.0 111.363 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 21' ' ' SER . 2.0 t -62.74 119.41 9.25 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.775 0.798 . . . . 0.0 110.961 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.57 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -43.85 -35.36 1.91 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.96 -112.4 1.88 Allowed Glycine 0 C--N 1.29 -2.006 0 N-CA-C 106.187 -2.765 . . . . 0.0 106.187 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.509 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -142.37 161.64 37.51 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.117 -1.225 . . . . 0.0 109.821 177.517 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 45.9 t -94.04 88.94 5.85 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.123 -0.985 . . . . 0.0 110.337 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 28' ' ' SER . 1.6 m -111.03 131.31 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.419 -0.8 . . . . 0.0 109.754 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER 64.56 33.05 11.14 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.222 1.01 . . . . 0.0 109.441 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.29 21.82 64.66 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.53 142.11 35.24 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.379 -1.071 . . . . 0.0 111.318 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 5' ' ' SER . 49.9 t -67.92 94.45 0.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.755 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.49 ' HB2' HG21 ' A' ' 23' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.097 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.426 ' HA ' ' CD1' ' A' ' 16' ' ' ILE . 4.2 ptp180 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.268 0.556 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.54 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 14.1 p -164.08 150.31 11.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.327 -0.858 . . . . 0.0 110.248 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.434 ' HG ' ' CG2' ' A' ' 16' ' ' ILE . 19.0 mt -97.84 137.0 20.92 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.463 -0.773 . . . . 0.0 110.171 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.477 ' O ' ' O ' ' A' ' 5' ' ' SER . 46.0 Cg_endo -72.45 135.15 23.83 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 O-C-N 124.08 1.568 . . . . 0.0 109.061 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.529 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 10.0 m -39.68 162.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.455 -0.778 . . . . 0.0 110.474 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.22 17.49 50.25 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -150.9 147.45 27.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.472 -1.016 . . . . 0.0 109.552 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -40.52 160.72 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.433 -0.792 . . . . 0.0 110.155 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 6.6 p -133.77 65.7 1.57 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.196 -0.94 . . . . 0.0 111.052 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.481 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -90.24 61.33 5.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.057 -1.027 . . . . 0.0 109.463 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.511 ' HA2' ' HG2' ' A' ' 14' ' ' GLN . . . -77.36 -10.2 86.38 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.5 t -80.4 -13.53 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.041 -1.27 . . . . 0.0 110.302 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.8 -17.59 2.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.159 -0.963 . . . . 0.0 111.278 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.511 ' HG2' ' HA2' ' A' ' 11' ' ' GLY . 14.7 pt20 -98.1 177.59 5.36 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.864 -1.148 . . . . 0.0 110.377 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.447 ' HG3' HG12 ' A' ' 16' ' ' ILE . 4.6 ptmt -88.47 -28.27 20.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.868 . . . . 0.0 110.608 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.447 HG12 ' HG3' ' A' ' 15' ' ' LYS . 32.5 mm -102.66 103.89 35.22 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 0.0 110.573 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.409 ' HD2' ' O ' ' A' ' 1' ' ' ARG . 50.6 Cg_endo -76.61 171.99 17.02 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.918 1.483 . . . . 0.0 110.228 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 21' ' ' SER . 29.8 t -72.22 116.55 12.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.248 -0.907 . . . . 0.0 110.109 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.54 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -46.53 -33.61 4.2 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.87 -110.34 2.71 Favored Glycine 0 C--N 1.292 -1.909 0 N-CA-C 106.204 -2.758 . . . . 0.0 106.204 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.458 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 1.2 m -141.98 164.98 28.7 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.042 -1.269 . . . . 0.0 109.42 177.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 54.1 t -99.8 92.68 5.42 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.713 -1.242 . . . . 0.0 110.722 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.443 HG21 ' HB3' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.27 135.0 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.292 -0.88 . . . . 0.0 110.402 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.91 33.79 20.78 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 122.067 0.937 . . . . 0.0 110.601 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.61 26.44 74.47 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.426 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 1.9 ttmm -141.52 143.65 33.89 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.173 -1.192 . . . . 0.0 111.075 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 5' ' ' SER . 23.9 t -77.22 111.38 12.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 109.195 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.443 ' HB3' HG21 ' A' ' 23' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.268 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.454 ' O ' HG22 ' A' ' 16' ' ' ILE . 8.1 mtm180 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.27 0.557 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.603 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 29.3 p -41.66 148.09 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 110.422 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 16' ' ' ILE . 0.5 OUTLIER -96.78 135.97 21.91 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.0 110.378 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 5' ' ' SER . 47.3 Cg_endo -74.85 149.53 37.6 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.964 1.507 . . . . 0.0 110.021 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 2.9 m -39.62 161.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.372 -0.83 . . . . 0.0 110.315 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.54 13.84 59.22 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -125.55 162.33 25.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -1.151 . . . . 0.0 109.81 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.21 98.72 11.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.001 -1.062 . . . . 0.0 111.291 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 29.1 p -85.91 95.11 9.36 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.134 -0.978 . . . . 0.0 108.612 178.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -107.22 68.16 0.72 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.112 -0.993 . . . . 0.0 110.617 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.49 ' O ' ' C ' ' A' ' 12' ' ' VAL . . . 158.7 65.4 0.01 OUTLIER Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.49 ' C ' ' O ' ' A' ' 11' ' ' GLY . 1.7 m -36.6 -33.41 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.785 -0.833 . . . . 0.0 109.896 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.9 t -88.46 42.73 1.09 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.448 -0.783 . . . . 0.0 109.103 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -91.46 154.87 18.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.507 -0.746 . . . . 0.0 110.121 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt -65.38 -35.88 82.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 108.865 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.47 HG23 ' HA ' ' A' ' 2' ' ' CYS . 5.9 mm -125.17 82.93 61.37 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.34 178.7 6.67 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 124.128 1.594 . . . . 0.0 111.332 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 21' ' ' SER . 3.9 t -61.79 120.02 9.89 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.556 0.693 . . . . 0.0 110.551 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.603 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -43.96 -35.72 2.15 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.027 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.35 -107.04 0.89 Allowed Glycine 0 C--N 1.291 -1.97 0 N-CA-C 105.983 -2.847 . . . . 0.0 105.983 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.507 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.2 OUTLIER -142.56 170.59 15.43 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.014 -1.286 . . . . 0.0 110.055 177.382 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 46.6 t -108.39 94.59 5.14 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.994 -1.066 . . . . 0.0 110.13 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.471 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -121.76 138.75 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -0.932 . . . . 0.0 109.776 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 37.7 mtp180 61.31 34.51 18.48 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.152 0.977 . . . . 0.0 110.203 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.6 18.49 59.02 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 7' ' ' LYS . 2.5 ttpp -140.84 131.48 25.58 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.327 -1.102 . . . . 0.0 111.528 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 5' ' ' SER . 25.2 t -58.13 119.95 7.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.457 -0.777 . . . . 0.0 109.645 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--N 1.3 -1.58 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.14 -179.837 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.223 0.535 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.585 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 8.9 p -162.85 138.84 7.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 110.517 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 5.8 mt -59.76 123.73 72.9 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.594 -0.692 . . . . 0.0 109.809 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' A' ' 5' ' ' SER . 43.1 Cg_endo -70.55 125.92 12.25 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.811 1.427 . . . . 0.0 109.746 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 16.0 t -38.7 156.82 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.547 -0.721 . . . . 0.0 110.504 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.9 14.84 58.8 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.98 169.92 14.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.401 -1.058 . . . . 0.0 109.746 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.82 112.7 24.73 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.923 -1.11 . . . . 0.0 111.094 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 25.9 p -91.74 91.02 7.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.316 -0.865 . . . . 0.0 109.209 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -110.27 63.14 0.6 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.246 -0.909 . . . . 0.0 109.435 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 14' ' ' GLN . . . -172.62 66.37 0.12 Allowed Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 m -50.54 -32.57 10.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.937 -1.331 . . . . 0.0 109.411 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 14' ' ' GLN . 12.8 t -89.53 -21.18 23.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.509 -0.745 . . . . 0.0 110.476 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.536 ' NE2' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -37.15 158.1 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.563 -0.711 . . . . 0.0 110.124 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.473 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 12.8 mttm -73.5 -35.64 65.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.008 -1.057 . . . . 0.0 110.34 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.423 ' N ' ' HG2' ' A' ' 14' ' ' GLN . 7.9 mt -99.93 103.06 19.84 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.48 -0.763 . . . . 0.0 110.273 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.536 ' HA ' ' NE2' ' A' ' 14' ' ' GLN . 48.3 Cg_endo -75.94 169.15 22.73 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.973 1.512 . . . . 0.0 110.697 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 21' ' ' SER . 3.0 t -68.56 116.65 9.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.87 . . . . 0.0 109.593 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.585 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -42.84 -33.23 0.73 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.72 -111.87 3.0 Favored Glycine 0 C--N 1.293 -1.817 0 N-CA-C 106.15 -2.78 . . . . 0.0 106.15 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.553 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -142.07 141.61 32.77 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.059 -1.259 . . . . 0.0 110.162 177.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.7 t -79.93 81.77 6.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.091 -1.006 . . . . 0.0 110.251 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 6.6 m -109.95 133.25 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.668 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 62.4 34.08 15.82 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.231 1.015 . . . . 0.0 109.722 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.29 24.46 67.42 Favored Glycine 0 C--N 1.291 -1.969 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -139.13 138.67 37.21 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.483 -1.01 . . . . 0.0 110.607 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 5' ' ' SER . 14.5 t -69.92 81.04 0.47 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.487 -0.758 . . . . 0.0 109.61 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.449 ' O ' ' OG ' ' A' ' 5' ' ' SER . 58.4 p . . . . . 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 0.0 110.174 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.515 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 120.76 0.314 . . . . 0.0 110.265 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.58 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 16.2 p 175.39 145.43 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.23 -0.919 . . . . 0.0 109.648 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.471 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 79.8 mt -86.44 122.69 71.95 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.068 -1.02 . . . . 0.0 110.985 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 5' ' ' SER . 44.6 Cg_endo -73.97 144.4 34.21 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.414 1.218 . . . . 0.0 110.945 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.559 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 2.2 m -39.28 153.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.532 -0.73 . . . . 0.0 110.641 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' A' ' 7' ' ' LYS . . . 90.87 24.85 26.46 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.119 -1.039 . . . . 0.0 110.535 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 34.0 mttt -159.27 148.31 18.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.084 -1.244 . . . . 0.0 110.373 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -44.3 125.97 4.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.97 . . . . 0.0 110.487 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.475 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 23.8 p -98.06 82.58 2.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.201 -0.937 . . . . 0.0 110.005 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.51 ' O ' ' CG ' ' A' ' 14' ' ' GLN . . . -91.37 60.55 4.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.048 -1.032 . . . . 0.0 109.974 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.495 ' HA2' ' HG2' ' A' ' 14' ' ' GLN . . . -87.68 -11.17 68.82 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -82.74 -5.32 8.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.3 -1.117 . . . . 0.0 110.1 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.16 -30.19 0.87 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 110.855 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.51 ' CG ' ' O ' ' A' ' 10' ' ' ALA . 15.8 pt20 -81.65 179.88 7.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.017 -1.052 . . . . 0.0 110.278 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.79 -35.76 51.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.356 -0.84 . . . . 0.0 111.437 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.529 ' CG2' ' HA ' ' A' ' 2' ' ' CYS . 7.8 mm -120.23 136.44 25.12 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.008 -1.057 . . . . 0.0 110.78 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.469 ' HA ' ' HA3' ' A' ' 11' ' ' GLY . 49.3 Cg_endo -77.0 -172.14 1.35 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.991 1.521 . . . . 0.0 110.696 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -79.35 127.96 32.74 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.99 0.9 . . . . 0.0 110.64 -179.067 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.58 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -46.35 -31.1 2.39 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.94 -112.99 2.36 Favored Glycine 0 C--N 1.294 -1.751 0 N-CA-C 105.544 -3.022 . . . . 0.0 105.544 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 14.4 m -143.05 162.24 36.04 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.098 -1.236 . . . . 0.0 109.387 177.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 48.9 t -101.7 115.67 31.04 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.941 -1.099 . . . . 0.0 109.836 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.528 ' O ' ' CG ' ' A' ' 24' ' ' ARG . 9.6 m -137.46 124.58 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.703 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.528 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 63.48 33.12 13.85 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.349 1.071 . . . . 0.0 109.818 -179.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.71 15.54 66.7 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.445 ' O ' HG23 ' A' ' 23' ' ' VAL . 7.1 tptt -140.77 126.08 18.68 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.471 -1.017 . . . . 0.0 110.437 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.559 ' HB3' ' HA ' ' A' ' 5' ' ' SER . 0.7 OUTLIER -46.93 125.1 7.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.427 -0.795 . . . . 0.0 110.234 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.459 ' OG ' HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.057 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.235 0.54 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.603 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 30.3 p -148.63 144.44 27.19 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.325 -0.86 . . . . 0.0 110.37 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.459 HD23 HG22 ' A' ' 16' ' ' ILE . 19.7 mt -83.89 134.39 44.24 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.555 -0.715 . . . . 0.0 110.269 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.47 ' O ' ' C ' ' A' ' 5' ' ' SER . 47.9 Cg_endo -81.51 144.2 14.08 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.026 1.54 . . . . 0.0 109.787 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.473 ' HB2' ' OXT' ' A' ' 28' ' ' SER . 4.6 t -38.73 151.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.391 -0.818 . . . . 0.0 110.216 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.473 ' HA2' ' HE2' ' A' ' 26' ' ' LYS . . . 90.52 15.7 56.46 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -122.08 172.21 8.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.392 -1.064 . . . . 0.0 109.778 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.77 155.26 18.37 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.017 -1.052 . . . . 0.0 110.477 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.424 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 27.1 p -160.72 73.02 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.575 -0.703 . . . . 0.0 109.287 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.28 72.17 0.89 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.323 -0.861 . . . . 0.0 110.484 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 12' ' ' VAL . . . -167.01 -48.3 0.02 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.562 ' CB ' ' O ' ' A' ' 11' ' ' GLY . 0.4 OUTLIER 81.49 -30.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.905 -0.762 . . . . 0.0 110.454 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.453 ' O ' ' C ' ' A' ' 14' ' ' GLN . 4.0 t -90.88 -13.6 33.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.111 -0.993 . . . . 0.0 109.732 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 13' ' ' THR . 15.9 pt20 -41.34 160.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.484 -0.76 . . . . 0.0 109.602 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -79.54 -19.38 49.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.946 -1.096 . . . . 0.0 110.562 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.473 HG21 ' HA ' ' A' ' 2' ' ' CYS . 71.2 mt -119.97 102.39 46.63 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 110.604 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.79 166.78 26.46 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.228 1.646 . . . . 0.0 110.203 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 19' ' ' CYS . 6.0 t -65.14 120.87 13.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.079 -1.013 . . . . 0.0 109.989 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.603 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -43.91 -30.72 0.73 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.162 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.427 ' N ' ' C ' ' A' ' 18' ' ' CYS . . . -108.74 -106.17 3.03 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 28' ' ' SER . 58.3 m -142.08 136.46 30.16 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.072 -1.252 . . . . 0.0 109.378 177.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.424 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 3.8 t -78.88 126.06 30.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.092 -1.005 . . . . 0.0 111.145 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.423 HG22 ' C ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -137.89 138.11 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.511 -0.743 . . . . 0.0 109.485 179.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 5.6 ttt180 60.77 33.38 20.11 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.999 0.904 . . . . 0.0 110.794 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.25 6.57 47.96 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.473 ' HE2' ' HA2' ' A' ' 6' ' ' GLY . 5.8 tptt -129.59 124.91 34.94 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.262 -1.14 . . . . 0.0 111.236 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.469 ' HB3' ' HA ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -42.53 124.41 2.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.568 -0.707 . . . . 0.0 109.574 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 21' ' ' SER . 39.0 t . . . . . 0 C--N 1.299 -1.614 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.186 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.4 ' HB2' HD12 ' A' ' 16' ' ' ILE . 53.2 mtm180 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.252 0.548 . . . . 0.0 110.324 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.541 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 17.0 p -158.87 150.34 20.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.364 -0.835 . . . . 0.0 110.139 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.51 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 81.1 mt -113.84 101.1 53.53 Favored Pre-proline 0 N--CA 1.493 1.704 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.013 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.516 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 48.2 Cg_endo -97.7 16.86 0.58 Allowed 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 121.629 1.552 . . . . 0.0 109.464 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 t -93.55 11.4 28.83 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.366 -0.833 . . . . 0.0 112.435 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 27' ' ' CYS . . . 67.91 20.99 73.08 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -59.63 144.9 46.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.499 -1.0 . . . . 0.0 109.521 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 25' ' ' GLY . . . -59.7 103.23 0.19 Allowed 'General case' 0 C--N 1.29 -1.985 0 O-C-N 120.582 -1.324 . . . . 0.0 110.144 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 25.4 p -86.99 88.28 7.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.575 -0.703 . . . . 0.0 110.278 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.66 64.0 0.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.981 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 12' ' ' VAL . . . 176.69 68.14 0.06 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 11' ' ' GLY . 24.3 t -40.28 -30.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.429 -1.042 . . . . 0.0 110.368 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 11' ' ' GLY . 6.6 t -88.29 38.01 0.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.947 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -89.75 146.25 24.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 110.123 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HG3' HG12 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -68.97 -24.42 64.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.115 -0.991 . . . . 0.0 109.578 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.476 HG12 ' HG3' ' A' ' 15' ' ' LYS . 12.4 mm -110.67 99.64 42.43 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.35 -0.844 . . . . 0.0 109.844 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.473 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 44.4 Cg_endo -72.04 167.06 27.78 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.125 1.592 . . . . 0.0 111.188 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.1 t -76.4 127.93 33.83 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.535 -0.728 . . . . 0.0 110.816 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -57.96 -29.13 64.95 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.42 -113.57 3.81 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 106.357 -2.697 . . . . 0.0 106.357 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.4 t -142.61 157.75 44.37 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.87 -1.371 . . . . 0.0 110.691 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.6 t -83.44 91.73 7.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.834 . . . . 0.0 109.849 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -124.15 131.29 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.21 -0.931 . . . . 0.0 111.566 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 1.9 mmp_? 63.23 34.71 13.15 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 122.072 0.939 . . . . 0.0 110.229 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 8' ' ' ALA . . . 62.58 21.47 62.71 Favored Glycine 0 C--N 1.288 -2.1 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 6' ' ' GLY . 12.7 ttmt -129.09 138.17 51.68 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.723 -0.869 . . . . 0.0 110.038 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -75.0 78.52 2.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.423 -0.798 . . . . 0.0 110.474 -179.248 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 27' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.953 -1.023 . . . . 0.0 110.232 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.601 ' O ' ' O ' ' A' ' 2' ' ' CYS . 3.2 mtt85 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.601 ' O ' ' O ' ' A' ' 1' ' ' ARG . 13.4 p 46.14 140.7 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 CA-C-O 122.632 1.206 . . . . 0.0 112.521 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.482 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 94.7 mt -90.78 139.2 26.14 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.051 -1.031 . . . . 0.0 110.941 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -80.66 142.85 14.61 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.878 1.462 . . . . 0.0 110.342 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.48 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 40.8 t -43.65 151.24 0.2 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.283 -0.885 . . . . 0.0 110.431 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.76 27.93 20.34 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.03 -175.5 4.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -1.117 . . . . 0.0 109.694 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.39 111.01 22.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.414 -0.804 . . . . 0.0 109.223 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 26' ' ' LYS . 27.4 p -91.18 84.47 5.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -0.925 . . . . 0.0 111.078 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.533 ' O ' ' CG ' ' A' ' 14' ' ' GLN . . . -88.77 55.65 3.45 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.627 -1.295 . . . . 0.0 109.338 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.463 ' HA2' ' HG2' ' A' ' 14' ' ' GLN . . . -76.88 2.88 58.63 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.45 -22.41 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.185 -1.185 . . . . 0.0 109.908 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.6 t -142.75 3.23 1.43 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.288 -0.882 . . . . 0.0 111.053 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.533 ' CG ' ' O ' ' A' ' 10' ' ' ALA . 12.7 pt20 -99.92 -166.87 1.38 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.882 -1.136 . . . . 0.0 110.714 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.487 ' N ' ' HG3' ' A' ' 14' ' ' GLN . 7.6 ttpt -77.17 -49.26 15.58 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.696 -0.627 . . . . 0.0 111.024 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.515 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 5.6 mt -133.58 140.8 37.96 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.267 -0.895 . . . . 0.0 111.078 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.461 ' HB3' ' HA3' ' A' ' 11' ' ' GLY . 47.4 Cg_endo -78.28 -165.78 0.36 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 124.313 1.691 . . . . 0.0 112.17 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 20.2 t -68.9 122.31 18.38 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.737 0.78 . . . . 0.0 111.472 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.484 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -46.14 -35.71 5.27 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.072 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.1 -103.55 1.6 Allowed Glycine 0 C--N 1.295 -1.717 0 N-CA-C 106.768 -2.533 . . . . 0.0 106.768 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.1 p -142.23 122.96 14.28 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.268 -1.136 . . . . 0.0 109.007 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 26.2 t -77.98 121.12 23.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.075 -1.015 . . . . 0.0 111.353 -178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.47 134.95 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.804 0.811 . . . . 0.0 109.947 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 58.3 34.1 23.75 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.996 0.903 . . . . 0.0 110.439 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.38 26.12 70.44 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.512 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 11.7 tttp -139.18 123.05 17.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.603 -0.94 . . . . 0.0 110.219 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 3' ' ' LEU . 0.5 OUTLIER -52.9 107.17 0.2 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.4 -0.812 . . . . 0.0 109.956 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.413 ' HB3' ' OG ' ' A' ' 5' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.397 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.242 0.544 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.574 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 20.4 p -136.29 144.32 44.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.119 -0.988 . . . . 0.0 110.392 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.457 ' HG ' HG22 ' A' ' 16' ' ' ILE . 25.3 mt -86.22 141.58 35.08 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.481 -0.762 . . . . 0.0 110.644 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 5' ' ' SER . 46.8 Cg_endo -74.41 125.96 10.01 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.068 1.562 . . . . 0.0 109.638 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -39.46 158.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.453 -0.78 . . . . 0.0 110.757 -179.399 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.48 ' O ' ' HG2' ' A' ' 7' ' ' LYS . . . 90.24 25.03 27.47 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 6' ' ' GLY . 4.6 mmtt -151.69 153.7 34.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -1.102 . . . . 0.0 110.288 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.0 143.5 34.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.089 -1.007 . . . . 0.0 110.492 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -123.59 -91.06 0.56 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.702 0.763 . . . . 0.0 109.811 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -162.27 -135.42 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.245 1.022 . . . . 0.0 108.443 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.465 ' C ' ' CG2' ' A' ' 12' ' ' VAL . . . -102.99 -73.39 0.96 Allowed Glycine 0 C--N 1.273 -2.935 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.465 ' CG2' ' C ' ' A' ' 11' ' ' GLY . 5.2 t -149.98 -39.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.383 -1.069 . . . . 0.0 110.058 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.504 ' O ' ' CG2' ' A' ' 13' ' ' THR . 8.9 t -103.05 83.36 2.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.314 -0.866 . . . . 0.0 110.143 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -118.16 174.73 6.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.887 . . . . 0.0 110.053 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.503 ' HG2' ' N ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -67.01 -26.38 66.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.645 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.503 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 87.3 mt -141.02 107.56 6.28 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.452 -0.78 . . . . 0.0 109.683 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.59 157.36 56.14 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.944 1.497 . . . . 0.0 111.349 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.539 ' SG ' ' N ' ' A' ' 21' ' ' SER . 4.5 t -69.07 119.97 14.19 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.83 0.824 . . . . 0.0 109.878 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.574 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -45.52 -33.29 2.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.35 -104.88 2.02 Favored Glycine 0 C--N 1.293 -1.831 0 N-CA-C 106.149 -2.78 . . . . 0.0 106.149 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.539 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 1.7 p -141.68 116.97 10.11 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.132 -1.216 . . . . 0.0 109.547 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.522 ' N ' ' HB3' ' A' ' 18' ' ' CYS . 41.1 t -78.87 82.01 5.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 110.295 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.453 ' CG2' ' OG ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -106.72 143.68 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.454 -0.778 . . . . 0.0 109.851 179.725 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER 59.96 37.38 21.44 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.114 0.959 . . . . 0.0 109.879 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 61.04 26.13 65.26 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -140.21 140.24 35.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.48 -1.012 . . . . 0.0 111.203 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 5' ' ' SER . 36.9 t -83.29 89.43 7.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.56 -0.713 . . . . 0.0 109.337 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.313 -179.456 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 50.7 mtt-85 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.162 0.506 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.63 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 4.8 p 174.32 138.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -0.88 . . . . 0.0 110.168 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 2.9 mt -61.37 119.0 42.48 Favored Pre-proline 0 C--N 1.303 -1.453 0 C-N-CA 119.659 -0.817 . . . . 0.0 109.513 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 5' ' ' SER . 41.3 Cg_endo -68.22 125.96 13.68 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.951 1.5 . . . . 0.0 109.977 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 72.1 m -38.49 152.93 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.682 -0.637 . . . . 0.0 110.296 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.94 18.97 49.1 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 8' ' ' ALA . 10.8 mttt -154.89 148.44 25.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.395 -1.062 . . . . 0.0 110.147 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -42.03 160.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.883 . . . . 0.0 110.541 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . 4.8 p -147.37 68.64 1.14 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.49 -0.756 . . . . 0.0 110.231 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.01 59.07 5.41 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.149 -0.969 . . . . 0.0 109.789 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.528 ' HA2' ' CD ' ' A' ' 14' ' ' GLN . . . -85.41 -6.84 83.33 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 t -54.85 -20.3 5.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.093 -1.24 . . . . 0.0 108.562 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.6 t -123.99 -12.51 7.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.622 -0.674 . . . . 0.0 109.663 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.586 ' HG2' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -97.48 164.37 12.47 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.271 -0.893 . . . . 0.0 109.33 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.586 ' N ' ' HG2' ' A' ' 14' ' ' GLN . 4.7 mmtt -82.65 -35.64 26.74 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.933 -1.104 . . . . 0.0 112.386 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.593 ' CG2' ' HA ' ' A' ' 2' ' ' CYS . 9.6 mm -101.54 95.97 5.77 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.917 -1.114 . . . . 0.0 110.994 -178.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 46.8 Cg_endo -70.09 -176.01 1.43 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 124.15 1.605 . . . . 0.0 112.394 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -63.08 119.85 10.3 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.994 0.902 . . . . 0.0 110.504 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.63 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -42.35 -34.45 0.81 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 122.553 1.168 . . . . 0.0 107.993 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.36 -112.14 2.59 Favored Glycine 0 C--N 1.288 -2.126 0 N-CA-C 105.976 -2.85 . . . . 0.0 105.976 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.533 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.2 OUTLIER -141.79 133.08 26.45 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.24 -1.153 . . . . 0.0 109.126 177.053 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 47.1 t -78.84 119.91 22.71 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.098 -1.001 . . . . 0.0 110.208 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 2.4 t -140.95 160.93 23.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER 36.93 30.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.855 0.836 . . . . 0.0 111.836 -179.488 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 23' ' ' VAL . . . 87.11 -24.29 9.54 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.062 177.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.04 147.33 36.22 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.49 -1.594 . . . . 0.0 112.686 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 5' ' ' SER . 43.1 t -66.98 103.49 1.16 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.544 0.687 . . . . 0.0 109.69 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.137 -179.677 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.469 ' O ' ' C ' ' A' ' 2' ' ' CYS . 17.0 mmt180 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.013 0.435 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.583 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 32.1 p -35.45 147.78 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.534 -0.729 . . . . 0.0 111.07 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 3' ' ' LEU . 23.4 mt -80.26 123.42 83.18 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.501 -0.75 . . . . 0.0 110.822 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.484 ' O ' ' O ' ' A' ' 5' ' ' SER . 51.0 Cg_endo -75.82 143.89 27.06 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.95 1.5 . . . . 0.0 110.034 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 7.1 t -39.71 164.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.504 -0.747 . . . . 0.0 110.862 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.12 13.53 58.77 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 2.6 mptt -147.68 158.95 44.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.98 -1.306 . . . . 0.0 109.669 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -47.57 169.09 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.286 -1.509 . . . . 0.0 109.757 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.577 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 5.4 p -135.15 64.5 1.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 111.635 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.49 ' C ' ' NE2' ' A' ' 14' ' ' GLN . . . -86.55 59.12 5.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.059 -1.026 . . . . 0.0 109.152 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.565 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -69.43 84.3 0.26 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.565 ' CG2' ' O ' ' A' ' 11' ' ' GLY . 0.9 OUTLIER 174.12 -33.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.719 -0.871 . . . . 0.0 108.681 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -126.24 -26.35 3.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.573 -0.704 . . . . 0.0 109.954 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.562 ' OE1' ' HA ' ' A' ' 17' ' ' PRO . 3.3 pt20 -56.89 173.87 0.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 0.0 109.994 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.62 -39.03 81.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.896 . . . . 0.0 109.696 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.541 ' CG2' ' HD2' ' A' ' 17' ' ' PRO . 32.3 mt -134.34 143.69 48.0 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.576 -0.702 . . . . 0.0 109.699 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.562 ' HA ' ' OE1' ' A' ' 14' ' ' GLN . 47.3 Cg_endo -73.59 152.15 47.98 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.146 1.603 . . . . 0.0 111.983 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 19' ' ' CYS . 23.1 t -55.96 117.88 4.11 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.422 -0.799 . . . . 0.0 110.073 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.583 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -41.19 -32.7 0.29 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.568 1.175 . . . . 0.0 107.865 179.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 18' ' ' CYS . . . -106.62 -114.13 3.87 Favored Glycine 0 C--N 1.289 -2.072 0 N-CA-C 106.189 -2.764 . . . . 0.0 106.189 177.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 m -142.55 -179.12 6.11 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.108 -1.231 . . . . 0.0 109.613 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.577 ' HA ' ' CB ' ' A' ' 9' ' ' CYS . 53.7 t -96.65 88.52 4.67 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.059 -1.025 . . . . 0.0 110.071 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -113.12 143.42 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.503 -0.748 . . . . 0.0 109.466 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 60.79 36.36 19.24 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 122.102 0.953 . . . . 0.0 109.987 -179.448 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.85 20.46 48.26 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -141.47 176.71 8.66 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.675 -0.897 . . . . 0.0 111.339 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -86.02 119.7 26.61 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.5 ' HB3' ' CB ' ' A' ' 5' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.294 -1.83 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.208 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 6.5 mtp85 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.219 0.533 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.558 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 21.3 p -174.34 146.97 1.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.878 . . . . 0.0 110.682 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.479 ' HG ' HG21 ' A' ' 16' ' ' ILE . 39.1 mt -81.52 139.62 47.85 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.477 -0.764 . . . . 0.0 110.443 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.514 ' O ' ' O ' ' A' ' 5' ' ' SER . 47.3 Cg_endo -74.63 117.12 4.83 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.03 1.542 . . . . 0.0 110.191 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.514 ' O ' ' O ' ' A' ' 4' ' ' PRO . 27.4 p -40.88 168.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.39 -0.819 . . . . 0.0 110.959 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.21 3.88 69.27 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -149.23 154.22 38.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -1.139 . . . . 0.0 109.978 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.15 155.34 37.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.259 -0.901 . . . . 0.0 109.974 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.42 ' HA ' HD13 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -115.67 -85.98 0.61 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.671 0.748 . . . . 0.0 109.447 179.501 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.433 ' HB3' ' CD ' ' A' ' 14' ' ' GLN . . . -162.08 -137.69 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 122.432 1.11 . . . . 0.0 108.67 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.541 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -106.63 -67.99 0.68 Allowed Glycine 0 C--N 1.272 -2.976 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 11' ' ' GLY . 2.3 t -168.7 -33.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.466 -1.02 . . . . 0.0 110.132 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.9 t -84.91 19.14 2.19 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.188 -0.945 . . . . 0.0 111.413 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.433 ' CD ' ' HB3' ' A' ' 10' ' ' ALA . 6.2 tt0 -67.81 146.13 54.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.796 -1.19 . . . . 0.0 109.853 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 ptpt -67.53 -27.74 67.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.049 -1.032 . . . . 0.0 109.353 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.479 HG21 ' HG ' ' A' ' 3' ' ' LEU . 5.0 mt -117.26 106.18 47.48 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.52 -0.738 . . . . 0.0 109.48 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.32 158.94 53.2 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.995 1.524 . . . . 0.0 110.682 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 21' ' ' SER . 11.0 t -64.04 121.3 13.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.445 -0.784 . . . . 0.0 110.134 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.558 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -47.04 -34.35 5.67 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 179.222 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.92 -108.99 2.41 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 106.308 -2.717 . . . . 0.0 106.308 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.537 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 23.9 p -141.73 129.59 21.78 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.011 -1.288 . . . . 0.0 109.781 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 7.5 t -78.61 78.94 5.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 109.677 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.452 HG23 ' OG ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -113.11 138.51 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.342 -0.849 . . . . 0.0 111.156 -179.384 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 59.81 35.99 22.03 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.047 0.927 . . . . 0.0 110.247 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.43 27.09 71.24 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -133.24 152.8 51.94 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.645 -0.915 . . . . 0.0 110.084 -179.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.508 ' HB3' ' HA ' ' A' ' 5' ' ' SER . 46.2 t -91.0 62.48 4.91 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.995 -1.066 . . . . 0.0 110.417 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.231 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.448 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 13.2 mmt180 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.204 0.526 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.612 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 31.6 p -177.53 145.22 0.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.407 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.543 ' HG ' ' CG2' ' A' ' 16' ' ' ILE . 12.5 mt -107.97 144.2 28.89 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.393 -0.817 . . . . 0.0 110.305 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 5' ' ' SER . 48.0 Cg_endo -73.45 158.45 47.96 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 O-C-N 124.201 1.632 . . . . 0.0 109.776 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 60.7 p -42.6 169.28 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.929 . . . . 0.0 110.831 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.92 4.72 69.01 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -145.3 141.59 28.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.887 -1.361 . . . . 0.0 110.565 179.493 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -39.19 145.05 0.11 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.432 0.634 . . . . 0.0 110.708 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.471 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 9.0 p -119.91 59.9 0.87 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.558 -0.714 . . . . 0.0 109.865 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.529 ' CB ' HG22 ' A' ' 13' ' ' THR . . . -86.91 59.99 5.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.14 -0.975 . . . . 0.0 109.885 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.499 ' HA2' ' HG2' ' A' ' 14' ' ' GLN . . . -57.27 -45.38 92.8 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -59.59 -32.82 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.445 -1.033 . . . . 0.0 110.843 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.529 HG22 ' CB ' ' A' ' 10' ' ' ALA . 3.5 t -116.38 29.76 7.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.13 -0.981 . . . . 0.0 111.288 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.499 ' HG2' ' HA2' ' A' ' 11' ' ' GLY . 5.4 pt20 -152.54 176.07 12.09 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.876 -1.14 . . . . 0.0 110.222 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.465 ' HG3' HG13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -88.8 -34.47 17.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.891 . . . . 0.0 111.374 -179.039 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.543 ' CG2' ' HG ' ' A' ' 3' ' ' LEU . 50.5 mt -115.7 111.31 43.67 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.886 -1.134 . . . . 0.0 110.944 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.71 -179.26 5.01 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.896 1.472 . . . . 0.0 110.623 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.6 t -75.24 117.52 17.15 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.635 0.731 . . . . 0.0 110.171 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.612 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -48.65 -34.5 11.91 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.271 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.31 -111.15 0.82 Allowed Glycine 0 C--N 1.294 -1.789 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -142.26 148.52 38.22 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 120.915 -1.344 . . . . 0.0 109.724 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 53.2 t -78.84 122.09 25.63 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.999 -1.063 . . . . 0.0 110.09 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.727 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -140.0 -176.62 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.622 0 O-C-N 121.424 -0.798 . . . . 0.0 108.94 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.574 ' N ' ' CG1' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 10.28 44.58 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.727 ' N ' ' O ' ' A' ' 23' ' ' VAL . . . 73.17 -10.82 5.51 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.235 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 23' ' ' VAL . 3.2 tttp -129.27 150.69 50.53 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 120.413 -1.64 . . . . 0.0 110.791 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 5' ' ' SER . 7.6 t -63.39 137.06 58.03 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.76 0.791 . . . . 0.0 109.725 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 5' ' ' SER . 3.3 p . . . . . 0 C--N 1.296 -1.733 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.317 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.539 ' CB ' HG13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.314 0.578 . . . . 0.0 110.109 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.602 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 31.2 p -42.33 146.33 0.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 110.043 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.464 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 92.9 mt -89.92 128.52 49.73 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.411 -0.805 . . . . 0.0 110.519 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 5' ' ' SER . 48.2 Cg_endo -74.35 141.5 28.81 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.904 1.476 . . . . 0.0 109.512 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 87.9 p -40.11 159.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.323 -0.861 . . . . 0.0 110.764 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.55 15.6 56.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.81 163.35 22.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.099 -1.236 . . . . 0.0 109.837 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.0 91.7 7.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.053 . . . . 0.0 110.614 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 26.7 p -81.34 90.9 6.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.022 -1.048 . . . . 0.0 109.768 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.5 71.19 1.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 110.004 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 175.43 65.7 0.06 OUTLIER Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 11' ' ' GLY . 74.7 t -39.28 -28.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.675 -0.897 . . . . 0.0 110.311 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.471 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.9 t -89.78 38.64 0.92 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 109.605 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.483 ' NE2' ' HA ' ' A' ' 17' ' ' PRO . 29.7 pt20 -87.24 -178.55 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 0.0 110.016 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.607 ' O ' HD13 ' A' ' 16' ' ' ILE . 10.5 mmtt -71.31 -43.47 67.0 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.402 -0.811 . . . . 0.0 109.743 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.607 HD13 ' O ' ' A' ' 15' ' ' LYS . 21.1 mm -140.63 139.47 20.24 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.547 -0.72 . . . . 0.0 110.496 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.483 ' HA ' ' NE2' ' A' ' 14' ' ' GLN . 47.0 Cg_endo -74.42 -176.35 2.69 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.132 1.596 . . . . 0.0 111.05 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 7.5 t -66.82 122.08 16.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.589 -0.694 . . . . 0.0 110.397 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.602 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -44.17 -31.27 0.93 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.616 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.413 ' N ' ' C ' ' A' ' 18' ' ' CYS . . . -102.5 -107.3 3.1 Favored Glycine 0 C--N 1.296 -1.686 0 N-CA-C 106.062 -2.815 . . . . 0.0 106.062 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.2 p -142.7 123.69 14.42 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.084 -1.245 . . . . 0.0 109.732 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 18' ' ' CYS . 4.4 t -78.15 117.94 19.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.167 -0.958 . . . . 0.0 110.538 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.92 142.29 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.414 -0.804 . . . . 0.0 109.635 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 6.5 tpm_? 58.51 36.04 25.01 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.116 0.96 . . . . 0.0 110.183 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 59.86 28.2 65.54 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -140.47 116.43 10.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.692 -0.887 . . . . 0.0 110.953 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 5' ' ' SER . 0.3 OUTLIER -53.52 113.43 1.17 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.287 -0.883 . . . . 0.0 109.223 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.235 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.616 ' O ' HG23 ' A' ' 16' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.286 0.565 . . . . 0.0 110.252 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.671 ' HA ' HG22 ' A' ' 16' ' ' ILE . 14.8 p -162.52 143.21 9.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 110.401 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.86 HD22 ' HE3' ' A' ' 7' ' ' LYS . 11.2 mt -80.89 135.23 52.07 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.531 -0.731 . . . . 0.0 110.597 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 5' ' ' SER . 47.4 Cg_endo -76.09 149.74 32.78 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.016 1.534 . . . . 0.0 110.126 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 60.3 p -40.58 157.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.454 -0.779 . . . . 0.0 110.687 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 7' ' ' LYS . . . 87.57 20.09 52.45 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.86 ' HE3' HD22 ' A' ' 3' ' ' LEU . 7.8 mmmt -141.39 -172.16 3.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -1.093 . . . . 0.0 109.785 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.81 166.47 23.31 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.755 -0.778 . . . . 0.0 108.992 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 26' ' ' LYS . 8.4 p -147.37 45.41 1.14 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.786 -1.196 . . . . 0.0 111.083 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 14' ' ' GLN . . . -103.84 61.72 0.75 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.144 -0.972 . . . . 0.0 109.831 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.96 -18.22 11.25 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.547 HG23 ' N ' ' A' ' 13' ' ' THR . 27.6 m -53.9 -40.7 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -1.201 . . . . 0.0 109.478 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.547 ' N ' HG23 ' A' ' 12' ' ' VAL . 8.9 t -119.2 9.33 11.7 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.727 -0.608 . . . . 0.0 109.73 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -104.85 162.09 13.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.363 -0.836 . . . . 0.0 110.172 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.663 ' O ' HD13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -86.1 -15.97 39.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.3 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.671 HG22 ' HA ' ' A' ' 2' ' ' CYS . 49.1 mm -140.04 117.67 8.34 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.74 . . . . 0.0 109.74 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.1 170.35 19.85 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.867 1.456 . . . . 0.0 111.214 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 21' ' ' SER . 1.8 t -69.04 118.72 12.3 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.79 0.805 . . . . 0.0 110.118 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.645 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -45.15 -33.71 2.36 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.28 -111.67 2.32 Favored Glycine 0 C--N 1.292 -1.888 0 N-CA-C 106.321 -2.712 . . . . 0.0 106.321 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.522 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 29.7 m -141.9 173.26 11.68 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.955 -1.321 . . . . 0.0 109.889 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 48.3 t -95.82 106.96 19.16 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.134 -0.979 . . . . 0.0 110.704 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.49 HG21 ' CB ' ' A' ' 28' ' ' SER . 1.8 m -123.82 123.6 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.338 -0.851 . . . . 0.0 109.881 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.52 30.86 12.73 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 122.363 1.077 . . . . 0.0 109.283 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.422 ' C ' ' SG ' ' A' ' 9' ' ' CYS . . . 69.19 18.5 73.15 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 7' ' ' LYS . 5.9 ttmt -141.45 129.36 21.85 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.368 -1.078 . . . . 0.0 111.825 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 5' ' ' SER . 20.1 t -45.84 112.99 0.53 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.422 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.511 ' OXT' ' CB ' ' A' ' 5' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.505 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.54 ' C ' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.221 0.534 . . . . 0.0 110.149 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.585 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 22.4 p -176.96 145.67 0.49 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 0.0 110.331 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.961 HD11 ' O ' ' A' ' 16' ' ' ILE . 1.8 mp -87.43 131.77 43.03 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.557 -0.715 . . . . 0.0 110.498 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 5' ' ' SER . 45.7 Cg_endo -72.6 139.81 31.74 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.916 1.482 . . . . 0.0 109.301 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 1.8 m -39.32 161.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -0.834 . . . . 0.0 110.811 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.52 17.36 52.8 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' ALA . 7.9 mttp -149.58 146.57 27.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -1.208 . . . . 0.0 109.958 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -43.2 165.64 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.299 -0.875 . . . . 0.0 109.995 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.478 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 6.6 p -141.55 62.48 1.45 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 0.0 110.507 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 14' ' ' GLN . . . -86.41 57.2 4.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.868 -1.145 . . . . 0.0 110.134 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 14' ' ' GLN . . . -71.98 -11.05 74.02 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.468 HG22 ' H ' ' A' ' 12' ' ' VAL . 3.4 m -52.85 -33.69 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.143 . . . . 0.0 109.57 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -126.88 -26.26 3.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.589 -0.694 . . . . 0.0 109.764 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.512 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 8.0 tt0 -63.9 164.13 10.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 0.0 109.82 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.406 ' N ' ' CG ' ' A' ' 14' ' ' GLN . 10.4 mmtp -85.7 -38.91 17.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.43 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.961 ' O ' HD11 ' A' ' 3' ' ' LEU . 2.1 mp -108.21 108.03 60.78 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 110.258 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.747 ' O ' HD12 ' A' ' 3' ' ' LEU . 50.6 Cg_endo -76.75 175.3 11.55 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.062 1.559 . . . . 0.0 111.363 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 21' ' ' SER . 2.0 t -62.74 119.41 9.25 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.775 0.798 . . . . 0.0 110.961 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.585 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -43.85 -35.36 1.91 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.96 -112.4 1.88 Allowed Glycine 0 C--N 1.29 -2.006 0 N-CA-C 106.187 -2.765 . . . . 0.0 106.187 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.509 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -142.37 161.64 37.51 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.117 -1.225 . . . . 0.0 109.821 177.517 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 45.9 t -94.04 88.94 5.85 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.123 -0.985 . . . . 0.0 110.337 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.547 HG21 ' HB2' ' A' ' 28' ' ' SER . 1.6 m -111.03 131.31 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.419 -0.8 . . . . 0.0 109.754 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.474 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER 64.56 33.05 11.14 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.222 1.01 . . . . 0.0 109.441 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.29 21.82 64.66 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.53 142.11 35.24 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.379 -1.071 . . . . 0.0 111.318 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 5' ' ' SER . 49.9 t -67.92 94.45 0.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.755 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.547 ' HB2' HG21 ' A' ' 23' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.097 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.465 ' HA ' ' CD1' ' A' ' 16' ' ' ILE . 4.2 ptp180 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.268 0.556 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.547 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 14.1 p -164.08 150.31 11.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.327 -0.858 . . . . 0.0 110.248 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.534 ' HG ' HG22 ' A' ' 16' ' ' ILE . 19.0 mt -97.84 137.0 20.92 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.463 -0.773 . . . . 0.0 110.171 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.477 ' O ' ' O ' ' A' ' 5' ' ' SER . 46.0 Cg_endo -72.45 135.15 23.83 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 O-C-N 124.08 1.568 . . . . 0.0 109.061 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.555 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 10.0 m -39.68 162.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.455 -0.778 . . . . 0.0 110.474 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.22 17.49 50.25 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -150.9 147.45 27.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.472 -1.016 . . . . 0.0 109.552 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -40.52 160.72 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.433 -0.792 . . . . 0.0 110.155 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 6.6 p -133.77 65.7 1.57 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.196 -0.94 . . . . 0.0 111.052 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -90.24 61.33 5.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.057 -1.027 . . . . 0.0 109.463 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.522 ' HA2' ' HG2' ' A' ' 14' ' ' GLN . . . -77.36 -10.2 86.38 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.5 t -80.4 -13.53 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.041 -1.27 . . . . 0.0 110.302 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.8 -17.59 2.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.159 -0.963 . . . . 0.0 111.278 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.522 ' HG2' ' HA2' ' A' ' 11' ' ' GLY . 4.4 pt20 -98.1 177.59 5.36 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.864 -1.148 . . . . 0.0 110.377 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HG3' HG12 ' A' ' 16' ' ' ILE . 4.6 ptmt -88.47 -28.27 20.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.868 . . . . 0.0 110.608 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.534 HG22 ' HG ' ' A' ' 3' ' ' LEU . 32.5 mm -102.66 103.89 35.22 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 0.0 110.573 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.426 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 50.6 Cg_endo -76.61 171.99 17.02 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.918 1.483 . . . . 0.0 110.228 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 21' ' ' SER . 29.8 t -72.22 116.55 12.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.248 -0.907 . . . . 0.0 110.109 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.547 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -46.53 -33.61 4.2 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.486 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.87 -110.34 2.71 Favored Glycine 0 C--N 1.292 -1.909 0 N-CA-C 106.204 -2.758 . . . . 0.0 106.204 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.458 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 1.2 m -141.98 164.98 28.7 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.042 -1.269 . . . . 0.0 109.42 177.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 54.1 t -99.8 92.68 5.42 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.713 -1.242 . . . . 0.0 110.722 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.27 135.0 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.292 -0.88 . . . . 0.0 110.402 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.91 33.79 20.78 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 122.067 0.937 . . . . 0.0 110.601 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.61 26.44 74.47 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.426 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 1.9 ttmm -141.52 143.65 33.89 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.173 -1.192 . . . . 0.0 111.075 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 5' ' ' SER . 23.9 t -77.22 111.38 12.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 109.195 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.433 ' C ' ' OG ' ' A' ' 5' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.268 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 2' ' ' CYS . 8.1 mtm180 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.27 0.557 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.62 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 29.3 p -41.66 148.09 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 110.422 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.78 135.97 21.91 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.0 110.378 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 5' ' ' SER . 47.3 Cg_endo -74.85 149.53 37.6 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.964 1.507 . . . . 0.0 110.021 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 2.9 m -39.62 161.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.372 -0.83 . . . . 0.0 110.315 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.54 13.84 59.22 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.478 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -125.55 162.33 25.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -1.151 . . . . 0.0 109.81 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.21 98.72 11.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.001 -1.062 . . . . 0.0 111.291 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 29.1 p -85.91 95.11 9.36 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.134 -0.978 . . . . 0.0 108.612 178.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -107.22 68.16 0.72 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.112 -0.993 . . . . 0.0 110.617 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.49 ' O ' ' C ' ' A' ' 12' ' ' VAL . . . 158.7 65.4 0.01 OUTLIER Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.49 ' C ' ' O ' ' A' ' 11' ' ' GLY . 1.7 m -36.6 -33.41 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.785 -0.833 . . . . 0.0 109.896 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.9 t -88.46 42.73 1.09 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.448 -0.783 . . . . 0.0 109.103 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 11' ' ' GLY . 2.1 mt-30 -91.46 154.87 18.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.507 -0.746 . . . . 0.0 110.121 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt -65.38 -35.88 82.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 108.865 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.674 HG22 ' O ' ' A' ' 16' ' ' ILE . 5.9 mm -125.17 82.93 61.37 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.34 178.7 6.67 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 124.128 1.594 . . . . 0.0 111.332 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 21' ' ' SER . 3.9 t -61.79 120.02 9.89 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.556 0.693 . . . . 0.0 110.551 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.62 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -43.96 -35.72 2.15 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.027 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.35 -107.04 0.89 Allowed Glycine 0 C--N 1.291 -1.97 0 N-CA-C 105.983 -2.847 . . . . 0.0 105.983 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.507 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.2 OUTLIER -142.56 170.59 15.43 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.014 -1.286 . . . . 0.0 110.055 177.382 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 46.6 t -108.39 94.59 5.14 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.994 -1.066 . . . . 0.0 110.13 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -121.76 138.75 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -0.932 . . . . 0.0 109.776 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 37.7 mtp180 61.31 34.51 18.48 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.152 0.977 . . . . 0.0 110.203 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.6 18.49 59.02 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 7' ' ' LYS . 2.5 ttpp -140.84 131.48 25.58 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.327 -1.102 . . . . 0.0 111.528 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 5' ' ' SER . 25.2 t -58.13 119.95 7.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.457 -0.777 . . . . 0.0 109.645 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--N 1.3 -1.58 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.14 -179.837 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.223 0.535 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.607 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 8.9 p -162.85 138.84 7.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 110.517 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 5.8 mt -59.76 123.73 72.9 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.594 -0.692 . . . . 0.0 109.809 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' A' ' 5' ' ' SER . 43.1 Cg_endo -70.55 125.92 12.25 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.811 1.427 . . . . 0.0 109.746 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 16.0 t -38.7 156.82 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.547 -0.721 . . . . 0.0 110.504 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.9 14.84 58.8 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.98 169.92 14.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.401 -1.058 . . . . 0.0 109.746 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.82 112.7 24.73 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.923 -1.11 . . . . 0.0 111.094 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 25.9 p -91.74 91.02 7.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.316 -0.865 . . . . 0.0 109.209 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -110.27 63.14 0.6 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.246 -0.909 . . . . 0.0 109.435 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 14' ' ' GLN . . . -172.62 66.37 0.12 Allowed Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 m -50.54 -32.57 10.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.937 -1.331 . . . . 0.0 109.411 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 14' ' ' GLN . 12.8 t -89.53 -21.18 23.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.509 -0.745 . . . . 0.0 110.476 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.549 ' NE2' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -37.15 158.1 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.563 -0.711 . . . . 0.0 110.124 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 12.8 mttm -73.5 -35.64 65.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.008 -1.057 . . . . 0.0 110.34 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.436 ' N ' ' HG2' ' A' ' 14' ' ' GLN . 7.9 mt -99.93 103.06 19.84 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.48 -0.763 . . . . 0.0 110.273 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.549 ' HA ' ' NE2' ' A' ' 14' ' ' GLN . 48.3 Cg_endo -75.94 169.15 22.73 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.973 1.512 . . . . 0.0 110.697 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 21' ' ' SER . 3.0 t -68.56 116.65 9.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.87 . . . . 0.0 109.593 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.607 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -42.84 -33.23 0.73 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.72 -111.87 3.0 Favored Glycine 0 C--N 1.293 -1.817 0 N-CA-C 106.15 -2.78 . . . . 0.0 106.15 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.553 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -142.07 141.61 32.77 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.059 -1.259 . . . . 0.0 110.162 177.374 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.7 t -79.93 81.77 6.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.091 -1.006 . . . . 0.0 110.251 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 6.6 m -109.95 133.25 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.668 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 62.4 34.08 15.82 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.231 1.015 . . . . 0.0 109.722 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.29 24.46 67.42 Favored Glycine 0 C--N 1.291 -1.969 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -139.13 138.67 37.21 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.483 -1.01 . . . . 0.0 110.607 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 5' ' ' SER . 14.5 t -69.92 81.04 0.47 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.487 -0.758 . . . . 0.0 109.61 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.508 ' HG ' ' C ' ' A' ' 27' ' ' CYS . 58.4 p . . . . . 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 0.0 110.174 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.534 ' O ' HG21 ' A' ' 16' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 120.76 0.314 . . . . 0.0 110.265 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.594 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 16.2 p 175.39 145.43 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.23 -0.919 . . . . 0.0 109.648 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.471 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 79.8 mt -86.44 122.69 71.95 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.068 -1.02 . . . . 0.0 110.985 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 5' ' ' SER . 44.6 Cg_endo -73.97 144.4 34.21 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.414 1.218 . . . . 0.0 110.945 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.63 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 2.2 m -39.28 153.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.532 -0.73 . . . . 0.0 110.641 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' A' ' 7' ' ' LYS . . . 90.87 24.85 26.46 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.119 -1.039 . . . . 0.0 110.535 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 34.0 mttt -159.27 148.31 18.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.084 -1.244 . . . . 0.0 110.373 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -44.3 125.97 4.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.97 . . . . 0.0 110.487 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.475 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 23.8 p -98.06 82.58 2.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.201 -0.937 . . . . 0.0 110.005 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.51 ' O ' ' CG ' ' A' ' 14' ' ' GLN . . . -91.37 60.55 4.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.048 -1.032 . . . . 0.0 109.974 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.511 ' HA2' ' HG2' ' A' ' 14' ' ' GLN . . . -87.68 -11.17 68.82 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -82.74 -5.32 8.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.3 -1.117 . . . . 0.0 110.1 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.16 -30.19 0.87 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 110.855 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.511 ' HG2' ' HA2' ' A' ' 11' ' ' GLY . 3.9 pt20 -81.65 179.88 7.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.017 -1.052 . . . . 0.0 110.278 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.79 -35.76 51.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.356 -0.84 . . . . 0.0 111.437 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.534 HG21 ' O ' ' A' ' 1' ' ' ARG . 7.8 mm -120.23 136.44 25.12 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.008 -1.057 . . . . 0.0 110.78 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.481 ' HA ' ' HA3' ' A' ' 11' ' ' GLY . 49.3 Cg_endo -77.0 -172.14 1.35 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.991 1.521 . . . . 0.0 110.696 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -79.35 127.96 32.74 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.99 0.9 . . . . 0.0 110.64 -179.067 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.594 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -46.35 -31.1 2.39 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.94 -112.99 2.36 Favored Glycine 0 C--N 1.294 -1.751 0 N-CA-C 105.544 -3.022 . . . . 0.0 105.544 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 14.4 m -143.05 162.24 36.04 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.098 -1.236 . . . . 0.0 109.387 177.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 48.9 t -101.7 115.67 31.04 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.941 -1.099 . . . . 0.0 109.836 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.609 HG21 ' CB ' ' A' ' 28' ' ' SER . 9.6 m -137.46 124.58 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.703 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.528 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 63.48 33.12 13.85 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.349 1.071 . . . . 0.0 109.818 -179.549 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.71 15.54 66.7 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.1 tptt -140.77 126.08 18.68 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.471 -1.017 . . . . 0.0 110.437 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.63 ' HB3' ' HA ' ' A' ' 5' ' ' SER . 0.7 OUTLIER -46.93 125.1 7.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.427 -0.795 . . . . 0.0 110.234 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.609 ' CB ' HG21 ' A' ' 23' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.057 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.523 ' C ' HG23 ' A' ' 16' ' ' ILE . 19.5 mmm180 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.235 0.54 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.624 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 30.3 p -148.63 144.44 27.19 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.325 -0.86 . . . . 0.0 110.37 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.644 ' HG ' HG22 ' A' ' 16' ' ' ILE . 19.7 mt -83.89 134.39 44.24 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.555 -0.715 . . . . 0.0 110.269 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.47 ' O ' ' C ' ' A' ' 5' ' ' SER . 47.9 Cg_endo -81.51 144.2 14.08 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.026 1.54 . . . . 0.0 109.787 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.492 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 4.6 t -38.73 151.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.391 -0.818 . . . . 0.0 110.216 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.49 ' HA2' ' HE2' ' A' ' 26' ' ' LYS . . . 90.52 15.7 56.46 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -122.08 172.21 8.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.392 -1.064 . . . . 0.0 109.778 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.77 155.26 18.37 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.017 -1.052 . . . . 0.0 110.477 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.424 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 27.1 p -160.72 73.02 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.575 -0.703 . . . . 0.0 109.287 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.28 72.17 0.89 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.323 -0.861 . . . . 0.0 110.484 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 12' ' ' VAL . . . -167.01 -48.3 0.02 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.562 ' CB ' ' O ' ' A' ' 11' ' ' GLY . 0.4 OUTLIER 81.49 -30.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.905 -0.762 . . . . 0.0 110.454 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 13' ' ' THR . 4.0 t -90.88 -13.6 33.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.111 -0.993 . . . . 0.0 109.732 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 13' ' ' THR . 15.9 pt20 -41.34 160.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.484 -0.76 . . . . 0.0 109.602 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -79.54 -19.38 49.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.946 -1.096 . . . . 0.0 110.562 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.644 HG22 ' HG ' ' A' ' 3' ' ' LEU . 71.2 mt -119.97 102.39 46.63 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 110.604 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.79 166.78 26.46 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.228 1.646 . . . . 0.0 110.203 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 19' ' ' CYS . 6.0 t -65.14 120.87 13.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.079 -1.013 . . . . 0.0 109.989 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.624 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -43.91 -30.72 0.73 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.162 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.427 ' N ' ' C ' ' A' ' 18' ' ' CYS . . . -108.74 -106.17 3.03 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.519 ' O ' ' HB2' ' A' ' 28' ' ' SER . 58.3 m -142.08 136.46 30.16 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.072 -1.252 . . . . 0.0 109.378 177.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.424 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 3.8 t -78.88 126.06 30.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.092 -1.005 . . . . 0.0 111.145 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.419 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -137.89 138.11 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.511 -0.743 . . . . 0.0 109.485 179.174 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.419 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 5.6 ttt180 60.77 33.38 20.11 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.999 0.904 . . . . 0.0 110.794 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.25 6.57 47.96 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.49 ' HE2' ' HA2' ' A' ' 6' ' ' GLY . 5.8 tptt -129.59 124.91 34.94 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.262 -1.14 . . . . 0.0 111.236 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.492 ' HB3' ' HA ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -42.53 124.41 2.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.568 -0.707 . . . . 0.0 109.574 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 21' ' ' SER . 39.0 t . . . . . 0 C--N 1.299 -1.614 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.186 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.609 ' HB2' HD12 ' A' ' 16' ' ' ILE . 53.2 mtm180 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.252 0.548 . . . . 0.0 110.324 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.541 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 17.0 p -158.87 150.34 20.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.364 -0.835 . . . . 0.0 110.139 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.51 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 81.1 mt -113.84 101.1 53.53 Favored Pre-proline 0 N--CA 1.493 1.704 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.013 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 48.2 Cg_endo -97.7 16.86 0.58 Allowed 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 121.629 1.552 . . . . 0.0 109.464 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 t -93.55 11.4 28.83 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.366 -0.833 . . . . 0.0 112.435 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 26' ' ' LYS . . . 67.91 20.99 73.08 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -59.63 144.9 46.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.499 -1.0 . . . . 0.0 109.521 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 25' ' ' GLY . . . -59.7 103.23 0.19 Allowed 'General case' 0 C--N 1.29 -1.985 0 O-C-N 120.582 -1.324 . . . . 0.0 110.144 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 25.4 p -86.99 88.28 7.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.575 -0.703 . . . . 0.0 110.278 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.66 64.0 0.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.981 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 12' ' ' VAL . . . 176.69 68.14 0.06 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 11' ' ' GLY . 24.3 t -40.28 -30.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.429 -1.042 . . . . 0.0 110.368 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 13' ' ' THR . 6.6 t -88.29 38.01 0.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.947 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -89.75 146.25 24.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 110.123 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.503 ' HG3' HG12 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -68.97 -24.42 64.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.115 -0.991 . . . . 0.0 109.578 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.609 HD12 ' HB2' ' A' ' 1' ' ' ARG . 12.4 mm -110.67 99.64 42.43 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.35 -0.844 . . . . 0.0 109.844 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.514 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 44.4 Cg_endo -72.04 167.06 27.78 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.125 1.592 . . . . 0.0 111.188 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.1 t -76.4 127.93 33.83 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.535 -0.728 . . . . 0.0 110.816 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.541 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -57.96 -29.13 64.95 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.337 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.42 -113.57 3.81 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 106.357 -2.697 . . . . 0.0 106.357 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.4 t -142.61 157.75 44.37 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.87 -1.371 . . . . 0.0 110.691 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.6 t -83.44 91.73 7.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.834 . . . . 0.0 109.849 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -124.15 131.29 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.21 -0.931 . . . . 0.0 111.566 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 1.9 mmp_? 63.23 34.71 13.15 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 122.072 0.939 . . . . 0.0 110.229 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 8' ' ' ALA . . . 62.58 21.47 62.71 Favored Glycine 0 C--N 1.288 -2.1 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 6' ' ' GLY . 12.7 ttmt -129.09 138.17 51.68 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.723 -0.869 . . . . 0.0 110.038 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -75.0 78.52 2.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.423 -0.798 . . . . 0.0 110.474 -179.248 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 27' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.953 -1.023 . . . . 0.0 110.232 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.64 ' N ' HD13 ' A' ' 16' ' ' ILE . 3.2 mtt85 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.601 ' O ' ' O ' ' A' ' 1' ' ' ARG . 13.4 p 46.14 140.7 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 CA-C-O 122.632 1.206 . . . . 0.0 112.521 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.543 HD11 HE22 ' A' ' 14' ' ' GLN . 94.7 mt -90.78 139.2 26.14 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.051 -1.031 . . . . 0.0 110.941 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -80.66 142.85 14.61 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.878 1.462 . . . . 0.0 110.342 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.524 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 40.8 t -43.65 151.24 0.2 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.283 -0.885 . . . . 0.0 110.431 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.76 27.93 20.34 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.03 -175.5 4.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -1.117 . . . . 0.0 109.694 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.39 111.01 22.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.414 -0.804 . . . . 0.0 109.223 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 26' ' ' LYS . 27.4 p -91.18 84.47 5.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -0.925 . . . . 0.0 111.078 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.533 ' O ' ' CG ' ' A' ' 14' ' ' GLN . . . -88.77 55.65 3.45 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.627 -1.295 . . . . 0.0 109.338 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 17' ' ' PRO . . . -76.88 2.88 58.63 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.45 -22.41 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.185 -1.185 . . . . 0.0 109.908 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.6 t -142.75 3.23 1.43 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.288 -0.882 . . . . 0.0 111.053 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.543 HE22 HD11 ' A' ' 3' ' ' LEU . 3.5 pt20 -99.92 -166.87 1.38 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.882 -1.136 . . . . 0.0 110.714 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.494 ' N ' ' HG3' ' A' ' 14' ' ' GLN . 7.6 ttpt -77.17 -49.26 15.58 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.696 -0.627 . . . . 0.0 111.024 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.64 HD13 ' N ' ' A' ' 1' ' ' ARG . 5.6 mt -133.58 140.8 37.96 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.267 -0.895 . . . . 0.0 111.078 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.48 ' HB3' ' HA3' ' A' ' 11' ' ' GLY . 47.4 Cg_endo -78.28 -165.78 0.36 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 124.313 1.691 . . . . 0.0 112.17 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 20.2 t -68.9 122.31 18.38 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.737 0.78 . . . . 0.0 111.472 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.489 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -46.14 -35.71 5.27 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.072 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.1 -103.55 1.6 Allowed Glycine 0 C--N 1.295 -1.717 0 N-CA-C 106.768 -2.533 . . . . 0.0 106.768 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.1 p -142.23 122.96 14.28 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.268 -1.136 . . . . 0.0 109.007 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 26.2 t -77.98 121.12 23.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.075 -1.015 . . . . 0.0 111.353 -178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.47 134.95 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.804 0.811 . . . . 0.0 109.947 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 58.3 34.1 23.75 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.996 0.903 . . . . 0.0 110.439 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.38 26.12 70.44 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.512 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 11.7 tttp -139.18 123.05 17.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.603 -0.94 . . . . 0.0 110.219 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 5' ' ' SER . 0.5 OUTLIER -52.9 107.17 0.2 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.4 -0.812 . . . . 0.0 109.956 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.43 ' HB3' ' OG ' ' A' ' 5' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.397 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.242 0.544 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.585 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 20.4 p -136.29 144.32 44.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.119 -0.988 . . . . 0.0 110.392 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.461 ' HG ' HG22 ' A' ' 16' ' ' ILE . 25.3 mt -86.22 141.58 35.08 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.481 -0.762 . . . . 0.0 110.644 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 5' ' ' SER . 46.8 Cg_endo -74.41 125.96 10.01 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.068 1.562 . . . . 0.0 109.638 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -39.46 158.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.453 -0.78 . . . . 0.0 110.757 -179.399 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 7' ' ' LYS . . . 90.24 25.03 27.47 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 6' ' ' GLY . 4.6 mmtt -151.69 153.7 34.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -1.102 . . . . 0.0 110.288 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.0 143.5 34.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.089 -1.007 . . . . 0.0 110.492 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -123.59 -91.06 0.56 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.702 0.763 . . . . 0.0 109.811 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 14' ' ' GLN . . . -162.27 -135.42 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.245 1.022 . . . . 0.0 108.443 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.486 ' C ' HG23 ' A' ' 12' ' ' VAL . . . -102.99 -73.39 0.96 Allowed Glycine 0 C--N 1.273 -2.935 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.486 HG23 ' C ' ' A' ' 11' ' ' GLY . 5.2 t -149.98 -39.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.383 -1.069 . . . . 0.0 110.058 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.778 ' O ' HG23 ' A' ' 13' ' ' THR . 8.9 t -103.05 83.36 2.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.314 -0.866 . . . . 0.0 110.143 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.452 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 1.7 pm0 -118.16 174.73 6.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.887 . . . . 0.0 110.053 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.518 ' HG2' ' N ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -67.01 -26.38 66.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.645 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.518 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 87.3 mt -141.02 107.56 6.28 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.452 -0.78 . . . . 0.0 109.683 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 16' ' ' ILE . 45.1 Cg_endo -71.59 157.36 56.14 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.944 1.497 . . . . 0.0 111.349 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.539 ' SG ' ' N ' ' A' ' 21' ' ' SER . 4.5 t -69.07 119.97 14.19 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.83 0.824 . . . . 0.0 109.878 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.585 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -45.52 -33.29 2.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.35 -104.88 2.02 Favored Glycine 0 C--N 1.293 -1.831 0 N-CA-C 106.149 -2.78 . . . . 0.0 106.149 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.539 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 1.7 p -141.68 116.97 10.11 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.132 -1.216 . . . . 0.0 109.547 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.536 ' N ' ' HB3' ' A' ' 18' ' ' CYS . 41.1 t -78.87 82.01 5.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 110.295 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.453 ' CG2' ' OG ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -106.72 143.68 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.454 -0.778 . . . . 0.0 109.851 179.725 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER 59.96 37.38 21.44 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.114 0.959 . . . . 0.0 109.879 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 10' ' ' ALA . . . 61.04 26.13 65.26 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -140.21 140.24 35.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.48 -1.012 . . . . 0.0 111.203 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 5' ' ' SER . 36.9 t -83.29 89.43 7.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.56 -0.713 . . . . 0.0 109.337 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.313 -179.456 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.48 ' O ' HD12 ' A' ' 16' ' ' ILE . 50.7 mtt-85 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.162 0.506 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.659 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 4.8 p 174.32 138.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -0.88 . . . . 0.0 110.168 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.805 HD13 ' HA ' ' A' ' 9' ' ' CYS . 2.9 mt -61.37 119.0 42.48 Favored Pre-proline 0 C--N 1.303 -1.453 0 C-N-CA 119.659 -0.817 . . . . 0.0 109.513 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 5' ' ' SER . 41.3 Cg_endo -68.22 125.96 13.68 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.951 1.5 . . . . 0.0 109.977 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 72.1 m -38.49 152.93 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.682 -0.637 . . . . 0.0 110.296 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.94 18.97 49.1 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 8' ' ' ALA . 10.8 mttt -154.89 148.44 25.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.395 -1.062 . . . . 0.0 110.147 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -42.03 160.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.883 . . . . 0.0 110.541 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.805 ' HA ' HD13 ' A' ' 3' ' ' LEU . 4.8 p -147.37 68.64 1.14 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.49 -0.756 . . . . 0.0 110.231 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.01 59.07 5.41 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.149 -0.969 . . . . 0.0 109.789 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.569 ' HA2' ' CD ' ' A' ' 14' ' ' GLN . . . -85.41 -6.84 83.33 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 12' ' ' VAL . 6.2 t -54.85 -20.3 5.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.093 -1.24 . . . . 0.0 108.562 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.6 t -123.99 -12.51 7.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.622 -0.674 . . . . 0.0 109.663 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.591 ' HG2' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -97.48 164.37 12.47 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.271 -0.893 . . . . 0.0 109.33 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.591 ' N ' ' HG2' ' A' ' 14' ' ' GLN . 4.7 mmtt -82.65 -35.64 26.74 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.933 -1.104 . . . . 0.0 112.386 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.593 ' CG2' ' HA ' ' A' ' 2' ' ' CYS . 9.6 mm -101.54 95.97 5.77 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.917 -1.114 . . . . 0.0 110.994 -178.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 46.8 Cg_endo -70.09 -176.01 1.43 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 124.15 1.605 . . . . 0.0 112.394 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -63.08 119.85 10.3 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.994 0.902 . . . . 0.0 110.504 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.659 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -42.35 -34.45 0.81 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 122.553 1.168 . . . . 0.0 107.993 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.36 -112.14 2.59 Favored Glycine 0 C--N 1.288 -2.126 0 N-CA-C 105.976 -2.85 . . . . 0.0 105.976 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.533 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.2 OUTLIER -141.79 133.08 26.45 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.24 -1.153 . . . . 0.0 109.126 177.053 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 47.1 t -78.84 119.91 22.71 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.098 -1.001 . . . . 0.0 110.208 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.544 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 2.4 t -140.95 160.93 23.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER 36.93 30.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.855 0.836 . . . . 0.0 111.836 -179.488 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 23' ' ' VAL . . . 87.11 -24.29 9.54 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.062 177.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.04 147.33 36.22 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.49 -1.594 . . . . 0.0 112.686 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 5' ' ' SER . 43.1 t -66.98 103.49 1.16 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.544 0.687 . . . . 0.0 109.69 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.137 -179.677 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.469 ' O ' ' C ' ' A' ' 2' ' ' CYS . 17.0 mmt180 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.013 0.435 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.601 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 32.1 p -35.45 147.78 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.534 -0.729 . . . . 0.0 111.07 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 3' ' ' LEU . 23.4 mt -80.26 123.42 83.18 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.501 -0.75 . . . . 0.0 110.822 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.484 ' O ' ' O ' ' A' ' 5' ' ' SER . 51.0 Cg_endo -75.82 143.89 27.06 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.95 1.5 . . . . 0.0 110.034 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.561 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 7.1 t -39.71 164.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.504 -0.747 . . . . 0.0 110.862 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.12 13.53 58.77 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.573 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 2.6 mptt -147.68 158.95 44.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.98 -1.306 . . . . 0.0 109.669 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -47.57 169.09 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.286 -1.509 . . . . 0.0 109.757 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.569 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 5.4 p -135.15 64.5 1.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 111.635 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.49 ' C ' ' NE2' ' A' ' 14' ' ' GLN . . . -86.55 59.12 5.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.059 -1.026 . . . . 0.0 109.152 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.866 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -69.43 84.3 0.26 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 11' ' ' GLY . 0.9 OUTLIER 174.12 -33.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.719 -0.871 . . . . 0.0 108.681 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -126.24 -26.35 3.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.573 -0.704 . . . . 0.0 109.954 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.64 ' OE1' ' HA ' ' A' ' 17' ' ' PRO . 3.3 pt20 -56.89 173.87 0.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 0.0 109.994 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.62 -39.03 81.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.896 . . . . 0.0 109.696 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 2' ' ' CYS . 32.3 mt -134.34 143.69 48.0 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.576 -0.702 . . . . 0.0 109.699 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.64 ' HA ' ' OE1' ' A' ' 14' ' ' GLN . 47.3 Cg_endo -73.59 152.15 47.98 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.146 1.603 . . . . 0.0 111.983 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 19' ' ' CYS . 23.1 t -55.96 117.88 4.11 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.422 -0.799 . . . . 0.0 110.073 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.601 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -41.19 -32.7 0.29 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.568 1.175 . . . . 0.0 107.865 179.121 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 18' ' ' CYS . . . -106.62 -114.13 3.87 Favored Glycine 0 C--N 1.289 -2.072 0 N-CA-C 106.189 -2.764 . . . . 0.0 106.189 177.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 m -142.55 -179.12 6.11 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.108 -1.231 . . . . 0.0 109.613 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.569 ' HA ' ' CB ' ' A' ' 9' ' ' CYS . 53.7 t -96.65 88.52 4.67 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.059 -1.025 . . . . 0.0 110.071 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -113.12 143.42 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.503 -0.748 . . . . 0.0 109.466 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 60.79 36.36 19.24 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 122.102 0.953 . . . . 0.0 109.987 -179.448 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.85 20.46 48.26 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -141.47 176.71 8.66 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.675 -0.897 . . . . 0.0 111.339 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -86.02 119.7 26.61 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.515 ' HB3' ' CB ' ' A' ' 5' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.294 -1.83 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.208 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.219 0.533 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.568 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 21.3 p -174.34 146.97 1.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.878 . . . . 0.0 110.682 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.497 ' O ' ' HB2' ' A' ' 19' ' ' CYS . 39.1 mt -81.52 139.62 47.85 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.477 -0.764 . . . . 0.0 110.443 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.514 ' O ' ' O ' ' A' ' 5' ' ' SER . 47.3 Cg_endo -74.63 117.12 4.83 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.03 1.542 . . . . 0.0 110.191 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.54 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 27.4 p -40.88 168.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.39 -0.819 . . . . 0.0 110.959 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.21 3.88 69.27 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -149.23 154.22 38.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -1.139 . . . . 0.0 109.978 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.15 155.34 37.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.259 -0.901 . . . . 0.0 109.974 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.465 ' HA ' HD13 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -115.67 -85.98 0.61 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.671 0.748 . . . . 0.0 109.447 179.501 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -162.08 -137.69 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 122.432 1.11 . . . . 0.0 108.67 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.918 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -106.63 -67.99 0.68 Allowed Glycine 0 C--N 1.272 -2.976 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 11' ' ' GLY . 2.3 t -168.7 -33.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.466 -1.02 . . . . 0.0 110.132 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.9 t -84.91 19.14 2.19 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.188 -0.945 . . . . 0.0 111.413 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -67.81 146.13 54.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.796 -1.19 . . . . 0.0 109.853 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 ptpt -67.53 -27.74 67.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.049 -1.032 . . . . 0.0 109.353 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.0 mt -117.26 106.18 47.48 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.52 -0.738 . . . . 0.0 109.48 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.32 158.94 53.2 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.995 1.524 . . . . 0.0 110.682 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 21' ' ' SER . 11.0 t -64.04 121.3 13.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.445 -0.784 . . . . 0.0 110.134 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.568 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -47.04 -34.35 5.67 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 179.222 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.92 -108.99 2.41 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 106.308 -2.717 . . . . 0.0 106.308 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.537 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 23.9 p -141.73 129.59 21.78 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.011 -1.288 . . . . 0.0 109.781 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 7.5 t -78.61 78.94 5.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 109.677 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.442 HG22 ' OG ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -113.11 138.51 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.342 -0.849 . . . . 0.0 111.156 -179.384 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 59.81 35.99 22.03 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.047 0.927 . . . . 0.0 110.247 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.43 27.09 71.24 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -133.24 152.8 51.94 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.645 -0.915 . . . . 0.0 110.084 -179.758 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.54 ' HB3' ' HA ' ' A' ' 5' ' ' SER . 46.2 t -91.0 62.48 4.91 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.995 -1.066 . . . . 0.0 110.417 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.231 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 13.2 mmt180 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.204 0.526 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.627 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 31.6 p -177.53 145.22 0.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.407 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.623 ' HG ' HG22 ' A' ' 16' ' ' ILE . 12.5 mt -107.97 144.2 28.89 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.393 -0.817 . . . . 0.0 110.305 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 5' ' ' SER . 48.0 Cg_endo -73.45 158.45 47.96 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 O-C-N 124.201 1.632 . . . . 0.0 109.776 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 60.7 p -42.6 169.28 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.929 . . . . 0.0 110.831 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.92 4.72 69.01 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -145.3 141.59 28.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.887 -1.361 . . . . 0.0 110.565 179.493 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -39.19 145.05 0.11 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.432 0.634 . . . . 0.0 110.708 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.471 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 9.0 p -119.91 59.9 0.87 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.558 -0.714 . . . . 0.0 109.865 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.98 ' HB1' ' CG2' ' A' ' 13' ' ' THR . . . -86.91 59.99 5.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.14 -0.975 . . . . 0.0 109.885 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.506 ' HA2' ' HG2' ' A' ' 14' ' ' GLN . . . -57.27 -45.38 92.8 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.462 HG22 ' H ' ' A' ' 12' ' ' VAL . 3.3 m -59.59 -32.82 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.445 -1.033 . . . . 0.0 110.843 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.98 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 3.5 t -116.38 29.76 7.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.13 -0.981 . . . . 0.0 111.288 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.506 ' HG2' ' HA2' ' A' ' 11' ' ' GLY . 2.9 pt20 -152.54 176.07 12.09 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.876 -1.14 . . . . 0.0 110.222 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.479 ' HG3' HG13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -88.8 -34.47 17.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.891 . . . . 0.0 111.374 -179.039 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.623 HG22 ' HG ' ' A' ' 3' ' ' LEU . 50.5 mt -115.7 111.31 43.67 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.886 -1.134 . . . . 0.0 110.944 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.71 -179.26 5.01 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.896 1.472 . . . . 0.0 110.623 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.6 t -75.24 117.52 17.15 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.635 0.731 . . . . 0.0 110.171 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.627 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -48.65 -34.5 11.91 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.271 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.31 -111.15 0.82 Allowed Glycine 0 C--N 1.294 -1.789 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -142.26 148.52 38.22 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 120.915 -1.344 . . . . 0.0 109.724 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 53.2 t -78.84 122.09 25.63 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.999 -1.063 . . . . 0.0 110.09 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.727 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -140.0 -176.62 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.622 0 O-C-N 121.424 -0.798 . . . . 0.0 108.94 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.684 ' N ' HG13 ' A' ' 23' ' ' VAL . 0.0 OUTLIER 10.28 44.58 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.727 ' N ' ' O ' ' A' ' 23' ' ' VAL . . . 73.17 -10.82 5.51 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.235 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 23' ' ' VAL . 3.2 tttp -129.27 150.69 50.53 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 120.413 -1.64 . . . . 0.0 110.791 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 5' ' ' SER . 7.6 t -63.39 137.06 58.03 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.76 0.791 . . . . 0.0 109.725 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 5' ' ' SER . 3.3 p . . . . . 0 C--N 1.296 -1.733 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.317 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.539 ' CB ' HG13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.314 0.578 . . . . 0.0 110.109 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.602 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 31.2 p -42.33 146.33 0.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 110.043 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.464 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 92.9 mt -89.92 128.52 49.73 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.411 -0.805 . . . . 0.0 110.519 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 5' ' ' SER . 48.2 Cg_endo -74.35 141.5 28.81 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.904 1.476 . . . . 0.0 109.512 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 87.9 p -40.11 159.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.323 -0.861 . . . . 0.0 110.764 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.55 15.6 56.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.81 163.35 22.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.099 -1.236 . . . . 0.0 109.837 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.0 91.7 7.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.053 . . . . 0.0 110.614 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 26.7 p -81.34 90.9 6.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.022 -1.048 . . . . 0.0 109.768 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.5 71.19 1.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 110.004 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 175.43 65.7 0.06 OUTLIER Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 11' ' ' GLY . 74.7 t -39.28 -28.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.675 -0.897 . . . . 0.0 110.311 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.471 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.9 t -89.78 38.64 0.92 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 109.605 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.483 ' NE2' ' HA ' ' A' ' 17' ' ' PRO . 29.7 pt20 -87.24 -178.55 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 0.0 110.016 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.607 ' O ' HD13 ' A' ' 16' ' ' ILE . 10.5 mmtt -71.31 -43.47 67.0 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.402 -0.811 . . . . 0.0 109.743 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.607 HD13 ' O ' ' A' ' 15' ' ' LYS . 21.1 mm -140.63 139.47 20.24 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.547 -0.72 . . . . 0.0 110.496 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.483 ' HA ' ' NE2' ' A' ' 14' ' ' GLN . 47.0 Cg_endo -74.42 -176.35 2.69 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.132 1.596 . . . . 0.0 111.05 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 7.5 t -66.82 122.08 16.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.589 -0.694 . . . . 0.0 110.397 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.602 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -44.17 -31.27 0.93 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.413 ' N ' ' C ' ' A' ' 18' ' ' CYS . . . -102.5 -107.3 3.1 Favored Glycine 0 C--N 1.296 -1.686 0 N-CA-C 106.062 -2.815 . . . . 0.0 106.062 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.2 p -142.7 123.69 14.42 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.084 -1.245 . . . . 0.0 109.732 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 18' ' ' CYS . 4.4 t -78.15 117.94 19.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.167 -0.958 . . . . 0.0 110.538 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.92 142.29 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.414 -0.804 . . . . 0.0 109.635 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 6.5 tpm_? 58.51 36.04 25.01 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.116 0.96 . . . . 0.0 110.183 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 59.86 28.2 65.54 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -140.47 116.43 10.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.692 -0.887 . . . . 0.0 110.953 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 5' ' ' SER . 0.3 OUTLIER -53.52 113.43 1.17 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.287 -0.883 . . . . 0.0 109.223 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.235 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.616 ' O ' HG23 ' A' ' 16' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.286 0.565 . . . . 0.0 110.252 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.671 ' HA ' HG22 ' A' ' 16' ' ' ILE . 14.8 p -162.52 143.21 9.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 110.401 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.86 HD22 ' HE3' ' A' ' 7' ' ' LYS . 11.2 mt -80.89 135.23 52.07 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.531 -0.731 . . . . 0.0 110.597 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 5' ' ' SER . 47.4 Cg_endo -76.09 149.74 32.78 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.016 1.534 . . . . 0.0 110.126 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 60.3 p -40.58 157.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.454 -0.779 . . . . 0.0 110.687 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 7' ' ' LYS . . . 87.57 20.09 52.45 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.86 ' HE3' HD22 ' A' ' 3' ' ' LEU . 7.8 mmmt -141.39 -172.16 3.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -1.093 . . . . 0.0 109.785 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.81 166.47 23.31 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.755 -0.778 . . . . 0.0 108.992 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 26' ' ' LYS . 8.4 p -147.37 45.41 1.14 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.786 -1.196 . . . . 0.0 111.083 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 14' ' ' GLN . . . -103.84 61.72 0.75 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.144 -0.972 . . . . 0.0 109.831 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.96 -18.22 11.25 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.547 HG23 ' N ' ' A' ' 13' ' ' THR . 27.6 m -53.9 -40.7 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -1.201 . . . . 0.0 109.478 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.547 ' N ' HG23 ' A' ' 12' ' ' VAL . 8.9 t -119.2 9.33 11.7 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.727 -0.608 . . . . 0.0 109.73 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -104.85 162.09 13.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.363 -0.836 . . . . 0.0 110.172 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.663 ' O ' HD13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -86.1 -15.97 39.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.3 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.671 HG22 ' HA ' ' A' ' 2' ' ' CYS . 49.1 mm -140.04 117.67 8.34 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.74 . . . . 0.0 109.74 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.1 170.35 19.85 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.867 1.456 . . . . 0.0 111.214 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 21' ' ' SER . 1.8 t -69.04 118.72 12.3 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.79 0.805 . . . . 0.0 110.118 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.645 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -45.15 -33.71 2.36 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.28 -111.67 2.32 Favored Glycine 0 C--N 1.292 -1.888 0 N-CA-C 106.321 -2.712 . . . . 0.0 106.321 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.522 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 29.7 m -141.9 173.26 11.68 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.955 -1.321 . . . . 0.0 109.889 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 48.3 t -95.82 106.96 19.16 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.134 -0.979 . . . . 0.0 110.704 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.49 HG21 ' CB ' ' A' ' 28' ' ' SER . 1.8 m -123.82 123.6 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.338 -0.851 . . . . 0.0 109.881 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.52 30.86 12.73 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 122.363 1.077 . . . . 0.0 109.283 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.422 ' C ' ' SG ' ' A' ' 9' ' ' CYS . . . 69.19 18.5 73.15 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 7' ' ' LYS . 5.9 ttmt -141.45 129.36 21.85 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.368 -1.078 . . . . 0.0 111.825 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 5' ' ' SER . 20.1 t -45.84 112.99 0.53 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.422 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.511 ' OXT' ' CB ' ' A' ' 5' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.505 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.54 ' C ' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.221 0.534 . . . . 0.0 110.149 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.585 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 22.4 p -176.96 145.67 0.49 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 0.0 110.331 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.961 HD11 ' O ' ' A' ' 16' ' ' ILE . 1.8 mp -87.43 131.77 43.03 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.557 -0.715 . . . . 0.0 110.498 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 5' ' ' SER . 45.7 Cg_endo -72.6 139.81 31.74 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.916 1.482 . . . . 0.0 109.301 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 1.8 m -39.32 161.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -0.834 . . . . 0.0 110.811 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.52 17.36 52.8 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' ALA . 7.9 mttp -149.58 146.57 27.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -1.208 . . . . 0.0 109.958 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -43.2 165.64 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.299 -0.875 . . . . 0.0 109.995 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.478 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 6.6 p -141.55 62.48 1.45 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 0.0 110.507 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 14' ' ' GLN . . . -86.41 57.2 4.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.868 -1.145 . . . . 0.0 110.134 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 14' ' ' GLN . . . -71.98 -11.05 74.02 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.468 HG22 ' H ' ' A' ' 12' ' ' VAL . 3.4 m -52.85 -33.69 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.143 . . . . 0.0 109.57 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -126.88 -26.26 3.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.589 -0.694 . . . . 0.0 109.764 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.512 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 8.0 tt0 -63.9 164.13 10.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 0.0 109.82 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.406 ' N ' ' CG ' ' A' ' 14' ' ' GLN . 10.4 mmtp -85.7 -38.91 17.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.43 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.961 ' O ' HD11 ' A' ' 3' ' ' LEU . 2.1 mp -108.21 108.03 60.78 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 110.258 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.747 ' O ' HD12 ' A' ' 3' ' ' LEU . 50.6 Cg_endo -76.75 175.3 11.55 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.062 1.559 . . . . 0.0 111.363 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 21' ' ' SER . 2.0 t -62.74 119.41 9.25 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.775 0.798 . . . . 0.0 110.961 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.585 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -43.85 -35.36 1.91 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.96 -112.4 1.88 Allowed Glycine 0 C--N 1.29 -2.006 0 N-CA-C 106.187 -2.765 . . . . 0.0 106.187 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.509 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -142.37 161.64 37.51 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.117 -1.225 . . . . 0.0 109.821 177.517 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 45.9 t -94.04 88.94 5.85 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.123 -0.985 . . . . 0.0 110.337 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.547 HG21 ' HB2' ' A' ' 28' ' ' SER . 1.6 m -111.03 131.31 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.419 -0.8 . . . . 0.0 109.754 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.474 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER 64.56 33.05 11.14 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.222 1.01 . . . . 0.0 109.441 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.29 21.82 64.66 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.53 142.11 35.24 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.379 -1.071 . . . . 0.0 111.318 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 5' ' ' SER . 49.9 t -67.92 94.45 0.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.755 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.547 ' HB2' HG21 ' A' ' 23' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.097 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.465 ' HA ' ' CD1' ' A' ' 16' ' ' ILE . 4.2 ptp180 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.268 0.556 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.547 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 14.1 p -164.08 150.31 11.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.327 -0.858 . . . . 0.0 110.248 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.534 ' HG ' HG22 ' A' ' 16' ' ' ILE . 19.0 mt -97.84 137.0 20.92 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.463 -0.773 . . . . 0.0 110.171 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.477 ' O ' ' O ' ' A' ' 5' ' ' SER . 46.0 Cg_endo -72.45 135.15 23.83 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 O-C-N 124.08 1.568 . . . . 0.0 109.061 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.555 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 10.0 m -39.68 162.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.455 -0.778 . . . . 0.0 110.474 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.22 17.49 50.25 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -150.9 147.45 27.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.472 -1.016 . . . . 0.0 109.552 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -40.52 160.72 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.433 -0.792 . . . . 0.0 110.155 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 6.6 p -133.77 65.7 1.57 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.196 -0.94 . . . . 0.0 111.052 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -90.24 61.33 5.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.057 -1.027 . . . . 0.0 109.463 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.522 ' HA2' ' HG2' ' A' ' 14' ' ' GLN . . . -77.36 -10.2 86.38 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.5 t -80.4 -13.53 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.041 -1.27 . . . . 0.0 110.302 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.8 -17.59 2.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.159 -0.963 . . . . 0.0 111.278 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.522 ' HG2' ' HA2' ' A' ' 11' ' ' GLY . 4.4 pt20 -98.1 177.59 5.36 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.864 -1.148 . . . . 0.0 110.377 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HG3' HG12 ' A' ' 16' ' ' ILE . 4.6 ptmt -88.47 -28.27 20.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.868 . . . . 0.0 110.608 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.534 HG22 ' HG ' ' A' ' 3' ' ' LEU . 32.5 mm -102.66 103.89 35.22 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 0.0 110.573 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.426 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 50.6 Cg_endo -76.61 171.99 17.02 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.918 1.483 . . . . 0.0 110.228 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 21' ' ' SER . 29.8 t -72.22 116.55 12.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.248 -0.907 . . . . 0.0 110.109 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.547 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -46.53 -33.61 4.2 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.486 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.87 -110.34 2.71 Favored Glycine 0 C--N 1.292 -1.909 0 N-CA-C 106.204 -2.758 . . . . 0.0 106.204 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.458 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 1.2 m -141.98 164.98 28.7 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.042 -1.269 . . . . 0.0 109.42 177.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 54.1 t -99.8 92.68 5.42 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.713 -1.242 . . . . 0.0 110.722 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.27 135.0 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.292 -0.88 . . . . 0.0 110.402 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.91 33.79 20.78 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 122.067 0.937 . . . . 0.0 110.601 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.61 26.44 74.47 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.426 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 1.9 ttmm -141.52 143.65 33.89 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.173 -1.192 . . . . 0.0 111.075 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 5' ' ' SER . 23.9 t -77.22 111.38 12.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 109.195 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.433 ' C ' ' OG ' ' A' ' 5' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.268 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 2' ' ' CYS . 8.1 mtm180 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.27 0.557 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.62 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 29.3 p -41.66 148.09 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 110.422 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.78 135.97 21.91 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.0 110.378 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 5' ' ' SER . 47.3 Cg_endo -74.85 149.53 37.6 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.964 1.507 . . . . 0.0 110.021 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 2.9 m -39.62 161.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.372 -0.83 . . . . 0.0 110.315 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.54 13.84 59.22 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -125.55 162.33 25.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -1.151 . . . . 0.0 109.81 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.21 98.72 11.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.001 -1.062 . . . . 0.0 111.291 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 29.1 p -85.91 95.11 9.36 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.134 -0.978 . . . . 0.0 108.612 178.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -107.22 68.16 0.72 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.112 -0.993 . . . . 0.0 110.617 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.49 ' O ' ' C ' ' A' ' 12' ' ' VAL . . . 158.7 65.4 0.01 OUTLIER Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.49 ' C ' ' O ' ' A' ' 11' ' ' GLY . 1.7 m -36.6 -33.41 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.785 -0.833 . . . . 0.0 109.896 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.9 t -88.46 42.73 1.09 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.448 -0.783 . . . . 0.0 109.103 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 11' ' ' GLY . 2.1 mt-30 -91.46 154.87 18.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.507 -0.746 . . . . 0.0 110.121 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt -65.38 -35.88 82.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 108.865 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.674 HG22 ' O ' ' A' ' 16' ' ' ILE . 5.9 mm -125.17 82.93 61.37 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.34 178.7 6.67 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 124.128 1.594 . . . . 0.0 111.332 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 21' ' ' SER . 3.9 t -61.79 120.02 9.89 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.556 0.693 . . . . 0.0 110.551 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.62 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -43.96 -35.72 2.15 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.027 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.35 -107.04 0.89 Allowed Glycine 0 C--N 1.291 -1.97 0 N-CA-C 105.983 -2.847 . . . . 0.0 105.983 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.507 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.2 OUTLIER -142.56 170.59 15.43 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.014 -1.286 . . . . 0.0 110.055 177.382 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 46.6 t -108.39 94.59 5.14 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.994 -1.066 . . . . 0.0 110.13 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -121.76 138.75 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -0.932 . . . . 0.0 109.776 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 37.7 mtp180 61.31 34.51 18.48 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.152 0.977 . . . . 0.0 110.203 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.6 18.49 59.02 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 7' ' ' LYS . 2.5 ttpp -140.84 131.48 25.58 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.327 -1.102 . . . . 0.0 111.528 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 5' ' ' SER . 25.2 t -58.13 119.95 7.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.457 -0.777 . . . . 0.0 109.645 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--N 1.3 -1.58 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.14 -179.837 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.223 0.535 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.607 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 8.9 p -162.85 138.84 7.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 110.517 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 5.8 mt -59.76 123.73 72.9 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.594 -0.692 . . . . 0.0 109.809 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' A' ' 5' ' ' SER . 43.1 Cg_endo -70.55 125.92 12.25 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.811 1.427 . . . . 0.0 109.746 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 16.0 t -38.7 156.82 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.547 -0.721 . . . . 0.0 110.504 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.9 14.84 58.8 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.98 169.92 14.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.401 -1.058 . . . . 0.0 109.746 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.82 112.7 24.73 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.923 -1.11 . . . . 0.0 111.094 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 25.9 p -91.74 91.02 7.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.316 -0.865 . . . . 0.0 109.209 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -110.27 63.14 0.6 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.246 -0.909 . . . . 0.0 109.435 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 14' ' ' GLN . . . -172.62 66.37 0.12 Allowed Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 m -50.54 -32.57 10.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.937 -1.331 . . . . 0.0 109.411 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 14' ' ' GLN . 12.8 t -89.53 -21.18 23.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.509 -0.745 . . . . 0.0 110.476 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.549 ' NE2' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -37.15 158.1 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.563 -0.711 . . . . 0.0 110.124 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 12.8 mttm -73.5 -35.64 65.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.008 -1.057 . . . . 0.0 110.34 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.436 ' N ' ' HG2' ' A' ' 14' ' ' GLN . 7.9 mt -99.93 103.06 19.84 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.48 -0.763 . . . . 0.0 110.273 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.549 ' HA ' ' NE2' ' A' ' 14' ' ' GLN . 48.3 Cg_endo -75.94 169.15 22.73 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.973 1.512 . . . . 0.0 110.697 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 21' ' ' SER . 3.0 t -68.56 116.65 9.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.87 . . . . 0.0 109.593 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.607 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -42.84 -33.23 0.73 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.72 -111.87 3.0 Favored Glycine 0 C--N 1.293 -1.817 0 N-CA-C 106.15 -2.78 . . . . 0.0 106.15 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.553 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -142.07 141.61 32.77 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.059 -1.259 . . . . 0.0 110.162 177.374 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.7 t -79.93 81.77 6.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.091 -1.006 . . . . 0.0 110.251 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 6.6 m -109.95 133.25 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.668 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 62.4 34.08 15.82 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.231 1.015 . . . . 0.0 109.722 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.29 24.46 67.42 Favored Glycine 0 C--N 1.291 -1.969 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -139.13 138.67 37.21 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.483 -1.01 . . . . 0.0 110.607 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 5' ' ' SER . 14.5 t -69.92 81.04 0.47 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.487 -0.758 . . . . 0.0 109.61 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.508 ' HG ' ' C ' ' A' ' 27' ' ' CYS . 58.4 p . . . . . 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 0.0 110.174 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.534 ' O ' HG21 ' A' ' 16' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 120.76 0.314 . . . . 0.0 110.265 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.594 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 16.2 p 175.39 145.43 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.23 -0.919 . . . . 0.0 109.648 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.471 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 79.8 mt -86.44 122.69 71.95 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.068 -1.02 . . . . 0.0 110.985 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 5' ' ' SER . 44.6 Cg_endo -73.97 144.4 34.21 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.414 1.218 . . . . 0.0 110.945 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.63 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 2.2 m -39.28 153.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.532 -0.73 . . . . 0.0 110.641 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' A' ' 7' ' ' LYS . . . 90.87 24.85 26.46 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.119 -1.039 . . . . 0.0 110.535 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 34.0 mttt -159.27 148.31 18.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.084 -1.244 . . . . 0.0 110.373 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -44.3 125.97 4.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.97 . . . . 0.0 110.487 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.475 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 23.8 p -98.06 82.58 2.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.201 -0.937 . . . . 0.0 110.005 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.51 ' O ' ' CG ' ' A' ' 14' ' ' GLN . . . -91.37 60.55 4.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.048 -1.032 . . . . 0.0 109.974 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.511 ' HA2' ' HG2' ' A' ' 14' ' ' GLN . . . -87.68 -11.17 68.82 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -82.74 -5.32 8.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.3 -1.117 . . . . 0.0 110.1 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.16 -30.19 0.87 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 110.855 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.511 ' HG2' ' HA2' ' A' ' 11' ' ' GLY . 3.9 pt20 -81.65 179.88 7.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.017 -1.052 . . . . 0.0 110.278 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.79 -35.76 51.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.356 -0.84 . . . . 0.0 111.437 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.534 HG21 ' O ' ' A' ' 1' ' ' ARG . 7.8 mm -120.23 136.44 25.12 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.008 -1.057 . . . . 0.0 110.78 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.481 ' HA ' ' HA3' ' A' ' 11' ' ' GLY . 49.3 Cg_endo -77.0 -172.14 1.35 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.991 1.521 . . . . 0.0 110.696 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -79.35 127.96 32.74 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.99 0.9 . . . . 0.0 110.64 -179.067 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.594 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -46.35 -31.1 2.39 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.94 -112.99 2.36 Favored Glycine 0 C--N 1.294 -1.751 0 N-CA-C 105.544 -3.022 . . . . 0.0 105.544 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 14.4 m -143.05 162.24 36.04 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.098 -1.236 . . . . 0.0 109.387 177.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 48.9 t -101.7 115.67 31.04 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.941 -1.099 . . . . 0.0 109.836 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.609 HG21 ' CB ' ' A' ' 28' ' ' SER . 9.6 m -137.46 124.58 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.703 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.528 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 63.48 33.12 13.85 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.349 1.071 . . . . 0.0 109.818 -179.549 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.71 15.54 66.7 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.1 tptt -140.77 126.08 18.68 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.471 -1.017 . . . . 0.0 110.437 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.63 ' HB3' ' HA ' ' A' ' 5' ' ' SER . 0.7 OUTLIER -46.93 125.1 7.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.427 -0.795 . . . . 0.0 110.234 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.609 ' CB ' HG21 ' A' ' 23' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.057 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.523 ' C ' HG23 ' A' ' 16' ' ' ILE . 19.5 mmm180 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.235 0.54 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.624 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 30.3 p -148.63 144.44 27.19 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.325 -0.86 . . . . 0.0 110.37 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.644 ' HG ' HG22 ' A' ' 16' ' ' ILE . 19.7 mt -83.89 134.39 44.24 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.555 -0.715 . . . . 0.0 110.269 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.47 ' O ' ' C ' ' A' ' 5' ' ' SER . 47.9 Cg_endo -81.51 144.2 14.08 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.026 1.54 . . . . 0.0 109.787 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.492 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 4.6 t -38.73 151.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.391 -0.818 . . . . 0.0 110.216 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.49 ' HA2' ' HE2' ' A' ' 26' ' ' LYS . . . 90.52 15.7 56.46 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -122.08 172.21 8.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.392 -1.064 . . . . 0.0 109.778 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.77 155.26 18.37 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.017 -1.052 . . . . 0.0 110.477 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.424 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 27.1 p -160.72 73.02 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.575 -0.703 . . . . 0.0 109.287 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.28 72.17 0.89 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.323 -0.861 . . . . 0.0 110.484 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 12' ' ' VAL . . . -167.01 -48.3 0.02 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.562 ' CB ' ' O ' ' A' ' 11' ' ' GLY . 0.4 OUTLIER 81.49 -30.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.905 -0.762 . . . . 0.0 110.454 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 13' ' ' THR . 4.0 t -90.88 -13.6 33.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.111 -0.993 . . . . 0.0 109.732 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 13' ' ' THR . 15.9 pt20 -41.34 160.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.484 -0.76 . . . . 0.0 109.602 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -79.54 -19.38 49.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.946 -1.096 . . . . 0.0 110.562 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.644 HG22 ' HG ' ' A' ' 3' ' ' LEU . 71.2 mt -119.97 102.39 46.63 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 110.604 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.79 166.78 26.46 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.228 1.646 . . . . 0.0 110.203 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 19' ' ' CYS . 6.0 t -65.14 120.87 13.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.079 -1.013 . . . . 0.0 109.989 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.624 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -43.91 -30.72 0.73 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.162 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.427 ' N ' ' C ' ' A' ' 18' ' ' CYS . . . -108.74 -106.17 3.03 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.519 ' O ' ' HB2' ' A' ' 28' ' ' SER . 58.3 m -142.08 136.46 30.16 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.072 -1.252 . . . . 0.0 109.378 177.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.424 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 3.8 t -78.88 126.06 30.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.092 -1.005 . . . . 0.0 111.145 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.419 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -137.89 138.11 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.511 -0.743 . . . . 0.0 109.485 179.174 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.419 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 5.6 ttt180 60.77 33.38 20.11 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.999 0.904 . . . . 0.0 110.794 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.25 6.57 47.96 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.49 ' HE2' ' HA2' ' A' ' 6' ' ' GLY . 5.8 tptt -129.59 124.91 34.94 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.262 -1.14 . . . . 0.0 111.236 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.492 ' HB3' ' HA ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -42.53 124.41 2.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.568 -0.707 . . . . 0.0 109.574 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 21' ' ' SER . 39.0 t . . . . . 0 C--N 1.299 -1.614 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.186 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.609 ' HB2' HD12 ' A' ' 16' ' ' ILE . 53.2 mtm180 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.252 0.548 . . . . 0.0 110.324 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.541 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 17.0 p -158.87 150.34 20.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.364 -0.835 . . . . 0.0 110.139 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.51 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 81.1 mt -113.84 101.1 53.53 Favored Pre-proline 0 N--CA 1.493 1.704 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.013 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 48.2 Cg_endo -97.7 16.86 0.58 Allowed 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 121.629 1.552 . . . . 0.0 109.464 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 t -93.55 11.4 28.83 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.366 -0.833 . . . . 0.0 112.435 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 26' ' ' LYS . . . 67.91 20.99 73.08 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -59.63 144.9 46.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.499 -1.0 . . . . 0.0 109.521 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 25' ' ' GLY . . . -59.7 103.23 0.19 Allowed 'General case' 0 C--N 1.29 -1.985 0 O-C-N 120.582 -1.324 . . . . 0.0 110.144 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 25.4 p -86.99 88.28 7.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.575 -0.703 . . . . 0.0 110.278 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.66 64.0 0.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.981 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 12' ' ' VAL . . . 176.69 68.14 0.06 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 11' ' ' GLY . 24.3 t -40.28 -30.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.429 -1.042 . . . . 0.0 110.368 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 13' ' ' THR . 6.6 t -88.29 38.01 0.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.947 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -89.75 146.25 24.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 110.123 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.503 ' HG3' HG12 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -68.97 -24.42 64.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.115 -0.991 . . . . 0.0 109.578 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.609 HD12 ' HB2' ' A' ' 1' ' ' ARG . 12.4 mm -110.67 99.64 42.43 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.35 -0.844 . . . . 0.0 109.844 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.514 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 44.4 Cg_endo -72.04 167.06 27.78 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.125 1.592 . . . . 0.0 111.188 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.1 t -76.4 127.93 33.83 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.535 -0.728 . . . . 0.0 110.816 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.541 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -57.96 -29.13 64.95 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.337 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.42 -113.57 3.81 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 106.357 -2.697 . . . . 0.0 106.357 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.4 t -142.61 157.75 44.37 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.87 -1.371 . . . . 0.0 110.691 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.6 t -83.44 91.73 7.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.834 . . . . 0.0 109.849 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -124.15 131.29 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.21 -0.931 . . . . 0.0 111.566 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 1.9 mmp_? 63.23 34.71 13.15 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 122.072 0.939 . . . . 0.0 110.229 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 8' ' ' ALA . . . 62.58 21.47 62.71 Favored Glycine 0 C--N 1.288 -2.1 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 6' ' ' GLY . 12.7 ttmt -129.09 138.17 51.68 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.723 -0.869 . . . . 0.0 110.038 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -75.0 78.52 2.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.423 -0.798 . . . . 0.0 110.474 -179.248 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 27' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.953 -1.023 . . . . 0.0 110.232 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.64 ' N ' HD13 ' A' ' 16' ' ' ILE . 3.2 mtt85 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.601 ' O ' ' O ' ' A' ' 1' ' ' ARG . 13.4 p 46.14 140.7 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 CA-C-O 122.632 1.206 . . . . 0.0 112.521 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.543 HD11 HE22 ' A' ' 14' ' ' GLN . 94.7 mt -90.78 139.2 26.14 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.051 -1.031 . . . . 0.0 110.941 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -80.66 142.85 14.61 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.878 1.462 . . . . 0.0 110.342 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.524 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 40.8 t -43.65 151.24 0.2 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.283 -0.885 . . . . 0.0 110.431 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.76 27.93 20.34 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.03 -175.5 4.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -1.117 . . . . 0.0 109.694 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.39 111.01 22.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.414 -0.804 . . . . 0.0 109.223 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 26' ' ' LYS . 27.4 p -91.18 84.47 5.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -0.925 . . . . 0.0 111.078 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.533 ' O ' ' CG ' ' A' ' 14' ' ' GLN . . . -88.77 55.65 3.45 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.627 -1.295 . . . . 0.0 109.338 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 17' ' ' PRO . . . -76.88 2.88 58.63 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.45 -22.41 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.185 -1.185 . . . . 0.0 109.908 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.6 t -142.75 3.23 1.43 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.288 -0.882 . . . . 0.0 111.053 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.543 HE22 HD11 ' A' ' 3' ' ' LEU . 3.5 pt20 -99.92 -166.87 1.38 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.882 -1.136 . . . . 0.0 110.714 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.494 ' N ' ' HG3' ' A' ' 14' ' ' GLN . 7.6 ttpt -77.17 -49.26 15.58 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.696 -0.627 . . . . 0.0 111.024 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.64 HD13 ' N ' ' A' ' 1' ' ' ARG . 5.6 mt -133.58 140.8 37.96 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.267 -0.895 . . . . 0.0 111.078 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.48 ' HB3' ' HA3' ' A' ' 11' ' ' GLY . 47.4 Cg_endo -78.28 -165.78 0.36 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 124.313 1.691 . . . . 0.0 112.17 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 20.2 t -68.9 122.31 18.38 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.737 0.78 . . . . 0.0 111.472 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.489 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -46.14 -35.71 5.27 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.072 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.1 -103.55 1.6 Allowed Glycine 0 C--N 1.295 -1.717 0 N-CA-C 106.768 -2.533 . . . . 0.0 106.768 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.1 p -142.23 122.96 14.28 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.268 -1.136 . . . . 0.0 109.007 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 26.2 t -77.98 121.12 23.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.075 -1.015 . . . . 0.0 111.353 -178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.47 134.95 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.804 0.811 . . . . 0.0 109.947 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 58.3 34.1 23.75 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.996 0.903 . . . . 0.0 110.439 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.38 26.12 70.44 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.512 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 11.7 tttp -139.18 123.05 17.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.603 -0.94 . . . . 0.0 110.219 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 5' ' ' SER . 0.5 OUTLIER -52.9 107.17 0.2 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.4 -0.812 . . . . 0.0 109.956 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.43 ' HB3' ' OG ' ' A' ' 5' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.397 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.242 0.544 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.585 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 20.4 p -136.29 144.32 44.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.119 -0.988 . . . . 0.0 110.392 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.461 ' HG ' HG22 ' A' ' 16' ' ' ILE . 25.3 mt -86.22 141.58 35.08 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.481 -0.762 . . . . 0.0 110.644 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 5' ' ' SER . 46.8 Cg_endo -74.41 125.96 10.01 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.068 1.562 . . . . 0.0 109.638 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -39.46 158.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.453 -0.78 . . . . 0.0 110.757 -179.399 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 7' ' ' LYS . . . 90.24 25.03 27.47 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 6' ' ' GLY . 4.6 mmtt -151.69 153.7 34.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -1.102 . . . . 0.0 110.288 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.0 143.5 34.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.089 -1.007 . . . . 0.0 110.492 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -123.59 -91.06 0.56 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.702 0.763 . . . . 0.0 109.811 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 14' ' ' GLN . . . -162.27 -135.42 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.245 1.022 . . . . 0.0 108.443 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.486 ' C ' HG23 ' A' ' 12' ' ' VAL . . . -102.99 -73.39 0.96 Allowed Glycine 0 C--N 1.273 -2.935 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.486 HG23 ' C ' ' A' ' 11' ' ' GLY . 5.2 t -149.98 -39.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.383 -1.069 . . . . 0.0 110.058 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.778 ' O ' HG23 ' A' ' 13' ' ' THR . 8.9 t -103.05 83.36 2.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.314 -0.866 . . . . 0.0 110.143 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.452 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 1.7 pm0 -118.16 174.73 6.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.887 . . . . 0.0 110.053 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.518 ' HG2' ' N ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -67.01 -26.38 66.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.645 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.518 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 87.3 mt -141.02 107.56 6.28 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.452 -0.78 . . . . 0.0 109.683 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 16' ' ' ILE . 45.1 Cg_endo -71.59 157.36 56.14 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.944 1.497 . . . . 0.0 111.349 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.539 ' SG ' ' N ' ' A' ' 21' ' ' SER . 4.5 t -69.07 119.97 14.19 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.83 0.824 . . . . 0.0 109.878 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.585 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -45.52 -33.29 2.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.35 -104.88 2.02 Favored Glycine 0 C--N 1.293 -1.831 0 N-CA-C 106.149 -2.78 . . . . 0.0 106.149 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.539 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 1.7 p -141.68 116.97 10.11 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.132 -1.216 . . . . 0.0 109.547 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.536 ' N ' ' HB3' ' A' ' 18' ' ' CYS . 41.1 t -78.87 82.01 5.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 110.295 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.453 ' CG2' ' OG ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -106.72 143.68 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.454 -0.778 . . . . 0.0 109.851 179.725 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER 59.96 37.38 21.44 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.114 0.959 . . . . 0.0 109.879 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 10' ' ' ALA . . . 61.04 26.13 65.26 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -140.21 140.24 35.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.48 -1.012 . . . . 0.0 111.203 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 5' ' ' SER . 36.9 t -83.29 89.43 7.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.56 -0.713 . . . . 0.0 109.337 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.313 -179.456 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.48 ' O ' HD12 ' A' ' 16' ' ' ILE . 50.7 mtt-85 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.162 0.506 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.659 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 4.8 p 174.32 138.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -0.88 . . . . 0.0 110.168 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.805 HD13 ' HA ' ' A' ' 9' ' ' CYS . 2.9 mt -61.37 119.0 42.48 Favored Pre-proline 0 C--N 1.303 -1.453 0 C-N-CA 119.659 -0.817 . . . . 0.0 109.513 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 5' ' ' SER . 41.3 Cg_endo -68.22 125.96 13.68 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.951 1.5 . . . . 0.0 109.977 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 72.1 m -38.49 152.93 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.682 -0.637 . . . . 0.0 110.296 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.94 18.97 49.1 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 8' ' ' ALA . 10.8 mttt -154.89 148.44 25.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.395 -1.062 . . . . 0.0 110.147 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -42.03 160.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.883 . . . . 0.0 110.541 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.805 ' HA ' HD13 ' A' ' 3' ' ' LEU . 4.8 p -147.37 68.64 1.14 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.49 -0.756 . . . . 0.0 110.231 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.01 59.07 5.41 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.149 -0.969 . . . . 0.0 109.789 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.569 ' HA2' ' CD ' ' A' ' 14' ' ' GLN . . . -85.41 -6.84 83.33 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 12' ' ' VAL . 6.2 t -54.85 -20.3 5.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.093 -1.24 . . . . 0.0 108.562 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.6 t -123.99 -12.51 7.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.622 -0.674 . . . . 0.0 109.663 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.591 ' HG2' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -97.48 164.37 12.47 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.271 -0.893 . . . . 0.0 109.33 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.591 ' N ' ' HG2' ' A' ' 14' ' ' GLN . 4.7 mmtt -82.65 -35.64 26.74 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.933 -1.104 . . . . 0.0 112.386 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.593 ' CG2' ' HA ' ' A' ' 2' ' ' CYS . 9.6 mm -101.54 95.97 5.77 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.917 -1.114 . . . . 0.0 110.994 -178.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 46.8 Cg_endo -70.09 -176.01 1.43 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 124.15 1.605 . . . . 0.0 112.394 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -63.08 119.85 10.3 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.994 0.902 . . . . 0.0 110.504 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.659 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -42.35 -34.45 0.81 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 122.553 1.168 . . . . 0.0 107.993 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.36 -112.14 2.59 Favored Glycine 0 C--N 1.288 -2.126 0 N-CA-C 105.976 -2.85 . . . . 0.0 105.976 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.533 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.2 OUTLIER -141.79 133.08 26.45 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.24 -1.153 . . . . 0.0 109.126 177.053 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 47.1 t -78.84 119.91 22.71 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.098 -1.001 . . . . 0.0 110.208 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.544 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 2.4 t -140.95 160.93 23.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER 36.93 30.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.855 0.836 . . . . 0.0 111.836 -179.488 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 23' ' ' VAL . . . 87.11 -24.29 9.54 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.062 177.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.04 147.33 36.22 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.49 -1.594 . . . . 0.0 112.686 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 5' ' ' SER . 43.1 t -66.98 103.49 1.16 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.544 0.687 . . . . 0.0 109.69 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.137 -179.677 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.469 ' O ' ' C ' ' A' ' 2' ' ' CYS . 17.0 mmt180 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.013 0.435 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.601 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 32.1 p -35.45 147.78 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.534 -0.729 . . . . 0.0 111.07 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 3' ' ' LEU . 23.4 mt -80.26 123.42 83.18 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.501 -0.75 . . . . 0.0 110.822 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.484 ' O ' ' O ' ' A' ' 5' ' ' SER . 51.0 Cg_endo -75.82 143.89 27.06 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.95 1.5 . . . . 0.0 110.034 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.561 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 7.1 t -39.71 164.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.504 -0.747 . . . . 0.0 110.862 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.12 13.53 58.77 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.573 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 2.6 mptt -147.68 158.95 44.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.98 -1.306 . . . . 0.0 109.669 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -47.57 169.09 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.286 -1.509 . . . . 0.0 109.757 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.569 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 5.4 p -135.15 64.5 1.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 111.635 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.49 ' C ' ' NE2' ' A' ' 14' ' ' GLN . . . -86.55 59.12 5.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.059 -1.026 . . . . 0.0 109.152 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.866 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -69.43 84.3 0.26 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 11' ' ' GLY . 0.9 OUTLIER 174.12 -33.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.719 -0.871 . . . . 0.0 108.681 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -126.24 -26.35 3.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.573 -0.704 . . . . 0.0 109.954 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.64 ' OE1' ' HA ' ' A' ' 17' ' ' PRO . 3.3 pt20 -56.89 173.87 0.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 0.0 109.994 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.62 -39.03 81.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.896 . . . . 0.0 109.696 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 2' ' ' CYS . 32.3 mt -134.34 143.69 48.0 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.576 -0.702 . . . . 0.0 109.699 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.64 ' HA ' ' OE1' ' A' ' 14' ' ' GLN . 47.3 Cg_endo -73.59 152.15 47.98 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.146 1.603 . . . . 0.0 111.983 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 19' ' ' CYS . 23.1 t -55.96 117.88 4.11 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.422 -0.799 . . . . 0.0 110.073 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.601 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -41.19 -32.7 0.29 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.568 1.175 . . . . 0.0 107.865 179.121 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 18' ' ' CYS . . . -106.62 -114.13 3.87 Favored Glycine 0 C--N 1.289 -2.072 0 N-CA-C 106.189 -2.764 . . . . 0.0 106.189 177.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 m -142.55 -179.12 6.11 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.108 -1.231 . . . . 0.0 109.613 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.569 ' HA ' ' CB ' ' A' ' 9' ' ' CYS . 53.7 t -96.65 88.52 4.67 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.059 -1.025 . . . . 0.0 110.071 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -113.12 143.42 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.503 -0.748 . . . . 0.0 109.466 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 60.79 36.36 19.24 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 122.102 0.953 . . . . 0.0 109.987 -179.448 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.85 20.46 48.26 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -141.47 176.71 8.66 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.675 -0.897 . . . . 0.0 111.339 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -86.02 119.7 26.61 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.515 ' HB3' ' CB ' ' A' ' 5' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.294 -1.83 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.208 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.219 0.533 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.568 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 21.3 p -174.34 146.97 1.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.878 . . . . 0.0 110.682 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.497 ' O ' ' HB2' ' A' ' 19' ' ' CYS . 39.1 mt -81.52 139.62 47.85 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.477 -0.764 . . . . 0.0 110.443 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.514 ' O ' ' O ' ' A' ' 5' ' ' SER . 47.3 Cg_endo -74.63 117.12 4.83 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.03 1.542 . . . . 0.0 110.191 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.54 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 27.4 p -40.88 168.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.39 -0.819 . . . . 0.0 110.959 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.21 3.88 69.27 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -149.23 154.22 38.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -1.139 . . . . 0.0 109.978 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.15 155.34 37.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.259 -0.901 . . . . 0.0 109.974 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.465 ' HA ' HD13 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -115.67 -85.98 0.61 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.671 0.748 . . . . 0.0 109.447 179.501 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -162.08 -137.69 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 122.432 1.11 . . . . 0.0 108.67 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.918 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -106.63 -67.99 0.68 Allowed Glycine 0 C--N 1.272 -2.976 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 11' ' ' GLY . 2.3 t -168.7 -33.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.466 -1.02 . . . . 0.0 110.132 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.9 t -84.91 19.14 2.19 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.188 -0.945 . . . . 0.0 111.413 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -67.81 146.13 54.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.796 -1.19 . . . . 0.0 109.853 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 ptpt -67.53 -27.74 67.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.049 -1.032 . . . . 0.0 109.353 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.0 mt -117.26 106.18 47.48 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.52 -0.738 . . . . 0.0 109.48 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.32 158.94 53.2 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.995 1.524 . . . . 0.0 110.682 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 21' ' ' SER . 11.0 t -64.04 121.3 13.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.445 -0.784 . . . . 0.0 110.134 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.568 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -47.04 -34.35 5.67 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 179.222 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.92 -108.99 2.41 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 106.308 -2.717 . . . . 0.0 106.308 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.537 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 23.9 p -141.73 129.59 21.78 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.011 -1.288 . . . . 0.0 109.781 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 7.5 t -78.61 78.94 5.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 109.677 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.442 HG22 ' OG ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -113.11 138.51 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.342 -0.849 . . . . 0.0 111.156 -179.384 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 59.81 35.99 22.03 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.047 0.927 . . . . 0.0 110.247 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.43 27.09 71.24 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -133.24 152.8 51.94 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.645 -0.915 . . . . 0.0 110.084 -179.758 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.54 ' HB3' ' HA ' ' A' ' 5' ' ' SER . 46.2 t -91.0 62.48 4.91 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.995 -1.066 . . . . 0.0 110.417 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.231 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 13.2 mmt180 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.204 0.526 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.627 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 31.6 p -177.53 145.22 0.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.407 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.623 ' HG ' HG22 ' A' ' 16' ' ' ILE . 12.5 mt -107.97 144.2 28.89 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.393 -0.817 . . . . 0.0 110.305 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 5' ' ' SER . 48.0 Cg_endo -73.45 158.45 47.96 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 O-C-N 124.201 1.632 . . . . 0.0 109.776 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 60.7 p -42.6 169.28 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.929 . . . . 0.0 110.831 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.92 4.72 69.01 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -145.3 141.59 28.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.887 -1.361 . . . . 0.0 110.565 179.493 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -39.19 145.05 0.11 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.432 0.634 . . . . 0.0 110.708 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.471 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 9.0 p -119.91 59.9 0.87 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.558 -0.714 . . . . 0.0 109.865 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.98 ' HB1' ' CG2' ' A' ' 13' ' ' THR . . . -86.91 59.99 5.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.14 -0.975 . . . . 0.0 109.885 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.506 ' HA2' ' HG2' ' A' ' 14' ' ' GLN . . . -57.27 -45.38 92.8 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.462 HG22 ' H ' ' A' ' 12' ' ' VAL . 3.3 m -59.59 -32.82 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.445 -1.033 . . . . 0.0 110.843 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.98 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 3.5 t -116.38 29.76 7.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.13 -0.981 . . . . 0.0 111.288 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.506 ' HG2' ' HA2' ' A' ' 11' ' ' GLY . 2.9 pt20 -152.54 176.07 12.09 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.876 -1.14 . . . . 0.0 110.222 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.479 ' HG3' HG13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -88.8 -34.47 17.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.891 . . . . 0.0 111.374 -179.039 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.623 HG22 ' HG ' ' A' ' 3' ' ' LEU . 50.5 mt -115.7 111.31 43.67 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.886 -1.134 . . . . 0.0 110.944 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.71 -179.26 5.01 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.896 1.472 . . . . 0.0 110.623 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.6 t -75.24 117.52 17.15 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.635 0.731 . . . . 0.0 110.171 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.627 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -48.65 -34.5 11.91 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.271 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.31 -111.15 0.82 Allowed Glycine 0 C--N 1.294 -1.789 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -142.26 148.52 38.22 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 120.915 -1.344 . . . . 0.0 109.724 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 53.2 t -78.84 122.09 25.63 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.999 -1.063 . . . . 0.0 110.09 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.727 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -140.0 -176.62 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.622 0 O-C-N 121.424 -0.798 . . . . 0.0 108.94 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.684 ' N ' HG13 ' A' ' 23' ' ' VAL . 0.0 OUTLIER 10.28 44.58 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.727 ' N ' ' O ' ' A' ' 23' ' ' VAL . . . 73.17 -10.82 5.51 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.235 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 23' ' ' VAL . 3.2 tttp -129.27 150.69 50.53 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 120.413 -1.64 . . . . 0.0 110.791 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 5' ' ' SER . 7.6 t -63.39 137.06 58.03 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.76 0.791 . . . . 0.0 109.725 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 5' ' ' SER . 3.3 p . . . . . 0 C--N 1.296 -1.733 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.317 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.539 ' CB ' HG13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.314 0.578 . . . . 0.0 110.109 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.602 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 31.2 p -42.33 146.33 0.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 110.043 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.464 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 92.9 mt -89.92 128.52 49.73 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.411 -0.805 . . . . 0.0 110.519 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 5' ' ' SER . 48.2 Cg_endo -74.35 141.5 28.81 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.904 1.476 . . . . 0.0 109.512 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 87.9 p -40.11 159.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.323 -0.861 . . . . 0.0 110.764 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.55 15.6 56.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.81 163.35 22.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.099 -1.236 . . . . 0.0 109.837 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.0 91.7 7.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.053 . . . . 0.0 110.614 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 26.7 p -81.34 90.9 6.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.022 -1.048 . . . . 0.0 109.768 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.5 71.19 1.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 110.004 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 175.43 65.7 0.06 OUTLIER Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 11' ' ' GLY . 74.7 t -39.28 -28.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.675 -0.897 . . . . 0.0 110.311 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.471 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.9 t -89.78 38.64 0.92 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 109.605 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.483 ' NE2' ' HA ' ' A' ' 17' ' ' PRO . 29.7 pt20 -87.24 -178.55 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 0.0 110.016 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.607 ' O ' HD13 ' A' ' 16' ' ' ILE . 10.5 mmtt -71.31 -43.47 67.0 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.402 -0.811 . . . . 0.0 109.743 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.607 HD13 ' O ' ' A' ' 15' ' ' LYS . 21.1 mm -140.63 139.47 20.24 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.547 -0.72 . . . . 0.0 110.496 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.483 ' HA ' ' NE2' ' A' ' 14' ' ' GLN . 47.0 Cg_endo -74.42 -176.35 2.69 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.132 1.596 . . . . 0.0 111.05 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 7.5 t -66.82 122.08 16.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.589 -0.694 . . . . 0.0 110.397 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.602 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -44.17 -31.27 0.93 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.413 ' N ' ' C ' ' A' ' 18' ' ' CYS . . . -102.5 -107.3 3.1 Favored Glycine 0 C--N 1.296 -1.686 0 N-CA-C 106.062 -2.815 . . . . 0.0 106.062 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.2 p -142.7 123.69 14.42 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.084 -1.245 . . . . 0.0 109.732 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 18' ' ' CYS . 4.4 t -78.15 117.94 19.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.167 -0.958 . . . . 0.0 110.538 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.92 142.29 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.414 -0.804 . . . . 0.0 109.635 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 6.5 tpm_? 58.51 36.04 25.01 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.116 0.96 . . . . 0.0 110.183 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 59.86 28.2 65.54 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -140.47 116.43 10.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.692 -0.887 . . . . 0.0 110.953 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 5' ' ' SER . 0.3 OUTLIER -53.52 113.43 1.17 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.287 -0.883 . . . . 0.0 109.223 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.235 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.616 ' O ' HG23 ' A' ' 16' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.286 0.565 . . . . 0.0 110.252 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.671 ' HA ' HG22 ' A' ' 16' ' ' ILE . 14.8 p -162.52 143.21 9.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 110.401 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.86 HD22 ' HE3' ' A' ' 7' ' ' LYS . 11.2 mt -80.89 135.23 52.07 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.531 -0.731 . . . . 0.0 110.597 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 5' ' ' SER . 47.4 Cg_endo -76.09 149.74 32.78 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.016 1.534 . . . . 0.0 110.126 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 60.3 p -40.58 157.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.454 -0.779 . . . . 0.0 110.687 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 7' ' ' LYS . . . 87.57 20.09 52.45 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.86 ' HE3' HD22 ' A' ' 3' ' ' LEU . 7.8 mmmt -141.39 -172.16 3.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -1.093 . . . . 0.0 109.785 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.81 166.47 23.31 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.755 -0.778 . . . . 0.0 108.992 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 26' ' ' LYS . 8.4 p -147.37 45.41 1.14 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.786 -1.196 . . . . 0.0 111.083 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 14' ' ' GLN . . . -103.84 61.72 0.75 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.144 -0.972 . . . . 0.0 109.831 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.96 -18.22 11.25 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.547 HG23 ' N ' ' A' ' 13' ' ' THR . 27.6 m -53.9 -40.7 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -1.201 . . . . 0.0 109.478 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.547 ' N ' HG23 ' A' ' 12' ' ' VAL . 8.9 t -119.2 9.33 11.7 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.727 -0.608 . . . . 0.0 109.73 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -104.85 162.09 13.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.363 -0.836 . . . . 0.0 110.172 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.663 ' O ' HD13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -86.1 -15.97 39.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.3 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.671 HG22 ' HA ' ' A' ' 2' ' ' CYS . 49.1 mm -140.04 117.67 8.34 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.74 . . . . 0.0 109.74 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.1 170.35 19.85 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.867 1.456 . . . . 0.0 111.214 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 21' ' ' SER . 1.8 t -69.04 118.72 12.3 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.79 0.805 . . . . 0.0 110.118 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.645 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -45.15 -33.71 2.36 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.28 -111.67 2.32 Favored Glycine 0 C--N 1.292 -1.888 0 N-CA-C 106.321 -2.712 . . . . 0.0 106.321 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.522 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 29.7 m -141.9 173.26 11.68 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.955 -1.321 . . . . 0.0 109.889 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 48.3 t -95.82 106.96 19.16 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.134 -0.979 . . . . 0.0 110.704 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.49 HG21 ' CB ' ' A' ' 28' ' ' SER . 1.8 m -123.82 123.6 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.338 -0.851 . . . . 0.0 109.881 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.52 30.86 12.73 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 122.363 1.077 . . . . 0.0 109.283 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.422 ' C ' ' SG ' ' A' ' 9' ' ' CYS . . . 69.19 18.5 73.15 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 7' ' ' LYS . 5.9 ttmt -141.45 129.36 21.85 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.368 -1.078 . . . . 0.0 111.825 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 5' ' ' SER . 20.1 t -45.84 112.99 0.53 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.422 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.511 ' OXT' ' CB ' ' A' ' 5' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.505 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.54 ' C ' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.221 0.534 . . . . 0.0 110.149 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.585 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 22.4 p -176.96 145.67 0.49 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 0.0 110.331 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.961 HD11 ' O ' ' A' ' 16' ' ' ILE . 1.8 mp -87.43 131.77 43.03 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.557 -0.715 . . . . 0.0 110.498 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 5' ' ' SER . 45.7 Cg_endo -72.6 139.81 31.74 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.916 1.482 . . . . 0.0 109.301 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 1.8 m -39.32 161.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -0.834 . . . . 0.0 110.811 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.52 17.36 52.8 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' ALA . 7.9 mttp -149.58 146.57 27.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -1.208 . . . . 0.0 109.958 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -43.2 165.64 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.299 -0.875 . . . . 0.0 109.995 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.478 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 6.6 p -141.55 62.48 1.45 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 0.0 110.507 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 14' ' ' GLN . . . -86.41 57.2 4.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.868 -1.145 . . . . 0.0 110.134 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 14' ' ' GLN . . . -71.98 -11.05 74.02 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.468 ' H ' HG22 ' A' ' 12' ' ' VAL . 3.4 m -52.85 -33.69 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.143 . . . . 0.0 109.57 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -126.88 -26.26 3.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.589 -0.694 . . . . 0.0 109.764 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.512 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 8.0 tt0 -63.9 164.13 10.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 0.0 109.82 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.406 ' N ' ' CG ' ' A' ' 14' ' ' GLN . 10.4 mmtp -85.7 -38.91 17.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.43 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.961 ' O ' HD11 ' A' ' 3' ' ' LEU . 2.1 mp -108.21 108.03 60.78 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 110.258 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.747 ' O ' HD12 ' A' ' 3' ' ' LEU . 50.6 Cg_endo -76.75 175.3 11.55 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.062 1.559 . . . . 0.0 111.363 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 21' ' ' SER . 2.0 t -62.74 119.41 9.25 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.775 0.798 . . . . 0.0 110.961 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.585 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -43.85 -35.36 1.91 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.96 -112.4 1.88 Allowed Glycine 0 C--N 1.29 -2.006 0 N-CA-C 106.187 -2.765 . . . . 0.0 106.187 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.509 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -142.37 161.64 37.51 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.117 -1.225 . . . . 0.0 109.821 177.517 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 45.9 t -94.04 88.94 5.85 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.123 -0.985 . . . . 0.0 110.337 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.547 HG21 ' HB2' ' A' ' 28' ' ' SER . 1.6 m -111.03 131.31 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.419 -0.8 . . . . 0.0 109.754 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.474 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER 64.56 33.05 11.14 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.222 1.01 . . . . 0.0 109.441 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.29 21.82 64.66 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.53 142.11 35.24 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.379 -1.071 . . . . 0.0 111.318 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 5' ' ' SER . 49.9 t -67.92 94.45 0.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.755 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.547 ' HB2' HG21 ' A' ' 23' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.097 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.465 ' HA ' ' CD1' ' A' ' 16' ' ' ILE . 4.2 ptp180 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.268 0.556 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.547 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 14.1 p -164.08 150.31 11.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.327 -0.858 . . . . 0.0 110.248 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.534 ' HG ' HG22 ' A' ' 16' ' ' ILE . 19.0 mt -97.84 137.0 20.92 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.463 -0.773 . . . . 0.0 110.171 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.477 ' O ' ' O ' ' A' ' 5' ' ' SER . 46.0 Cg_endo -72.45 135.15 23.83 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 O-C-N 124.08 1.568 . . . . 0.0 109.061 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.555 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 10.0 m -39.68 162.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.455 -0.778 . . . . 0.0 110.474 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.22 17.49 50.25 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -150.9 147.45 27.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.472 -1.016 . . . . 0.0 109.552 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -40.52 160.72 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.433 -0.792 . . . . 0.0 110.155 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 6.6 p -133.77 65.7 1.57 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.196 -0.94 . . . . 0.0 111.052 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -90.24 61.33 5.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.057 -1.027 . . . . 0.0 109.463 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.522 ' HA2' ' HG2' ' A' ' 14' ' ' GLN . . . -77.36 -10.2 86.38 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.5 t -80.4 -13.53 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.041 -1.27 . . . . 0.0 110.302 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.8 -17.59 2.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.159 -0.963 . . . . 0.0 111.278 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.522 ' HG2' ' HA2' ' A' ' 11' ' ' GLY . 14.7 pt20 -98.1 177.59 5.36 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.864 -1.148 . . . . 0.0 110.377 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HG3' HG12 ' A' ' 16' ' ' ILE . 4.6 ptmt -88.47 -28.27 20.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.868 . . . . 0.0 110.608 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.534 HG22 ' HG ' ' A' ' 3' ' ' LEU . 32.5 mm -102.66 103.89 35.22 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 0.0 110.573 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.426 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 50.6 Cg_endo -76.61 171.99 17.02 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.918 1.483 . . . . 0.0 110.228 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 21' ' ' SER . 29.8 t -72.22 116.55 12.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.248 -0.907 . . . . 0.0 110.109 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.547 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -46.53 -33.61 4.2 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.87 -110.34 2.71 Favored Glycine 0 C--N 1.292 -1.909 0 N-CA-C 106.204 -2.758 . . . . 0.0 106.204 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.458 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 1.2 m -141.98 164.98 28.7 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.042 -1.269 . . . . 0.0 109.42 177.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 54.1 t -99.8 92.68 5.42 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.713 -1.242 . . . . 0.0 110.722 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.27 135.0 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.292 -0.88 . . . . 0.0 110.402 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.91 33.79 20.78 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 122.067 0.937 . . . . 0.0 110.601 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.61 26.44 74.47 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.426 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 1.9 ttmm -141.52 143.65 33.89 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.173 -1.192 . . . . 0.0 111.075 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 5' ' ' SER . 23.9 t -77.22 111.38 12.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 109.195 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.433 ' C ' ' OG ' ' A' ' 5' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.268 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 2' ' ' CYS . 8.1 mtm180 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.27 0.557 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.62 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 29.3 p -41.66 148.09 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 110.422 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.78 135.97 21.91 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.0 110.378 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 5' ' ' SER . 47.3 Cg_endo -74.85 149.53 37.6 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.964 1.507 . . . . 0.0 110.021 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 2.9 m -39.62 161.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.372 -0.83 . . . . 0.0 110.315 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.54 13.84 59.22 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.478 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -125.55 162.33 25.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -1.151 . . . . 0.0 109.81 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.21 98.72 11.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.001 -1.062 . . . . 0.0 111.291 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.489 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 29.1 p -85.91 95.11 9.36 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.134 -0.978 . . . . 0.0 108.612 178.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -107.22 68.16 0.72 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.112 -0.993 . . . . 0.0 110.617 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 14' ' ' GLN . . . 158.7 65.4 0.01 OUTLIER Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.49 ' C ' ' O ' ' A' ' 11' ' ' GLY . 1.7 m -36.6 -33.41 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.785 -0.833 . . . . 0.0 109.896 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.9 t -88.46 42.73 1.09 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.448 -0.783 . . . . 0.0 109.103 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -91.46 154.87 18.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.507 -0.746 . . . . 0.0 110.121 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt -65.38 -35.88 82.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 108.865 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.674 ' O ' HG22 ' A' ' 16' ' ' ILE . 5.9 mm -125.17 82.93 61.37 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.34 178.7 6.67 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 124.128 1.594 . . . . 0.0 111.332 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 21' ' ' SER . 3.9 t -61.79 120.02 9.89 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.556 0.693 . . . . 0.0 110.551 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.62 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -43.96 -35.72 2.15 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.027 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.35 -107.04 0.89 Allowed Glycine 0 C--N 1.291 -1.97 0 N-CA-C 105.983 -2.847 . . . . 0.0 105.983 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.507 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.2 OUTLIER -142.56 170.59 15.43 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.014 -1.286 . . . . 0.0 110.055 177.382 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 46.6 t -108.39 94.59 5.14 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.994 -1.066 . . . . 0.0 110.13 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -121.76 138.75 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -0.932 . . . . 0.0 109.776 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 37.7 mtp180 61.31 34.51 18.48 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.152 0.977 . . . . 0.0 110.203 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.6 18.49 59.02 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 7' ' ' LYS . 2.5 ttpp -140.84 131.48 25.58 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.327 -1.102 . . . . 0.0 111.528 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 5' ' ' SER . 25.2 t -58.13 119.95 7.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.457 -0.777 . . . . 0.0 109.645 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--N 1.3 -1.58 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.14 -179.837 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.223 0.535 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.607 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 8.9 p -162.85 138.84 7.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 110.517 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 5.8 mt -59.76 123.73 72.9 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.594 -0.692 . . . . 0.0 109.809 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' A' ' 5' ' ' SER . 43.1 Cg_endo -70.55 125.92 12.25 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.811 1.427 . . . . 0.0 109.746 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 16.0 t -38.7 156.82 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.547 -0.721 . . . . 0.0 110.504 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.9 14.84 58.8 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.98 169.92 14.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.401 -1.058 . . . . 0.0 109.746 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.82 112.7 24.73 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.923 -1.11 . . . . 0.0 111.094 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.464 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 25.9 p -91.74 91.02 7.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.316 -0.865 . . . . 0.0 109.209 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -110.27 63.14 0.6 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.246 -0.909 . . . . 0.0 109.435 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 14' ' ' GLN . . . -172.62 66.37 0.12 Allowed Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 m -50.54 -32.57 10.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.937 -1.331 . . . . 0.0 109.411 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 14' ' ' GLN . 12.8 t -89.53 -21.18 23.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.509 -0.745 . . . . 0.0 110.476 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.549 ' NE2' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -37.15 158.1 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.563 -0.711 . . . . 0.0 110.124 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 12.8 mttm -73.5 -35.64 65.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.008 -1.057 . . . . 0.0 110.34 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.436 ' N ' ' HG2' ' A' ' 14' ' ' GLN . 7.9 mt -99.93 103.06 19.84 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.48 -0.763 . . . . 0.0 110.273 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.549 ' HA ' ' NE2' ' A' ' 14' ' ' GLN . 48.3 Cg_endo -75.94 169.15 22.73 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.973 1.512 . . . . 0.0 110.697 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 21' ' ' SER . 3.0 t -68.56 116.65 9.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.87 . . . . 0.0 109.593 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.607 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -42.84 -33.23 0.73 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.72 -111.87 3.0 Favored Glycine 0 C--N 1.293 -1.817 0 N-CA-C 106.15 -2.78 . . . . 0.0 106.15 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.553 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -142.07 141.61 32.77 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.059 -1.259 . . . . 0.0 110.162 177.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.7 t -79.93 81.77 6.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.091 -1.006 . . . . 0.0 110.251 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 6.6 m -109.95 133.25 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.668 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 62.4 34.08 15.82 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.231 1.015 . . . . 0.0 109.722 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.29 24.46 67.42 Favored Glycine 0 C--N 1.291 -1.969 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -139.13 138.67 37.21 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.483 -1.01 . . . . 0.0 110.607 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 5' ' ' SER . 14.5 t -69.92 81.04 0.47 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.487 -0.758 . . . . 0.0 109.61 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.508 ' HG ' ' C ' ' A' ' 27' ' ' CYS . 58.4 p . . . . . 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 0.0 110.174 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.534 ' O ' HG21 ' A' ' 16' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 120.76 0.314 . . . . 0.0 110.265 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.594 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 16.2 p 175.39 145.43 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.23 -0.919 . . . . 0.0 109.648 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.595 HD12 HE22 ' A' ' 14' ' ' GLN . 79.8 mt -86.44 122.69 71.95 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.068 -1.02 . . . . 0.0 110.985 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 5' ' ' SER . 44.6 Cg_endo -73.97 144.4 34.21 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.414 1.218 . . . . 0.0 110.945 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.63 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 2.2 m -39.28 153.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.532 -0.73 . . . . 0.0 110.641 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' A' ' 7' ' ' LYS . . . 90.87 24.85 26.46 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.119 -1.039 . . . . 0.0 110.535 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 34.0 mttt -159.27 148.31 18.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.084 -1.244 . . . . 0.0 110.373 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -44.3 125.97 4.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.97 . . . . 0.0 110.487 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.475 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 23.8 p -98.06 82.58 2.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.201 -0.937 . . . . 0.0 110.005 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.51 ' O ' ' CG ' ' A' ' 14' ' ' GLN . . . -91.37 60.55 4.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.048 -1.032 . . . . 0.0 109.974 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.511 ' HA2' ' HG2' ' A' ' 14' ' ' GLN . . . -87.68 -11.17 68.82 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -82.74 -5.32 8.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.3 -1.117 . . . . 0.0 110.1 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.16 -30.19 0.87 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 110.855 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.595 HE22 HD12 ' A' ' 3' ' ' LEU . 15.8 pt20 -81.65 179.88 7.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.017 -1.052 . . . . 0.0 110.278 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.79 -35.76 51.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.356 -0.84 . . . . 0.0 111.437 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.534 HG21 ' O ' ' A' ' 1' ' ' ARG . 7.8 mm -120.23 136.44 25.12 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.008 -1.057 . . . . 0.0 110.78 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.481 ' HA ' ' HA3' ' A' ' 11' ' ' GLY . 49.3 Cg_endo -77.0 -172.14 1.35 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.991 1.521 . . . . 0.0 110.696 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -79.35 127.96 32.74 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.99 0.9 . . . . 0.0 110.64 -179.067 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.594 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -46.35 -31.1 2.39 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.94 -112.99 2.36 Favored Glycine 0 C--N 1.294 -1.751 0 N-CA-C 105.544 -3.022 . . . . 0.0 105.544 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 14.4 m -143.05 162.24 36.04 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.098 -1.236 . . . . 0.0 109.387 177.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 48.9 t -101.7 115.67 31.04 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.941 -1.099 . . . . 0.0 109.836 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.609 HG21 ' CB ' ' A' ' 28' ' ' SER . 9.6 m -137.46 124.58 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.703 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.528 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 63.48 33.12 13.85 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.349 1.071 . . . . 0.0 109.818 -179.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.71 15.54 66.7 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.1 tptt -140.77 126.08 18.68 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.471 -1.017 . . . . 0.0 110.437 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.63 ' HB3' ' HA ' ' A' ' 5' ' ' SER . 0.7 OUTLIER -46.93 125.1 7.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.427 -0.795 . . . . 0.0 110.234 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.609 ' CB ' HG21 ' A' ' 23' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.057 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.523 ' C ' HG23 ' A' ' 16' ' ' ILE . 19.5 mmm180 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.235 0.54 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.624 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 30.3 p -148.63 144.44 27.19 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.325 -0.86 . . . . 0.0 110.37 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.644 ' HG ' HG22 ' A' ' 16' ' ' ILE . 19.7 mt -83.89 134.39 44.24 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.555 -0.715 . . . . 0.0 110.269 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.47 ' O ' ' C ' ' A' ' 5' ' ' SER . 47.9 Cg_endo -81.51 144.2 14.08 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.026 1.54 . . . . 0.0 109.787 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.492 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 4.6 t -38.73 151.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.391 -0.818 . . . . 0.0 110.216 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.49 ' HA2' ' HE2' ' A' ' 26' ' ' LYS . . . 90.52 15.7 56.46 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -122.08 172.21 8.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.392 -1.064 . . . . 0.0 109.778 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.77 155.26 18.37 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.017 -1.052 . . . . 0.0 110.477 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.424 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 27.1 p -160.72 73.02 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.575 -0.703 . . . . 0.0 109.287 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.28 72.17 0.89 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.323 -0.861 . . . . 0.0 110.484 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 12' ' ' VAL . . . -167.01 -48.3 0.02 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.562 ' CB ' ' O ' ' A' ' 11' ' ' GLY . 0.4 OUTLIER 81.49 -30.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.905 -0.762 . . . . 0.0 110.454 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 13' ' ' THR . 4.0 t -90.88 -13.6 33.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.111 -0.993 . . . . 0.0 109.732 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 13' ' ' THR . 15.9 pt20 -41.34 160.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.484 -0.76 . . . . 0.0 109.602 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -79.54 -19.38 49.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.946 -1.096 . . . . 0.0 110.562 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.644 HG22 ' HG ' ' A' ' 3' ' ' LEU . 71.2 mt -119.97 102.39 46.63 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 110.604 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.79 166.78 26.46 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.228 1.646 . . . . 0.0 110.203 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 19' ' ' CYS . 6.0 t -65.14 120.87 13.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.079 -1.013 . . . . 0.0 109.989 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.624 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -43.91 -30.72 0.73 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.162 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.427 ' N ' ' C ' ' A' ' 18' ' ' CYS . . . -108.74 -106.17 3.03 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.519 ' O ' ' HB2' ' A' ' 28' ' ' SER . 58.3 m -142.08 136.46 30.16 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.072 -1.252 . . . . 0.0 109.378 177.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.424 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 3.8 t -78.88 126.06 30.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.092 -1.005 . . . . 0.0 111.145 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.419 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -137.89 138.11 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.511 -0.743 . . . . 0.0 109.485 179.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.419 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 5.6 ttt180 60.77 33.38 20.11 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.999 0.904 . . . . 0.0 110.794 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.25 6.57 47.96 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.49 ' HE2' ' HA2' ' A' ' 6' ' ' GLY . 5.8 tptt -129.59 124.91 34.94 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.262 -1.14 . . . . 0.0 111.236 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.492 ' HB3' ' HA ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -42.53 124.41 2.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.568 -0.707 . . . . 0.0 109.574 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 21' ' ' SER . 39.0 t . . . . . 0 C--N 1.299 -1.614 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.186 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.609 ' HB2' HD12 ' A' ' 16' ' ' ILE . 53.2 mtm180 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.252 0.548 . . . . 0.0 110.324 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.541 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 17.0 p -158.87 150.34 20.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.364 -0.835 . . . . 0.0 110.139 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.51 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 81.1 mt -113.84 101.1 53.53 Favored Pre-proline 0 N--CA 1.493 1.704 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.013 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 48.2 Cg_endo -97.7 16.86 0.58 Allowed 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 121.629 1.552 . . . . 0.0 109.464 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 t -93.55 11.4 28.83 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.366 -0.833 . . . . 0.0 112.435 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 26' ' ' LYS . . . 67.91 20.99 73.08 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -59.63 144.9 46.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.499 -1.0 . . . . 0.0 109.521 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 25' ' ' GLY . . . -59.7 103.23 0.19 Allowed 'General case' 0 C--N 1.29 -1.985 0 O-C-N 120.582 -1.324 . . . . 0.0 110.144 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 25.4 p -86.99 88.28 7.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.575 -0.703 . . . . 0.0 110.278 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.66 64.0 0.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.981 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 12' ' ' VAL . . . 176.69 68.14 0.06 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 11' ' ' GLY . 24.3 t -40.28 -30.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.429 -1.042 . . . . 0.0 110.368 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 13' ' ' THR . 6.6 t -88.29 38.01 0.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.947 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -89.75 146.25 24.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 110.123 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.503 ' HG3' HG12 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -68.97 -24.42 64.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.115 -0.991 . . . . 0.0 109.578 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.609 HD12 ' HB2' ' A' ' 1' ' ' ARG . 12.4 mm -110.67 99.64 42.43 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.35 -0.844 . . . . 0.0 109.844 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.514 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 44.4 Cg_endo -72.04 167.06 27.78 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.125 1.592 . . . . 0.0 111.188 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.1 t -76.4 127.93 33.83 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.535 -0.728 . . . . 0.0 110.816 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.541 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -57.96 -29.13 64.95 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.42 -113.57 3.81 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 106.357 -2.697 . . . . 0.0 106.357 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.4 t -142.61 157.75 44.37 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.87 -1.371 . . . . 0.0 110.691 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.6 t -83.44 91.73 7.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.834 . . . . 0.0 109.849 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -124.15 131.29 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.21 -0.931 . . . . 0.0 111.566 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 1.9 mmp_? 63.23 34.71 13.15 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 122.072 0.939 . . . . 0.0 110.229 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 8' ' ' ALA . . . 62.58 21.47 62.71 Favored Glycine 0 C--N 1.288 -2.1 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 6' ' ' GLY . 12.7 ttmt -129.09 138.17 51.68 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.723 -0.869 . . . . 0.0 110.038 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -75.0 78.52 2.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.423 -0.798 . . . . 0.0 110.474 -179.248 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 27' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.953 -1.023 . . . . 0.0 110.232 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.64 ' N ' HD13 ' A' ' 16' ' ' ILE . 3.2 mtt85 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.601 ' O ' ' O ' ' A' ' 1' ' ' ARG . 13.4 p 46.14 140.7 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 CA-C-O 122.632 1.206 . . . . 0.0 112.521 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.482 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 94.7 mt -90.78 139.2 26.14 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.051 -1.031 . . . . 0.0 110.941 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -80.66 142.85 14.61 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.878 1.462 . . . . 0.0 110.342 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.524 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 40.8 t -43.65 151.24 0.2 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.283 -0.885 . . . . 0.0 110.431 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.76 27.93 20.34 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.03 -175.5 4.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -1.117 . . . . 0.0 109.694 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.39 111.01 22.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.414 -0.804 . . . . 0.0 109.223 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 26' ' ' LYS . 27.4 p -91.18 84.47 5.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -0.925 . . . . 0.0 111.078 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.533 ' O ' ' CG ' ' A' ' 14' ' ' GLN . . . -88.77 55.65 3.45 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.627 -1.295 . . . . 0.0 109.338 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 17' ' ' PRO . . . -76.88 2.88 58.63 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.45 -22.41 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.185 -1.185 . . . . 0.0 109.908 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.6 t -142.75 3.23 1.43 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.288 -0.882 . . . . 0.0 111.053 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.533 ' CG ' ' O ' ' A' ' 10' ' ' ALA . 12.7 pt20 -99.92 -166.87 1.38 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.882 -1.136 . . . . 0.0 110.714 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.494 ' N ' ' HG3' ' A' ' 14' ' ' GLN . 7.6 ttpt -77.17 -49.26 15.58 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.696 -0.627 . . . . 0.0 111.024 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.64 HD13 ' N ' ' A' ' 1' ' ' ARG . 5.6 mt -133.58 140.8 37.96 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.267 -0.895 . . . . 0.0 111.078 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.48 ' HB3' ' HA3' ' A' ' 11' ' ' GLY . 47.4 Cg_endo -78.28 -165.78 0.36 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 124.313 1.691 . . . . 0.0 112.17 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 20.2 t -68.9 122.31 18.38 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.737 0.78 . . . . 0.0 111.472 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.489 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -46.14 -35.71 5.27 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.1 -103.55 1.6 Allowed Glycine 0 C--N 1.295 -1.717 0 N-CA-C 106.768 -2.533 . . . . 0.0 106.768 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.1 p -142.23 122.96 14.28 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.268 -1.136 . . . . 0.0 109.007 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 26.2 t -77.98 121.12 23.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.075 -1.015 . . . . 0.0 111.353 -178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.47 134.95 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.804 0.811 . . . . 0.0 109.947 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 58.3 34.1 23.75 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.996 0.903 . . . . 0.0 110.439 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.38 26.12 70.44 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.512 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 11.7 tttp -139.18 123.05 17.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.603 -0.94 . . . . 0.0 110.219 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 5' ' ' SER . 0.5 OUTLIER -52.9 107.17 0.2 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.4 -0.812 . . . . 0.0 109.956 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.43 ' HB3' ' OG ' ' A' ' 5' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.397 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.242 0.544 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.585 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 20.4 p -136.29 144.32 44.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.119 -0.988 . . . . 0.0 110.392 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.461 ' HG ' HG22 ' A' ' 16' ' ' ILE . 25.3 mt -86.22 141.58 35.08 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.481 -0.762 . . . . 0.0 110.644 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 5' ' ' SER . 46.8 Cg_endo -74.41 125.96 10.01 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.068 1.562 . . . . 0.0 109.638 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -39.46 158.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.453 -0.78 . . . . 0.0 110.757 -179.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 7' ' ' LYS . . . 90.24 25.03 27.47 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 6' ' ' GLY . 4.6 mmtt -151.69 153.7 34.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -1.102 . . . . 0.0 110.288 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.0 143.5 34.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.089 -1.007 . . . . 0.0 110.492 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -123.59 -91.06 0.56 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.702 0.763 . . . . 0.0 109.811 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.563 ' HB3' HE21 ' A' ' 14' ' ' GLN . . . -162.27 -135.42 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.245 1.022 . . . . 0.0 108.443 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.486 ' C ' HG23 ' A' ' 12' ' ' VAL . . . -102.99 -73.39 0.96 Allowed Glycine 0 C--N 1.273 -2.935 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.486 HG23 ' C ' ' A' ' 11' ' ' GLY . 5.2 t -149.98 -39.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.383 -1.069 . . . . 0.0 110.058 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 13' ' ' THR . 8.9 t -103.05 83.36 2.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.314 -0.866 . . . . 0.0 110.143 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.563 HE21 ' HB3' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -118.16 174.73 6.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.887 . . . . 0.0 110.053 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.518 ' HG2' ' N ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -67.01 -26.38 66.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.645 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.518 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 87.3 mt -141.02 107.56 6.28 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.452 -0.78 . . . . 0.0 109.683 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 16' ' ' ILE . 45.1 Cg_endo -71.59 157.36 56.14 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.944 1.497 . . . . 0.0 111.349 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.539 ' SG ' ' N ' ' A' ' 21' ' ' SER . 4.5 t -69.07 119.97 14.19 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.83 0.824 . . . . 0.0 109.878 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.585 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -45.52 -33.29 2.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.35 -104.88 2.02 Favored Glycine 0 C--N 1.293 -1.831 0 N-CA-C 106.149 -2.78 . . . . 0.0 106.149 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.539 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 1.7 p -141.68 116.97 10.11 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.132 -1.216 . . . . 0.0 109.547 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.536 ' N ' ' HB3' ' A' ' 18' ' ' CYS . 41.1 t -78.87 82.01 5.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 110.295 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.453 ' CG2' ' OG ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -106.72 143.68 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.454 -0.778 . . . . 0.0 109.851 179.725 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER 59.96 37.38 21.44 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.114 0.959 . . . . 0.0 109.879 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 10' ' ' ALA . . . 61.04 26.13 65.26 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -140.21 140.24 35.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.48 -1.012 . . . . 0.0 111.203 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 5' ' ' SER . 36.9 t -83.29 89.43 7.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.56 -0.713 . . . . 0.0 109.337 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.313 -179.456 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.48 ' O ' HD12 ' A' ' 16' ' ' ILE . 50.7 mtt-85 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.162 0.506 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.659 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 4.8 p 174.32 138.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -0.88 . . . . 0.0 110.168 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.805 HD13 ' HA ' ' A' ' 9' ' ' CYS . 2.9 mt -61.37 119.0 42.48 Favored Pre-proline 0 C--N 1.303 -1.453 0 C-N-CA 119.659 -0.817 . . . . 0.0 109.513 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 5' ' ' SER . 41.3 Cg_endo -68.22 125.96 13.68 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.951 1.5 . . . . 0.0 109.977 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 72.1 m -38.49 152.93 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.682 -0.637 . . . . 0.0 110.296 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.94 18.97 49.1 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 8' ' ' ALA . 10.8 mttt -154.89 148.44 25.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.395 -1.062 . . . . 0.0 110.147 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -42.03 160.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.883 . . . . 0.0 110.541 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.805 ' HA ' HD13 ' A' ' 3' ' ' LEU . 4.8 p -147.37 68.64 1.14 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.49 -0.756 . . . . 0.0 110.231 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.01 59.07 5.41 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.149 -0.969 . . . . 0.0 109.789 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.569 ' HA2' ' CD ' ' A' ' 14' ' ' GLN . . . -85.41 -6.84 83.33 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 12' ' ' VAL . 6.2 t -54.85 -20.3 5.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.093 -1.24 . . . . 0.0 108.562 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.6 t -123.99 -12.51 7.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.622 -0.674 . . . . 0.0 109.663 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.591 ' HG2' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -97.48 164.37 12.47 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.271 -0.893 . . . . 0.0 109.33 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.591 ' N ' ' HG2' ' A' ' 14' ' ' GLN . 4.7 mmtt -82.65 -35.64 26.74 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.933 -1.104 . . . . 0.0 112.386 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.593 ' CG2' ' HA ' ' A' ' 2' ' ' CYS . 9.6 mm -101.54 95.97 5.77 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.917 -1.114 . . . . 0.0 110.994 -178.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 46.8 Cg_endo -70.09 -176.01 1.43 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 124.15 1.605 . . . . 0.0 112.394 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -63.08 119.85 10.3 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.994 0.902 . . . . 0.0 110.504 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.659 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -42.35 -34.45 0.81 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 122.553 1.168 . . . . 0.0 107.993 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.36 -112.14 2.59 Favored Glycine 0 C--N 1.288 -2.126 0 N-CA-C 105.976 -2.85 . . . . 0.0 105.976 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.533 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.2 OUTLIER -141.79 133.08 26.45 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.24 -1.153 . . . . 0.0 109.126 177.053 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 47.1 t -78.84 119.91 22.71 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.098 -1.001 . . . . 0.0 110.208 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.544 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 2.4 t -140.95 160.93 23.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER 36.93 30.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.855 0.836 . . . . 0.0 111.836 -179.488 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 23' ' ' VAL . . . 87.11 -24.29 9.54 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.062 177.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.04 147.33 36.22 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.49 -1.594 . . . . 0.0 112.686 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 5' ' ' SER . 43.1 t -66.98 103.49 1.16 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.544 0.687 . . . . 0.0 109.69 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.137 -179.677 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.469 ' O ' ' C ' ' A' ' 2' ' ' CYS . 17.0 mmt180 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.013 0.435 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.601 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 32.1 p -35.45 147.78 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.534 -0.729 . . . . 0.0 111.07 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 3' ' ' LEU . 23.4 mt -80.26 123.42 83.18 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.501 -0.75 . . . . 0.0 110.822 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.484 ' O ' ' O ' ' A' ' 5' ' ' SER . 51.0 Cg_endo -75.82 143.89 27.06 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.95 1.5 . . . . 0.0 110.034 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.561 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 7.1 t -39.71 164.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.504 -0.747 . . . . 0.0 110.862 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.12 13.53 58.77 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.573 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 2.6 mptt -147.68 158.95 44.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.98 -1.306 . . . . 0.0 109.669 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -47.57 169.09 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.286 -1.509 . . . . 0.0 109.757 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.569 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 5.4 p -135.15 64.5 1.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 111.635 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.49 ' C ' ' NE2' ' A' ' 14' ' ' GLN . . . -86.55 59.12 5.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.059 -1.026 . . . . 0.0 109.152 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.866 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -69.43 84.3 0.26 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 11' ' ' GLY . 0.9 OUTLIER 174.12 -33.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.719 -0.871 . . . . 0.0 108.681 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -126.24 -26.35 3.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.573 -0.704 . . . . 0.0 109.954 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.64 ' OE1' ' HA ' ' A' ' 17' ' ' PRO . 3.3 pt20 -56.89 173.87 0.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 0.0 109.994 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.62 -39.03 81.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.896 . . . . 0.0 109.696 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 2' ' ' CYS . 32.3 mt -134.34 143.69 48.0 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.576 -0.702 . . . . 0.0 109.699 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.64 ' HA ' ' OE1' ' A' ' 14' ' ' GLN . 47.3 Cg_endo -73.59 152.15 47.98 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.146 1.603 . . . . 0.0 111.983 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 19' ' ' CYS . 23.1 t -55.96 117.88 4.11 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.422 -0.799 . . . . 0.0 110.073 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.601 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -41.19 -32.7 0.29 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.568 1.175 . . . . 0.0 107.865 179.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 18' ' ' CYS . . . -106.62 -114.13 3.87 Favored Glycine 0 C--N 1.289 -2.072 0 N-CA-C 106.189 -2.764 . . . . 0.0 106.189 177.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 m -142.55 -179.12 6.11 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.108 -1.231 . . . . 0.0 109.613 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.569 ' HA ' ' CB ' ' A' ' 9' ' ' CYS . 53.7 t -96.65 88.52 4.67 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.059 -1.025 . . . . 0.0 110.071 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -113.12 143.42 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.503 -0.748 . . . . 0.0 109.466 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 60.79 36.36 19.24 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 122.102 0.953 . . . . 0.0 109.987 -179.448 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.85 20.46 48.26 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -141.47 176.71 8.66 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.675 -0.897 . . . . 0.0 111.339 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -86.02 119.7 26.61 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.515 ' HB3' ' CB ' ' A' ' 5' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.294 -1.83 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.208 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.219 0.533 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.568 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 21.3 p -174.34 146.97 1.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.878 . . . . 0.0 110.682 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.497 ' O ' ' HB2' ' A' ' 19' ' ' CYS . 39.1 mt -81.52 139.62 47.85 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.477 -0.764 . . . . 0.0 110.443 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.514 ' O ' ' O ' ' A' ' 5' ' ' SER . 47.3 Cg_endo -74.63 117.12 4.83 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.03 1.542 . . . . 0.0 110.191 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.54 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 27.4 p -40.88 168.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.39 -0.819 . . . . 0.0 110.959 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.21 3.88 69.27 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -149.23 154.22 38.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -1.139 . . . . 0.0 109.978 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.15 155.34 37.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.259 -0.901 . . . . 0.0 109.974 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.465 ' HA ' HD13 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -115.67 -85.98 0.61 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.671 0.748 . . . . 0.0 109.447 179.501 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -162.08 -137.69 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 122.432 1.11 . . . . 0.0 108.67 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.918 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -106.63 -67.99 0.68 Allowed Glycine 0 C--N 1.272 -2.976 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 11' ' ' GLY . 2.3 t -168.7 -33.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.466 -1.02 . . . . 0.0 110.132 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.9 t -84.91 19.14 2.19 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.188 -0.945 . . . . 0.0 111.413 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -67.81 146.13 54.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.796 -1.19 . . . . 0.0 109.853 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 ptpt -67.53 -27.74 67.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.049 -1.032 . . . . 0.0 109.353 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.0 mt -117.26 106.18 47.48 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.52 -0.738 . . . . 0.0 109.48 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.32 158.94 53.2 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.995 1.524 . . . . 0.0 110.682 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 21' ' ' SER . 11.0 t -64.04 121.3 13.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.445 -0.784 . . . . 0.0 110.134 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.568 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -47.04 -34.35 5.67 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 179.222 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.92 -108.99 2.41 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 106.308 -2.717 . . . . 0.0 106.308 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.537 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 23.9 p -141.73 129.59 21.78 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.011 -1.288 . . . . 0.0 109.781 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 7.5 t -78.61 78.94 5.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 109.677 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.442 HG22 ' OG ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -113.11 138.51 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.342 -0.849 . . . . 0.0 111.156 -179.384 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 59.81 35.99 22.03 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.047 0.927 . . . . 0.0 110.247 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.43 27.09 71.24 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -133.24 152.8 51.94 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.645 -0.915 . . . . 0.0 110.084 -179.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.54 ' HB3' ' HA ' ' A' ' 5' ' ' SER . 46.2 t -91.0 62.48 4.91 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.995 -1.066 . . . . 0.0 110.417 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.231 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 13.2 mmt180 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.204 0.526 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.627 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 31.6 p -177.53 145.22 0.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.407 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.623 ' HG ' HG22 ' A' ' 16' ' ' ILE . 12.5 mt -107.97 144.2 28.89 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.393 -0.817 . . . . 0.0 110.305 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 5' ' ' SER . 48.0 Cg_endo -73.45 158.45 47.96 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 O-C-N 124.201 1.632 . . . . 0.0 109.776 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 60.7 p -42.6 169.28 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.929 . . . . 0.0 110.831 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.92 4.72 69.01 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -145.3 141.59 28.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.887 -1.361 . . . . 0.0 110.565 179.493 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -39.19 145.05 0.11 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.432 0.634 . . . . 0.0 110.708 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.471 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 9.0 p -119.91 59.9 0.87 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.558 -0.714 . . . . 0.0 109.865 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.98 ' HB1' ' CG2' ' A' ' 13' ' ' THR . . . -86.91 59.99 5.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.14 -0.975 . . . . 0.0 109.885 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.506 ' HA2' ' HG2' ' A' ' 14' ' ' GLN . . . -57.27 -45.38 92.8 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.462 ' H ' HG22 ' A' ' 12' ' ' VAL . 3.3 m -59.59 -32.82 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.445 -1.033 . . . . 0.0 110.843 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.98 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 3.5 t -116.38 29.76 7.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.13 -0.981 . . . . 0.0 111.288 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.506 ' HG2' ' HA2' ' A' ' 11' ' ' GLY . 5.4 pt20 -152.54 176.07 12.09 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.876 -1.14 . . . . 0.0 110.222 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.479 ' HG3' HG13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -88.8 -34.47 17.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.891 . . . . 0.0 111.374 -179.039 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.623 HG22 ' HG ' ' A' ' 3' ' ' LEU . 50.5 mt -115.7 111.31 43.67 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.886 -1.134 . . . . 0.0 110.944 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.71 -179.26 5.01 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.896 1.472 . . . . 0.0 110.623 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.6 t -75.24 117.52 17.15 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.635 0.731 . . . . 0.0 110.171 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.627 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -48.65 -34.5 11.91 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.271 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.31 -111.15 0.82 Allowed Glycine 0 C--N 1.294 -1.789 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -142.26 148.52 38.22 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 120.915 -1.344 . . . . 0.0 109.724 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 53.2 t -78.84 122.09 25.63 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.999 -1.063 . . . . 0.0 110.09 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.727 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -140.0 -176.62 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.622 0 O-C-N 121.424 -0.798 . . . . 0.0 108.94 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.684 ' N ' HG13 ' A' ' 23' ' ' VAL . 0.0 OUTLIER 10.28 44.58 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.727 ' N ' ' O ' ' A' ' 23' ' ' VAL . . . 73.17 -10.82 5.51 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.235 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 23' ' ' VAL . 3.2 tttp -129.27 150.69 50.53 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 120.413 -1.64 . . . . 0.0 110.791 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 5' ' ' SER . 7.6 t -63.39 137.06 58.03 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.76 0.791 . . . . 0.0 109.725 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 5' ' ' SER . 3.3 p . . . . . 0 C--N 1.296 -1.733 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.317 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.539 ' CB ' HG13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.314 0.578 . . . . 0.0 110.109 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.602 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 31.2 p -42.33 146.33 0.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 110.043 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.464 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 92.9 mt -89.92 128.52 49.73 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.411 -0.805 . . . . 0.0 110.519 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 5' ' ' SER . 48.2 Cg_endo -74.35 141.5 28.81 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.904 1.476 . . . . 0.0 109.512 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 87.9 p -40.11 159.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.323 -0.861 . . . . 0.0 110.764 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.55 15.6 56.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.81 163.35 22.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.099 -1.236 . . . . 0.0 109.837 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.0 91.7 7.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.053 . . . . 0.0 110.614 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 26.7 p -81.34 90.9 6.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.022 -1.048 . . . . 0.0 109.768 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.5 71.19 1.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 110.004 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 175.43 65.7 0.06 OUTLIER Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 11' ' ' GLY . 74.7 t -39.28 -28.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.675 -0.897 . . . . 0.0 110.311 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.471 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.9 t -89.78 38.64 0.92 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 109.605 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.483 ' NE2' ' HA ' ' A' ' 17' ' ' PRO . 29.7 pt20 -87.24 -178.55 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 0.0 110.016 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.607 ' O ' HD13 ' A' ' 16' ' ' ILE . 10.5 mmtt -71.31 -43.47 67.0 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.402 -0.811 . . . . 0.0 109.743 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.607 HD13 ' O ' ' A' ' 15' ' ' LYS . 21.1 mm -140.63 139.47 20.24 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.547 -0.72 . . . . 0.0 110.496 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.483 ' HA ' ' NE2' ' A' ' 14' ' ' GLN . 47.0 Cg_endo -74.42 -176.35 2.69 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.132 1.596 . . . . 0.0 111.05 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 7.5 t -66.82 122.08 16.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.589 -0.694 . . . . 0.0 110.397 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.602 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -44.17 -31.27 0.93 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.413 ' N ' ' C ' ' A' ' 18' ' ' CYS . . . -102.5 -107.3 3.1 Favored Glycine 0 C--N 1.296 -1.686 0 N-CA-C 106.062 -2.815 . . . . 0.0 106.062 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.2 p -142.7 123.69 14.42 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.084 -1.245 . . . . 0.0 109.732 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 18' ' ' CYS . 4.4 t -78.15 117.94 19.92 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.167 -0.958 . . . . 0.0 110.538 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.92 142.29 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.414 -0.804 . . . . 0.0 109.635 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 6.5 tpm_? 58.51 36.04 25.01 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.116 0.96 . . . . 0.0 110.183 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 59.86 28.2 65.54 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -140.47 116.43 10.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.692 -0.887 . . . . 0.0 110.953 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 5' ' ' SER . 0.3 OUTLIER -53.52 113.43 1.17 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.287 -0.883 . . . . 0.0 109.223 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.235 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.616 ' O ' HG23 ' A' ' 16' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.286 0.565 . . . . 0.0 110.252 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.671 ' HA ' HG22 ' A' ' 16' ' ' ILE . 14.8 p -162.52 143.21 9.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 110.401 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.86 HD22 ' HE3' ' A' ' 7' ' ' LYS . 11.2 mt -80.89 135.23 52.07 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.531 -0.731 . . . . 0.0 110.597 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 5' ' ' SER . 47.4 Cg_endo -76.09 149.74 32.78 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.016 1.534 . . . . 0.0 110.126 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 60.3 p -40.58 157.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.454 -0.779 . . . . 0.0 110.687 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 7' ' ' LYS . . . 87.57 20.09 52.45 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.86 ' HE3' HD22 ' A' ' 3' ' ' LEU . 7.8 mmmt -141.39 -172.16 3.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -1.093 . . . . 0.0 109.785 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.81 166.47 23.31 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.755 -0.778 . . . . 0.0 108.992 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 26' ' ' LYS . 8.4 p -147.37 45.41 1.14 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.786 -1.196 . . . . 0.0 111.083 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 14' ' ' GLN . . . -103.84 61.72 0.75 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.144 -0.972 . . . . 0.0 109.831 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.96 -18.22 11.25 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.547 HG23 ' N ' ' A' ' 13' ' ' THR . 27.6 m -53.9 -40.7 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -1.201 . . . . 0.0 109.478 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.547 ' N ' HG23 ' A' ' 12' ' ' VAL . 8.9 t -119.2 9.33 11.7 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.727 -0.608 . . . . 0.0 109.73 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -104.85 162.09 13.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.363 -0.836 . . . . 0.0 110.172 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.663 ' O ' HD13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -86.1 -15.97 39.49 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.3 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.671 HG22 ' HA ' ' A' ' 2' ' ' CYS . 49.1 mm -140.04 117.67 8.34 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.515 -0.74 . . . . 0.0 109.74 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.1 170.35 19.85 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.867 1.456 . . . . 0.0 111.214 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 21' ' ' SER . 1.8 t -69.04 118.72 12.3 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.79 0.805 . . . . 0.0 110.118 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.645 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -45.15 -33.71 2.36 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.28 -111.67 2.32 Favored Glycine 0 C--N 1.292 -1.888 0 N-CA-C 106.321 -2.712 . . . . 0.0 106.321 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.522 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 29.7 m -141.9 173.26 11.68 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 120.955 -1.321 . . . . 0.0 109.889 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 48.3 t -95.82 106.96 19.16 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.134 -0.979 . . . . 0.0 110.704 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.49 HG21 ' CB ' ' A' ' 28' ' ' SER . 1.8 m -123.82 123.6 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.338 -0.851 . . . . 0.0 109.881 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.52 30.86 12.73 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 122.363 1.077 . . . . 0.0 109.283 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.422 ' C ' ' SG ' ' A' ' 9' ' ' CYS . . . 69.19 18.5 73.15 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 7' ' ' LYS . 5.9 ttmt -141.45 129.36 21.85 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.368 -1.078 . . . . 0.0 111.825 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 5' ' ' SER . 20.1 t -45.84 112.99 0.53 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.422 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.511 ' OXT' ' CB ' ' A' ' 5' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.505 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.54 ' C ' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.221 0.534 . . . . 0.0 110.149 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.585 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 22.4 p -176.96 145.67 0.49 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 0.0 110.331 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.961 HD11 ' O ' ' A' ' 16' ' ' ILE . 1.8 mp -87.43 131.77 43.03 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.557 -0.715 . . . . 0.0 110.498 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 5' ' ' SER . 45.7 Cg_endo -72.6 139.81 31.74 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.916 1.482 . . . . 0.0 109.301 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 1.8 m -39.32 161.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -0.834 . . . . 0.0 110.811 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.52 17.36 52.8 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' ALA . 7.9 mttp -149.58 146.57 27.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -1.208 . . . . 0.0 109.958 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -43.2 165.64 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.299 -0.875 . . . . 0.0 109.995 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.478 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 6.6 p -141.55 62.48 1.45 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 0.0 110.507 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 14' ' ' GLN . . . -86.41 57.2 4.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.868 -1.145 . . . . 0.0 110.134 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 14' ' ' GLN . . . -71.98 -11.05 74.02 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.468 ' H ' HG22 ' A' ' 12' ' ' VAL . 3.4 m -52.85 -33.69 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.143 . . . . 0.0 109.57 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -126.88 -26.26 3.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.589 -0.694 . . . . 0.0 109.764 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.512 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 8.0 tt0 -63.9 164.13 10.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 0.0 109.82 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.406 ' N ' ' CG ' ' A' ' 14' ' ' GLN . 10.4 mmtp -85.7 -38.91 17.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.43 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.961 ' O ' HD11 ' A' ' 3' ' ' LEU . 2.1 mp -108.21 108.03 60.78 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 110.258 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.747 ' O ' HD12 ' A' ' 3' ' ' LEU . 50.6 Cg_endo -76.75 175.3 11.55 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.062 1.559 . . . . 0.0 111.363 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 21' ' ' SER . 2.0 t -62.74 119.41 9.25 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.775 0.798 . . . . 0.0 110.961 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.585 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -43.85 -35.36 1.91 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.96 -112.4 1.88 Allowed Glycine 0 C--N 1.29 -2.006 0 N-CA-C 106.187 -2.765 . . . . 0.0 106.187 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.509 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -142.37 161.64 37.51 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.117 -1.225 . . . . 0.0 109.821 177.517 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 45.9 t -94.04 88.94 5.85 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.123 -0.985 . . . . 0.0 110.337 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.547 HG21 ' HB2' ' A' ' 28' ' ' SER . 1.6 m -111.03 131.31 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.419 -0.8 . . . . 0.0 109.754 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.474 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER 64.56 33.05 11.14 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.222 1.01 . . . . 0.0 109.441 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.29 21.82 64.66 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.53 142.11 35.24 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.379 -1.071 . . . . 0.0 111.318 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 5' ' ' SER . 49.9 t -67.92 94.45 0.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.561 -0.712 . . . . 0.0 109.755 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.547 ' HB2' HG21 ' A' ' 23' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.097 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.465 ' HA ' ' CD1' ' A' ' 16' ' ' ILE . 4.2 ptp180 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.268 0.556 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.547 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 14.1 p -164.08 150.31 11.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.327 -0.858 . . . . 0.0 110.248 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.534 ' HG ' HG22 ' A' ' 16' ' ' ILE . 19.0 mt -97.84 137.0 20.92 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.463 -0.773 . . . . 0.0 110.171 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.477 ' O ' ' O ' ' A' ' 5' ' ' SER . 46.0 Cg_endo -72.45 135.15 23.83 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 O-C-N 124.08 1.568 . . . . 0.0 109.061 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.555 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 10.0 m -39.68 162.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.455 -0.778 . . . . 0.0 110.474 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.22 17.49 50.25 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -150.9 147.45 27.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.472 -1.016 . . . . 0.0 109.552 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -40.52 160.72 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.433 -0.792 . . . . 0.0 110.155 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 6.6 p -133.77 65.7 1.57 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.196 -0.94 . . . . 0.0 111.052 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -90.24 61.33 5.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.057 -1.027 . . . . 0.0 109.463 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.522 ' HA2' ' HG2' ' A' ' 14' ' ' GLN . . . -77.36 -10.2 86.38 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.5 t -80.4 -13.53 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.041 -1.27 . . . . 0.0 110.302 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.8 -17.59 2.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.159 -0.963 . . . . 0.0 111.278 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.522 ' HG2' ' HA2' ' A' ' 11' ' ' GLY . 14.7 pt20 -98.1 177.59 5.36 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.864 -1.148 . . . . 0.0 110.377 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HG3' HG12 ' A' ' 16' ' ' ILE . 4.6 ptmt -88.47 -28.27 20.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.868 . . . . 0.0 110.608 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.534 HG22 ' HG ' ' A' ' 3' ' ' LEU . 32.5 mm -102.66 103.89 35.22 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 0.0 110.573 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.426 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 50.6 Cg_endo -76.61 171.99 17.02 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.918 1.483 . . . . 0.0 110.228 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 21' ' ' SER . 29.8 t -72.22 116.55 12.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.248 -0.907 . . . . 0.0 110.109 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.547 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -46.53 -33.61 4.2 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.87 -110.34 2.71 Favored Glycine 0 C--N 1.292 -1.909 0 N-CA-C 106.204 -2.758 . . . . 0.0 106.204 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.458 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 1.2 m -141.98 164.98 28.7 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.042 -1.269 . . . . 0.0 109.42 177.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 54.1 t -99.8 92.68 5.42 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.713 -1.242 . . . . 0.0 110.722 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 28' ' ' SER . 0.1 OUTLIER -109.27 135.0 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.292 -0.88 . . . . 0.0 110.402 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.91 33.79 20.78 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 122.067 0.937 . . . . 0.0 110.601 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.61 26.44 74.47 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.426 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 1.9 ttmm -141.52 143.65 33.89 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.173 -1.192 . . . . 0.0 111.075 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 5' ' ' SER . 23.9 t -77.22 111.38 12.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 109.195 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.433 ' C ' ' OG ' ' A' ' 5' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.268 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 2' ' ' CYS . 8.1 mtm180 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.27 0.557 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.62 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 29.3 p -41.66 148.09 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 110.422 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.78 135.97 21.91 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.0 110.378 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 5' ' ' SER . 47.3 Cg_endo -74.85 149.53 37.6 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.964 1.507 . . . . 0.0 110.021 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 2.9 m -39.62 161.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.372 -0.83 . . . . 0.0 110.315 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.54 13.84 59.22 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -125.55 162.33 25.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -1.151 . . . . 0.0 109.81 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.21 98.72 11.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.001 -1.062 . . . . 0.0 111.291 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.489 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 29.1 p -85.91 95.11 9.36 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.134 -0.978 . . . . 0.0 108.612 178.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -107.22 68.16 0.72 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.112 -0.993 . . . . 0.0 110.617 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 14' ' ' GLN . . . 158.7 65.4 0.01 OUTLIER Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.49 ' C ' ' O ' ' A' ' 11' ' ' GLY . 1.7 m -36.6 -33.41 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.785 -0.833 . . . . 0.0 109.896 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.9 t -88.46 42.73 1.09 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.448 -0.783 . . . . 0.0 109.103 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -91.46 154.87 18.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.507 -0.746 . . . . 0.0 110.121 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt -65.38 -35.88 82.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 108.865 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.674 ' O ' HG22 ' A' ' 16' ' ' ILE . 5.9 mm -125.17 82.93 61.37 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.34 178.7 6.67 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 124.128 1.594 . . . . 0.0 111.332 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 21' ' ' SER . 3.9 t -61.79 120.02 9.89 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.556 0.693 . . . . 0.0 110.551 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.62 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -43.96 -35.72 2.15 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.027 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.35 -107.04 0.89 Allowed Glycine 0 C--N 1.291 -1.97 0 N-CA-C 105.983 -2.847 . . . . 0.0 105.983 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.507 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.2 OUTLIER -142.56 170.59 15.43 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.014 -1.286 . . . . 0.0 110.055 177.382 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 46.6 t -108.39 94.59 5.14 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.994 -1.066 . . . . 0.0 110.13 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -121.76 138.75 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -0.932 . . . . 0.0 109.776 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 37.7 mtp180 61.31 34.51 18.48 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.152 0.977 . . . . 0.0 110.203 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.6 18.49 59.02 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 7' ' ' LYS . 2.5 ttpp -140.84 131.48 25.58 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.327 -1.102 . . . . 0.0 111.528 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 5' ' ' SER . 25.2 t -58.13 119.95 7.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.457 -0.777 . . . . 0.0 109.645 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--N 1.3 -1.58 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.14 -179.837 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.223 0.535 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.607 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 8.9 p -162.85 138.84 7.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 110.517 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 5.8 mt -59.76 123.73 72.9 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.594 -0.692 . . . . 0.0 109.809 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' A' ' 5' ' ' SER . 43.1 Cg_endo -70.55 125.92 12.25 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.811 1.427 . . . . 0.0 109.746 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 16.0 t -38.7 156.82 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.547 -0.721 . . . . 0.0 110.504 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.9 14.84 58.8 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.98 169.92 14.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.401 -1.058 . . . . 0.0 109.746 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.82 112.7 24.73 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.923 -1.11 . . . . 0.0 111.094 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.464 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 25.9 p -91.74 91.02 7.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.316 -0.865 . . . . 0.0 109.209 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -110.27 63.14 0.6 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.246 -0.909 . . . . 0.0 109.435 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 14' ' ' GLN . . . -172.62 66.37 0.12 Allowed Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 m -50.54 -32.57 10.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.937 -1.331 . . . . 0.0 109.411 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 14' ' ' GLN . 12.8 t -89.53 -21.18 23.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.509 -0.745 . . . . 0.0 110.476 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.549 ' NE2' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -37.15 158.1 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.563 -0.711 . . . . 0.0 110.124 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 17' ' ' PRO . 12.8 mttm -73.5 -35.64 65.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.008 -1.057 . . . . 0.0 110.34 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.436 ' N ' ' HG2' ' A' ' 14' ' ' GLN . 7.9 mt -99.93 103.06 19.84 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.48 -0.763 . . . . 0.0 110.273 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.549 ' HA ' ' NE2' ' A' ' 14' ' ' GLN . 48.3 Cg_endo -75.94 169.15 22.73 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.973 1.512 . . . . 0.0 110.697 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 21' ' ' SER . 3.0 t -68.56 116.65 9.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.87 . . . . 0.0 109.593 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.607 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -42.84 -33.23 0.73 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.72 -111.87 3.0 Favored Glycine 0 C--N 1.293 -1.817 0 N-CA-C 106.15 -2.78 . . . . 0.0 106.15 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.553 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -142.07 141.61 32.77 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.059 -1.259 . . . . 0.0 110.162 177.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.7 t -79.93 81.77 6.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.091 -1.006 . . . . 0.0 110.251 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 6.6 m -109.95 133.25 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.668 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 62.4 34.08 15.82 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.231 1.015 . . . . 0.0 109.722 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.29 24.46 67.42 Favored Glycine 0 C--N 1.291 -1.969 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -139.13 138.67 37.21 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.483 -1.01 . . . . 0.0 110.607 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 5' ' ' SER . 14.5 t -69.92 81.04 0.47 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.487 -0.758 . . . . 0.0 109.61 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.508 ' HG ' ' C ' ' A' ' 27' ' ' CYS . 58.4 p . . . . . 0 N--CA 1.489 1.521 0 O-C-N 120.913 -1.117 . . . . 0.0 110.174 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.534 ' O ' HG21 ' A' ' 16' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 120.76 0.314 . . . . 0.0 110.265 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.594 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 16.2 p 175.39 145.43 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.23 -0.919 . . . . 0.0 109.648 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.595 HD12 HE22 ' A' ' 14' ' ' GLN . 79.8 mt -86.44 122.69 71.95 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.068 -1.02 . . . . 0.0 110.985 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 5' ' ' SER . 44.6 Cg_endo -73.97 144.4 34.21 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.414 1.218 . . . . 0.0 110.945 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.63 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 2.2 m -39.28 153.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.532 -0.73 . . . . 0.0 110.641 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' A' ' 7' ' ' LYS . . . 90.87 24.85 26.46 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.119 -1.039 . . . . 0.0 110.535 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 34.0 mttt -159.27 148.31 18.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.084 -1.244 . . . . 0.0 110.373 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -44.3 125.97 4.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.97 . . . . 0.0 110.487 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.475 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 23.8 p -98.06 82.58 2.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.201 -0.937 . . . . 0.0 110.005 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.51 ' O ' ' CG ' ' A' ' 14' ' ' GLN . . . -91.37 60.55 4.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.048 -1.032 . . . . 0.0 109.974 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.511 ' HA2' ' HG2' ' A' ' 14' ' ' GLN . . . -87.68 -11.17 68.82 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -82.74 -5.32 8.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.3 -1.117 . . . . 0.0 110.1 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.16 -30.19 0.87 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 110.855 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.595 HE22 HD12 ' A' ' 3' ' ' LEU . 15.8 pt20 -81.65 179.88 7.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.017 -1.052 . . . . 0.0 110.278 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.79 -35.76 51.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.356 -0.84 . . . . 0.0 111.437 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.534 HG21 ' O ' ' A' ' 1' ' ' ARG . 7.8 mm -120.23 136.44 25.12 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.008 -1.057 . . . . 0.0 110.78 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.481 ' HA ' ' HA3' ' A' ' 11' ' ' GLY . 49.3 Cg_endo -77.0 -172.14 1.35 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.991 1.521 . . . . 0.0 110.696 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -79.35 127.96 32.74 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.99 0.9 . . . . 0.0 110.64 -179.067 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.594 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -46.35 -31.1 2.39 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.94 -112.99 2.36 Favored Glycine 0 C--N 1.294 -1.751 0 N-CA-C 105.544 -3.022 . . . . 0.0 105.544 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 14.4 m -143.05 162.24 36.04 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.098 -1.236 . . . . 0.0 109.387 177.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 48.9 t -101.7 115.67 31.04 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.941 -1.099 . . . . 0.0 109.836 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.609 HG21 ' CB ' ' A' ' 28' ' ' SER . 9.6 m -137.46 124.58 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.703 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.528 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 63.48 33.12 13.85 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.349 1.071 . . . . 0.0 109.818 -179.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.71 15.54 66.7 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.1 tptt -140.77 126.08 18.68 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.471 -1.017 . . . . 0.0 110.437 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.63 ' HB3' ' HA ' ' A' ' 5' ' ' SER . 0.7 OUTLIER -46.93 125.1 7.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.427 -0.795 . . . . 0.0 110.234 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.609 ' CB ' HG21 ' A' ' 23' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.057 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.523 ' C ' HG23 ' A' ' 16' ' ' ILE . 19.5 mmm180 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.235 0.54 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.624 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 30.3 p -148.63 144.44 27.19 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.325 -0.86 . . . . 0.0 110.37 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.644 ' HG ' HG22 ' A' ' 16' ' ' ILE . 19.7 mt -83.89 134.39 44.24 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.555 -0.715 . . . . 0.0 110.269 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.47 ' O ' ' C ' ' A' ' 5' ' ' SER . 47.9 Cg_endo -81.51 144.2 14.08 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.026 1.54 . . . . 0.0 109.787 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.492 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 4.6 t -38.73 151.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.391 -0.818 . . . . 0.0 110.216 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.49 ' HA2' ' HE2' ' A' ' 26' ' ' LYS . . . 90.52 15.7 56.46 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -122.08 172.21 8.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.392 -1.064 . . . . 0.0 109.778 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.77 155.26 18.37 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.017 -1.052 . . . . 0.0 110.477 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.424 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 27.1 p -160.72 73.02 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.575 -0.703 . . . . 0.0 109.287 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.28 72.17 0.89 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.323 -0.861 . . . . 0.0 110.484 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 12' ' ' VAL . . . -167.01 -48.3 0.02 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.562 ' CB ' ' O ' ' A' ' 11' ' ' GLY . 0.4 OUTLIER 81.49 -30.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.905 -0.762 . . . . 0.0 110.454 -179.713 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 13' ' ' THR . 4.0 t -90.88 -13.6 33.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.111 -0.993 . . . . 0.0 109.732 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 13' ' ' THR . 15.9 pt20 -41.34 160.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.484 -0.76 . . . . 0.0 109.602 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -79.54 -19.38 49.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.946 -1.096 . . . . 0.0 110.562 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.644 HG22 ' HG ' ' A' ' 3' ' ' LEU . 71.2 mt -119.97 102.39 46.63 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 110.604 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.79 166.78 26.46 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.228 1.646 . . . . 0.0 110.203 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 19' ' ' CYS . 6.0 t -65.14 120.87 13.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.079 -1.013 . . . . 0.0 109.989 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.624 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -43.91 -30.72 0.73 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.162 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.427 ' N ' ' C ' ' A' ' 18' ' ' CYS . . . -108.74 -106.17 3.03 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.519 ' O ' ' HB2' ' A' ' 28' ' ' SER . 58.3 m -142.08 136.46 30.16 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.072 -1.252 . . . . 0.0 109.378 177.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.424 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 3.8 t -78.88 126.06 30.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.092 -1.005 . . . . 0.0 111.145 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.419 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -137.89 138.11 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.511 -0.743 . . . . 0.0 109.485 179.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.419 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 5.6 ttt180 60.77 33.38 20.11 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.999 0.904 . . . . 0.0 110.794 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.25 6.57 47.96 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.49 ' HE2' ' HA2' ' A' ' 6' ' ' GLY . 5.8 tptt -129.59 124.91 34.94 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.262 -1.14 . . . . 0.0 111.236 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.492 ' HB3' ' HA ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -42.53 124.41 2.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.568 -0.707 . . . . 0.0 109.574 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 21' ' ' SER . 39.0 t . . . . . 0 C--N 1.299 -1.614 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.186 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.609 ' HB2' HD12 ' A' ' 16' ' ' ILE . 53.2 mtm180 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.252 0.548 . . . . 0.0 110.324 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.541 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 17.0 p -158.87 150.34 20.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.364 -0.835 . . . . 0.0 110.139 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.51 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 81.1 mt -113.84 101.1 53.53 Favored Pre-proline 0 N--CA 1.493 1.704 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.013 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 48.2 Cg_endo -97.7 16.86 0.58 Allowed 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 121.629 1.552 . . . . 0.0 109.464 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 t -93.55 11.4 28.83 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.366 -0.833 . . . . 0.0 112.435 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 26' ' ' LYS . . . 67.91 20.99 73.08 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -59.63 144.9 46.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.499 -1.0 . . . . 0.0 109.521 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 25' ' ' GLY . . . -59.7 103.23 0.19 Allowed 'General case' 0 C--N 1.29 -1.985 0 O-C-N 120.582 -1.324 . . . . 0.0 110.144 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 25.4 p -86.99 88.28 7.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.575 -0.703 . . . . 0.0 110.278 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.66 64.0 0.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.981 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 12' ' ' VAL . . . 176.69 68.14 0.06 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 11' ' ' GLY . 24.3 t -40.28 -30.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.429 -1.042 . . . . 0.0 110.368 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 13' ' ' THR . 6.6 t -88.29 38.01 0.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.947 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -89.75 146.25 24.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 110.123 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.503 ' HG3' HG12 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -68.97 -24.42 64.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.115 -0.991 . . . . 0.0 109.578 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.609 HD12 ' HB2' ' A' ' 1' ' ' ARG . 12.4 mm -110.67 99.64 42.43 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.35 -0.844 . . . . 0.0 109.844 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.514 ' O ' ' HA ' ' A' ' 2' ' ' CYS . 44.4 Cg_endo -72.04 167.06 27.78 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.125 1.592 . . . . 0.0 111.188 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.1 t -76.4 127.93 33.83 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.535 -0.728 . . . . 0.0 110.816 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.541 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -57.96 -29.13 64.95 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.42 -113.57 3.81 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 106.357 -2.697 . . . . 0.0 106.357 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.4 t -142.61 157.75 44.37 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.87 -1.371 . . . . 0.0 110.691 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.6 t -83.44 91.73 7.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.834 . . . . 0.0 109.849 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -124.15 131.29 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.21 -0.931 . . . . 0.0 111.566 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 1.9 mmp_? 63.23 34.71 13.15 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 122.072 0.939 . . . . 0.0 110.229 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 8' ' ' ALA . . . 62.58 21.47 62.71 Favored Glycine 0 C--N 1.288 -2.1 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 6' ' ' GLY . 12.7 ttmt -129.09 138.17 51.68 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.723 -0.869 . . . . 0.0 110.038 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -75.0 78.52 2.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.423 -0.798 . . . . 0.0 110.474 -179.248 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 27' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.953 -1.023 . . . . 0.0 110.232 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.64 ' N ' HD13 ' A' ' 16' ' ' ILE . 3.2 mtt85 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.601 ' O ' ' O ' ' A' ' 1' ' ' ARG . 13.4 p 46.14 140.7 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 CA-C-O 122.632 1.206 . . . . 0.0 112.521 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.482 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 94.7 mt -90.78 139.2 26.14 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.051 -1.031 . . . . 0.0 110.941 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -80.66 142.85 14.61 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.878 1.462 . . . . 0.0 110.342 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.524 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 40.8 t -43.65 151.24 0.2 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.283 -0.885 . . . . 0.0 110.431 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.76 27.93 20.34 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.03 -175.5 4.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -1.117 . . . . 0.0 109.694 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.39 111.01 22.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.414 -0.804 . . . . 0.0 109.223 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 26' ' ' LYS . 27.4 p -91.18 84.47 5.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -0.925 . . . . 0.0 111.078 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.533 ' O ' ' CG ' ' A' ' 14' ' ' GLN . . . -88.77 55.65 3.45 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.627 -1.295 . . . . 0.0 109.338 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 17' ' ' PRO . . . -76.88 2.88 58.63 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.45 -22.41 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.185 -1.185 . . . . 0.0 109.908 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.6 t -142.75 3.23 1.43 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.288 -0.882 . . . . 0.0 111.053 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.533 ' CG ' ' O ' ' A' ' 10' ' ' ALA . 12.7 pt20 -99.92 -166.87 1.38 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.882 -1.136 . . . . 0.0 110.714 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.494 ' N ' ' HG3' ' A' ' 14' ' ' GLN . 7.6 ttpt -77.17 -49.26 15.58 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.696 -0.627 . . . . 0.0 111.024 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.64 HD13 ' N ' ' A' ' 1' ' ' ARG . 5.6 mt -133.58 140.8 37.96 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.267 -0.895 . . . . 0.0 111.078 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.48 ' HB3' ' HA3' ' A' ' 11' ' ' GLY . 47.4 Cg_endo -78.28 -165.78 0.36 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 124.313 1.691 . . . . 0.0 112.17 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 22' ' ' CYS . 20.2 t -68.9 122.31 18.38 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.737 0.78 . . . . 0.0 111.472 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.489 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -46.14 -35.71 5.27 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.1 -103.55 1.6 Allowed Glycine 0 C--N 1.295 -1.717 0 N-CA-C 106.768 -2.533 . . . . 0.0 106.768 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.1 p -142.23 122.96 14.28 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.268 -1.136 . . . . 0.0 109.007 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 26.2 t -77.98 121.12 23.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.075 -1.015 . . . . 0.0 111.353 -178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.47 134.95 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.804 0.811 . . . . 0.0 109.947 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 58.3 34.1 23.75 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.996 0.903 . . . . 0.0 110.439 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.38 26.12 70.44 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.512 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 11.7 tttp -139.18 123.05 17.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.603 -0.94 . . . . 0.0 110.219 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 5' ' ' SER . 0.5 OUTLIER -52.9 107.17 0.2 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.4 -0.812 . . . . 0.0 109.956 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.43 ' HB3' ' OG ' ' A' ' 5' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.397 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.242 0.544 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.585 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 20.4 p -136.29 144.32 44.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.119 -0.988 . . . . 0.0 110.392 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.461 ' HG ' HG22 ' A' ' 16' ' ' ILE . 25.3 mt -86.22 141.58 35.08 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.481 -0.762 . . . . 0.0 110.644 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 5' ' ' SER . 46.8 Cg_endo -74.41 125.96 10.01 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.068 1.562 . . . . 0.0 109.638 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -39.46 158.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.453 -0.78 . . . . 0.0 110.757 -179.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 7' ' ' LYS . . . 90.24 25.03 27.47 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 6' ' ' GLY . 4.6 mmtt -151.69 153.7 34.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -1.102 . . . . 0.0 110.288 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.0 143.5 34.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.089 -1.007 . . . . 0.0 110.492 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -123.59 -91.06 0.56 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.702 0.763 . . . . 0.0 109.811 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.563 ' HB3' HE21 ' A' ' 14' ' ' GLN . . . -162.27 -135.42 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.245 1.022 . . . . 0.0 108.443 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.486 ' C ' HG23 ' A' ' 12' ' ' VAL . . . -102.99 -73.39 0.96 Allowed Glycine 0 C--N 1.273 -2.935 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.486 HG23 ' C ' ' A' ' 11' ' ' GLY . 5.2 t -149.98 -39.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.383 -1.069 . . . . 0.0 110.058 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 13' ' ' THR . 8.9 t -103.05 83.36 2.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.314 -0.866 . . . . 0.0 110.143 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.563 HE21 ' HB3' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -118.16 174.73 6.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.887 . . . . 0.0 110.053 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.518 ' HG2' ' N ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -67.01 -26.38 66.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.645 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.518 ' N ' ' HG2' ' A' ' 15' ' ' LYS . 87.3 mt -141.02 107.56 6.28 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.452 -0.78 . . . . 0.0 109.683 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 16' ' ' ILE . 45.1 Cg_endo -71.59 157.36 56.14 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.944 1.497 . . . . 0.0 111.349 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.539 ' SG ' ' N ' ' A' ' 21' ' ' SER . 4.5 t -69.07 119.97 14.19 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.83 0.824 . . . . 0.0 109.878 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.585 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -45.52 -33.29 2.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.35 -104.88 2.02 Favored Glycine 0 C--N 1.293 -1.831 0 N-CA-C 106.149 -2.78 . . . . 0.0 106.149 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.539 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 1.7 p -141.68 116.97 10.11 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.132 -1.216 . . . . 0.0 109.547 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.536 ' N ' ' HB3' ' A' ' 18' ' ' CYS . 41.1 t -78.87 82.01 5.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 110.295 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.453 ' CG2' ' OG ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -106.72 143.68 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.454 -0.778 . . . . 0.0 109.851 179.725 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER 59.96 37.38 21.44 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.114 0.959 . . . . 0.0 109.879 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 10' ' ' ALA . . . 61.04 26.13 65.26 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -140.21 140.24 35.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.48 -1.012 . . . . 0.0 111.203 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 5' ' ' SER . 36.9 t -83.29 89.43 7.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.56 -0.713 . . . . 0.0 109.337 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.313 -179.456 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.48 ' O ' HD12 ' A' ' 16' ' ' ILE . 50.7 mtt-85 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.162 0.506 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.659 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 4.8 p 174.32 138.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.292 -0.88 . . . . 0.0 110.168 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.805 HD13 ' HA ' ' A' ' 9' ' ' CYS . 2.9 mt -61.37 119.0 42.48 Favored Pre-proline 0 C--N 1.303 -1.453 0 C-N-CA 119.659 -0.817 . . . . 0.0 109.513 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 5' ' ' SER . 41.3 Cg_endo -68.22 125.96 13.68 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.951 1.5 . . . . 0.0 109.977 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 72.1 m -38.49 152.93 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.682 -0.637 . . . . 0.0 110.296 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.94 18.97 49.1 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 8' ' ' ALA . 10.8 mttt -154.89 148.44 25.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.395 -1.062 . . . . 0.0 110.147 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -42.03 160.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.883 . . . . 0.0 110.541 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.805 ' HA ' HD13 ' A' ' 3' ' ' LEU . 4.8 p -147.37 68.64 1.14 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.49 -0.756 . . . . 0.0 110.231 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.01 59.07 5.41 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.149 -0.969 . . . . 0.0 109.789 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.569 ' HA2' ' CD ' ' A' ' 14' ' ' GLN . . . -85.41 -6.84 83.33 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 12' ' ' VAL . 6.2 t -54.85 -20.3 5.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.093 -1.24 . . . . 0.0 108.562 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.6 t -123.99 -12.51 7.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.622 -0.674 . . . . 0.0 109.663 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.591 ' HG2' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -97.48 164.37 12.47 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.271 -0.893 . . . . 0.0 109.33 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.591 ' N ' ' HG2' ' A' ' 14' ' ' GLN . 4.7 mmtt -82.65 -35.64 26.74 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.933 -1.104 . . . . 0.0 112.386 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.593 ' CG2' ' HA ' ' A' ' 2' ' ' CYS . 9.6 mm -101.54 95.97 5.77 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.917 -1.114 . . . . 0.0 110.994 -178.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 46.8 Cg_endo -70.09 -176.01 1.43 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 124.15 1.605 . . . . 0.0 112.394 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -63.08 119.85 10.3 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.994 0.902 . . . . 0.0 110.504 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.659 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -42.35 -34.45 0.81 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 122.553 1.168 . . . . 0.0 107.993 179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.36 -112.14 2.59 Favored Glycine 0 C--N 1.288 -2.126 0 N-CA-C 105.976 -2.85 . . . . 0.0 105.976 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.533 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.2 OUTLIER -141.79 133.08 26.45 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 121.24 -1.153 . . . . 0.0 109.126 177.053 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 47.1 t -78.84 119.91 22.71 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.098 -1.001 . . . . 0.0 110.208 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.544 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 2.4 t -140.95 160.93 23.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER 36.93 30.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.855 0.836 . . . . 0.0 111.836 -179.488 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 23' ' ' VAL . . . 87.11 -24.29 9.54 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.062 177.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.04 147.33 36.22 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.49 -1.594 . . . . 0.0 112.686 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 5' ' ' SER . 43.1 t -66.98 103.49 1.16 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.544 0.687 . . . . 0.0 109.69 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.137 -179.677 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.469 ' O ' ' C ' ' A' ' 2' ' ' CYS . 17.0 mmt180 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.013 0.435 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.601 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 32.1 p -35.45 147.78 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.534 -0.729 . . . . 0.0 111.07 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 3' ' ' LEU . 23.4 mt -80.26 123.42 83.18 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.501 -0.75 . . . . 0.0 110.822 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.484 ' O ' ' O ' ' A' ' 5' ' ' SER . 51.0 Cg_endo -75.82 143.89 27.06 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.95 1.5 . . . . 0.0 110.034 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.561 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 7.1 t -39.71 164.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.504 -0.747 . . . . 0.0 110.862 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.12 13.53 58.77 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.573 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 2.6 mptt -147.68 158.95 44.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.98 -1.306 . . . . 0.0 109.669 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -47.57 169.09 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.286 -1.509 . . . . 0.0 109.757 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.569 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 5.4 p -135.15 64.5 1.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 111.635 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.49 ' C ' ' NE2' ' A' ' 14' ' ' GLN . . . -86.55 59.12 5.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.059 -1.026 . . . . 0.0 109.152 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.866 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -69.43 84.3 0.26 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 11' ' ' GLY . 0.9 OUTLIER 174.12 -33.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.719 -0.871 . . . . 0.0 108.681 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 t -126.24 -26.35 3.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.573 -0.704 . . . . 0.0 109.954 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.64 ' OE1' ' HA ' ' A' ' 17' ' ' PRO . 3.3 pt20 -56.89 173.87 0.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 0.0 109.994 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.62 -39.03 81.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.896 . . . . 0.0 109.696 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 2' ' ' CYS . 32.3 mt -134.34 143.69 48.0 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.576 -0.702 . . . . 0.0 109.699 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.64 ' HA ' ' OE1' ' A' ' 14' ' ' GLN . 47.3 Cg_endo -73.59 152.15 47.98 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.146 1.603 . . . . 0.0 111.983 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 19' ' ' CYS . 23.1 t -55.96 117.88 4.11 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.422 -0.799 . . . . 0.0 110.073 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.601 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -41.19 -32.7 0.29 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.568 1.175 . . . . 0.0 107.865 179.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 18' ' ' CYS . . . -106.62 -114.13 3.87 Favored Glycine 0 C--N 1.289 -2.072 0 N-CA-C 106.189 -2.764 . . . . 0.0 106.189 177.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 m -142.55 -179.12 6.11 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.108 -1.231 . . . . 0.0 109.613 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.569 ' HA ' ' CB ' ' A' ' 9' ' ' CYS . 53.7 t -96.65 88.52 4.67 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.059 -1.025 . . . . 0.0 110.071 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -113.12 143.42 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.503 -0.748 . . . . 0.0 109.466 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 0.0 OUTLIER 60.79 36.36 19.24 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 122.102 0.953 . . . . 0.0 109.987 -179.448 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.85 20.46 48.26 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -141.47 176.71 8.66 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.675 -0.897 . . . . 0.0 111.339 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -86.02 119.7 26.61 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.515 ' HB3' ' CB ' ' A' ' 5' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.294 -1.83 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.208 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.219 0.533 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.568 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 21.3 p -174.34 146.97 1.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.878 . . . . 0.0 110.682 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.497 ' O ' ' HB2' ' A' ' 19' ' ' CYS . 39.1 mt -81.52 139.62 47.85 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.477 -0.764 . . . . 0.0 110.443 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.514 ' O ' ' O ' ' A' ' 5' ' ' SER . 47.3 Cg_endo -74.63 117.12 4.83 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.03 1.542 . . . . 0.0 110.191 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.54 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 27.4 p -40.88 168.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.39 -0.819 . . . . 0.0 110.959 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.21 3.88 69.27 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -149.23 154.22 38.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -1.139 . . . . 0.0 109.978 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.15 155.34 37.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.259 -0.901 . . . . 0.0 109.974 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.465 ' HA ' HD13 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -115.67 -85.98 0.61 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.671 0.748 . . . . 0.0 109.447 179.501 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -162.08 -137.69 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 122.432 1.11 . . . . 0.0 108.67 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.918 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -106.63 -67.99 0.68 Allowed Glycine 0 C--N 1.272 -2.976 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 11' ' ' GLY . 2.3 t -168.7 -33.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.466 -1.02 . . . . 0.0 110.132 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.9 t -84.91 19.14 2.19 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.188 -0.945 . . . . 0.0 111.413 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -67.81 146.13 54.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.796 -1.19 . . . . 0.0 109.853 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 ptpt -67.53 -27.74 67.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.049 -1.032 . . . . 0.0 109.353 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.0 mt -117.26 106.18 47.48 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.52 -0.738 . . . . 0.0 109.48 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.32 158.94 53.2 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.995 1.524 . . . . 0.0 110.682 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 21' ' ' SER . 11.0 t -64.04 121.3 13.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.445 -0.784 . . . . 0.0 110.134 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.568 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.3 OUTLIER -47.04 -34.35 5.67 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 179.222 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.92 -108.99 2.41 Favored Glycine 0 N--CA 1.482 1.766 0 N-CA-C 106.308 -2.717 . . . . 0.0 106.308 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.537 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 23.9 p -141.73 129.59 21.78 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.011 -1.288 . . . . 0.0 109.781 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 7.5 t -78.61 78.94 5.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 109.677 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.442 HG22 ' OG ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -113.11 138.51 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.342 -0.849 . . . . 0.0 111.156 -179.384 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 59.81 35.99 22.03 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.047 0.927 . . . . 0.0 110.247 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.43 27.09 71.24 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -133.24 152.8 51.94 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.645 -0.915 . . . . 0.0 110.084 -179.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.54 ' HB3' ' HA ' ' A' ' 5' ' ' SER . 46.2 t -91.0 62.48 4.91 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.995 -1.066 . . . . 0.0 110.417 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.231 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 13.2 mmt180 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.204 0.526 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.627 ' HB2' ' CA ' ' A' ' 19' ' ' CYS . 31.6 p -177.53 145.22 0.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.407 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.623 ' HG ' HG22 ' A' ' 16' ' ' ILE . 12.5 mt -107.97 144.2 28.89 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.393 -0.817 . . . . 0.0 110.305 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 5' ' ' SER . 48.0 Cg_endo -73.45 158.45 47.96 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 O-C-N 124.201 1.632 . . . . 0.0 109.776 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 60.7 p -42.6 169.28 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.929 . . . . 0.0 110.831 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.92 4.72 69.01 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -145.3 141.59 28.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.887 -1.361 . . . . 0.0 110.565 179.493 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -39.19 145.05 0.11 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.432 0.634 . . . . 0.0 110.708 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.471 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 9.0 p -119.91 59.9 0.87 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.558 -0.714 . . . . 0.0 109.865 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.98 ' HB1' ' CG2' ' A' ' 13' ' ' THR . . . -86.91 59.99 5.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.14 -0.975 . . . . 0.0 109.885 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.506 ' HA2' ' HG2' ' A' ' 14' ' ' GLN . . . -57.27 -45.38 92.8 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.462 ' H ' HG22 ' A' ' 12' ' ' VAL . 3.3 m -59.59 -32.82 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.445 -1.033 . . . . 0.0 110.843 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.98 ' CG2' ' HB1' ' A' ' 10' ' ' ALA . 3.5 t -116.38 29.76 7.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.13 -0.981 . . . . 0.0 111.288 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.506 ' HG2' ' HA2' ' A' ' 11' ' ' GLY . 5.4 pt20 -152.54 176.07 12.09 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.876 -1.14 . . . . 0.0 110.222 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.479 ' HG3' HG13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -88.8 -34.47 17.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.891 . . . . 0.0 111.374 -179.039 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.623 HG22 ' HG ' ' A' ' 3' ' ' LEU . 50.5 mt -115.7 111.31 43.67 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.886 -1.134 . . . . 0.0 110.944 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.71 -179.26 5.01 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.896 1.472 . . . . 0.0 110.623 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.6 t -75.24 117.52 17.15 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.635 0.731 . . . . 0.0 110.171 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.627 ' CA ' ' HB2' ' A' ' 2' ' ' CYS . 0.5 OUTLIER -48.65 -34.5 11.91 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.271 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.31 -111.15 0.82 Allowed Glycine 0 C--N 1.294 -1.789 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -142.26 148.52 38.22 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 120.915 -1.344 . . . . 0.0 109.724 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 53.2 t -78.84 122.09 25.63 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.999 -1.063 . . . . 0.0 110.09 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.727 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -140.0 -176.62 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.622 0 O-C-N 121.424 -0.798 . . . . 0.0 108.94 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.684 ' N ' HG13 ' A' ' 23' ' ' VAL . 0.0 OUTLIER 10.28 44.58 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.727 ' N ' ' O ' ' A' ' 23' ' ' VAL . . . 73.17 -10.82 5.51 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.235 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 23' ' ' VAL . 3.2 tttp -129.27 150.69 50.53 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 120.413 -1.64 . . . . 0.0 110.791 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 5' ' ' SER . 7.6 t -63.39 137.06 58.03 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.76 0.791 . . . . 0.0 109.725 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 5' ' ' SER . 3.3 p . . . . . 0 C--N 1.296 -1.733 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.317 -179.515 . . . . . . . . 1 1 . 1 stop_ save_